Method development for the investigation of freeze/thaw stress-induced protein instability by Wöll, Anna Katharina
METHOD DEVELOPMENT FOR THE
INVESTIGATION OF FREEZE/THAW
STRESS–INDUCED PROTEIN
INSTABILITY
zur Erlangung des akademischen Grades eines
DOKTORS DER INGENIEURWISSENSCHAFTEN (Dr.-Ing.)
von der KIT-Fakultät für Chemieingenieurwesen und Verfahrenstechnik des
Karlsruher Instituts für Technologie (KIT)
genehmigte
DISSERTATION
von
M.Sc. Anna Katharina Wöll
aus Heidelberg
Referent: Prof. Dr. Jürgen Hubbuch
Korreferent: Prof. Dr.-Ing. Michael Türk
Tag der mündlichen Prüfung: 06.03.2020

Danksagung
Diese Arbeit ist mit tatkräftiger, fachlicher und emotionaler Unterstützung von verschiede-
nen Personen angefertigt worden, welche im Folgenden erwähnt werden:
Zunächst möchte ich meinem Doktorvater Prof. Dr. Jürgen Hubbuch danken, die
Möglichkeit bekommen zu haben meine Dissertation in seiner Arbeitsgruppe und La-
boren anfertigen zu dürfen. Vielen Dank für die spannenden fachlichen Diskussionen, den
Freiraum den du mir gegeben hast und dein Vertrauen.
Für die freundliche Übernahme des Korreferats und das Interesse an meiner Arbeit möchte
ich Prof. Dr.-Ing. Michael Türk danken.
Vielen Dank auch an alle meine Kollegen für die tolle Zeit am Institut, die spannenden
und hilfreichen Diskussionen, die zahlreichen Partys und Freizeitaktivitäten.
Ganz besonderen Dank an Juliane Schütz, die mich mit der Bachelorarbeit ans Institut
geholt hat und in den ganzen Jahren unterstützend zur Seite stand und den Einstieg in die
Promotion erleichtert hat.
Herzlichen Dank auch an meine Studenten Angela Valentic, Jana Zabel, Monika Desom-
bre, Lena Enghauser und Rafaela Meutelet für die fleißige Unterstützung im Labor, den
interessanten Diskussionen und den unterhaltsamen Pausen.
Danke auch an meine Bürokollegen Marieke Klijn, Juliane Schütz, Nils Hillebrandt, Dennis
Weber und Angela Valentic für die angenehme Arbeitsatmosphäre, die unterhaltsame
Unterbrechungen und das Ertragen des niedrigen Sauerstoffsgehaltes dank meiner Käl-
teempfindlichkeit.
Susanna Suhm vielen Dank für die sehr unterhaltsame gemeinsame Zeit im Labor und die
zahlreichen lustigen Pausen.
Lukas Wenger danke für das Aufmuntern und gut zureden, wenn etwas schief gelaufen ist,
das Weiterhelfen und Erklären.
Danke auch an meine Freunde, ganz besonders meiner Studiums Clique mit Eva, Lukas,
Christian, Ursula und Marina sowie der ganzen CIWler Clique für viele unvergesslichen
Unternehmungen, Kochabende, Spielabende, Partys und gemeinsame Urlaube. Ohne
euch wäre das Studium und die Promotion mindestens doppelt so herausfordernd und
anstrengend und nicht mal annähernd so lustig gewesen.
Ganz besonders hervorheben möchte ich dabei Eva Conraths. Danke für die stundenlangen
Telefonate und die motivierenden Worte. Du warst und bist eine sehr große Unterstützung
iii
für mich!
Danke an meine Familie für die Unterstützung und den Rückhalt, ganz besonders meiner
Mutter die immer wieder aufbauenden Worte gefunden hat. Auch meiner Bremer Familie
möchte ich vom Herzen für den Zuspruch und die Ablenkung danken.
Zuletzt möchte ich meinem Freund Leonard Westkamp für den bedingungslosen Rückhalt,
stundenlanges Zuhören und Motivieren, von ganzem Herzen danken. Du hast mehr an
mich geglaubt, als ich es selber getan habe und mich oft daran erinnert, dass es wichtigere
Dinge als die Doktorarbeit im Leben gibt. Ich bin sehr dankbar dich an meiner Seite zu
haben und freue mich sehr auf unseren neuen Lebensabschnitt.
"Mögen sich alle deine Wünsche erfüllen...,außer einem, sodass du immer etwas hast,
wofür du ringen, wonach du streben kannst."
Irischer Segenswunsch
iv
Zusammenfassung
Das allgemeine Ziel dieser Arbeit ist die Entwicklung einer einfachen, zeitsparenden
Hochdurchsatz (high-throughput, HT) Methode zur Untersuchung des Einflusses von Einfrier-
/Auftau- (freeze/thaw, FT) Stress auf die Langzeitstabilität von rekombinanten Proteinen.
Rekombinante Proteine sind biologische Makromoleküle, die über eine hochspezialisierte
Funktionalität verfügen und deren Langzeitstabilität eine entscheidende Rolle bei der
biotechnologischen Produkt- und Prozessentwicklung spielt. Während des Produktion-
sprozesses (USP and DSP) von rekombinanten Proteinen sind ein oder mehrere FT–Schritte
zur Lagerung, beim Transport oder zur Zwischenlagerung aufgrund von Engpässen bei der
Aufreinigung notwenig. Innerhalb des FT–Schrittes sollen die Proteinstabilität garantiert,
sowie die Haltbarkeit der Proteine erhöht werden. Im Allgemeinen muss die Proteinstabilität
sowohl bei der Produktion und Aufreinigung, als auch beim Einfrieren/Auftauen, gewährleis-
tet werden. Die Proteinstabilität, einschließlich Konformation– und Kolloidstabilität, ist
sehr empfindlich gegenüber Umweltveränderungen wie Temperatur, Art und Konzentration
von gelösten Stoffen, sowie der pH–Wert. Geht die Proteinstabilität verloren, führt dies
auch zum Verlust der Funktionalität. Das ist problematisch im Bezug auf die Wirkung aber
auch der Sicherheit. Die Empfindlichkeit der Proteinstabilität gegenüber Umgebungsbedin-
gungen ist besonders am Ende der Aufreinigung problematisch, wenn die rekombinanten
Proteine formuliert werden. Dabei muss eine Langzeitstabilität des Proteins von mindestens
18–24 Monaten gewährleistet sein. Im Rahmen der Formulierungsentwicklung muss die
Proteinstabilität im Laufe der Zeit als Funktion verschiedener umweltbedingter Faktoren
untersucht werden. Dies ist sehr komplex, da alle Faktoren sich untereinander beeinflussen.
Insbesondere beim Einfrieren und Auftauen haben neben Formulierungsparametern (pH–
Wert, Additive und Puffersysteme), auch Prozessparameter (FT–Rampe, Probenvolumen,
Lagerzeit und Temperatur) einen Einfluss auf die Proteinstabilität. Darüber hinaus wer-
den Systemparameter wie die Glasübergangstemperatur (glass transition point, Tg) oder
der Trübungspunkt (cloud point, Tcloud) durch die Formulierungs– und Prozessparameter
beeinflusst und haben wiederum auch einen Einfluss auf die Proteinstabilität. Daher ist es
wichtig, ein Gesamtverständnis über die Beziehung all dieser Parameter und ihren Einfluss
auf die langfristige Proteinstabilität zu generieren, um ein hohes Maß an Proteinstabilität
nach einem oder mehreren FT–Schritten zu gewährleisten. Zur Charakterisierung der
Proteinstabilität können verschiedene Analytikmethoden verwendet werden. Beispielsweise
werden Größenmessungen mittels Größenausslusschromatographie (size exclusion chro-
matography, SEC), Strukturmessungen mittels Fourier–Transform–Infrarotspektrometer
(Fourier–transform infrared spectroscopy, FTIR) oder Aktivitätsmessungen mit Hilfe von
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Aktivitätsassays durchgeführt. Diese Methoden sind zeitaufwändig, teuer und die Kor-
relation der Daten ist komplex und nicht immer offensichtlich. Um den Einfluss der
Formulierungsparameter auf die Langzeitstabilität von Proteinen zu untersuchen werden
zum Beispiel Phasendiagramme verwendet. Ein großer Vorteil dabei ist die hohe Flexibilität
und Freiheit bei der Erstellung der Phasendiagramme. Vor diesem Hintergrund wurde
im ersten Schritt dieser Arbeit die Entwicklung einer phasendiagrammbasierten Methode
angestrebt, um die Möglichkeit eines einfachen, zeitsparenden HT–Screenings verschiedener
Formulierungs- und Prozessparameter, sowie die Erkennung von Systemparametern zu er-
möglichen. Bei der Erstellung der Phasendiagramme mittels eines Pipettierroboters wurden
die Protein- und Salzkonzentration variiert und der Einfluss des Phasenverhaltens in Ab-
hängigkeit von verschiedenen Formulierungsparametern (Puffersysteme, Pufferkapazitäten,
pH–Wert, Ionenstärke) untersucht. Es wurden Phasendiagramme mit dem Modellprotein
Lysozym aus Hühnereiweiß und dem Fällungsmittel Natriumchlorid erstellt. Um die FT
Stress–induzierten Instabilitäten zu bewerten, wurden nach 40-tägiger Lagerung bei 20℃ in
einer Inkubationskammer Veränderungen im Phasenverhalten, in der Kristallmorphologie
und in der Proteinlöslichkeit als sensitive Parameter identifiziert. Das Phasenverhalten
und die Kristallmorphologie wurden visuell bewertet und die Proteinlöslichkeit anhand der
Proteinkonzentration, gemessen mittels UV-Vis-Spektroskopie, im Überstand berechnet.
Im ersten Schritt konzentriert sich diese Studie zunächst auf den Einfluss verschiedener
Formulierungsparameter als Funktion der FT Zyklenanzahl. Dabei wurden die Platten in
einem Gefrierschrank auf -80℃ gefroren und bei 20℃ aufgetaut. Die Ergebnisse zeigten
einen Einfluss von FT Stress auf alle Parameter (Phasenverhalten, Kristallmorphologie
und Proteinlöslichkeit), während dieser Einfluss durch die Erhöhung der Zyklenanzahl,
unabhängig vom verwendeten pH–Wert oder Puffersystem, zunahm. Die Erhöhung der
Zyklenanzahl führte zu kleineren Bereichen in denen das Protein stabil/löslich blieb, zu
kleineren und komplexer strukturierten Kristallen und zu niedrigeren Proteinlöslichkeiten,
was ingesamt eine erhöhte Instabilität repräsentierte. Diese Trends wurden immer so
bewertet, dass sie mehr Instabilitäten repräsentieren. Die Wirkung von FT Stress wurde
in Abhängigkeit der Pufferkomponente und dem pH–Wert ermittelt. Wurden die Proteine
bereits durch den pH–Wert destabilisiert (z.B. pH3), so wurde eine geringerer Einfluss
vom FT Stress beobachtet, als bei den Proteinen bei denen eine Destabilisierung durch den
pH–Wert selbst nicht angenommen wurde (z.B. pH5). Formulierungen mit Pufferkompo-
nenten, von denen bekannt ist, dass sie mit dem Protein interagieren, zeigten ein höheres
Maß an FT Stress–induzierten Instabilitäten.
Die beobachteten Möglichkeiten den Einfluss verschiedener Formulierungsparameter beim
Einfrieren und Auftauen zu bewerten konnte durch die Anwendung der entwickelten Meth-
ode mittels Variation der Prozessparameter bestätigt werden. Dafür wurden verschiedene
Einfrier- und Auftaurampen getestet, wobei jeweils eine Rampe konstant gehalten wurde
um die Einfrier– und Auftaueinflüsse voneinander zu trennen. Zudem wurde der Ein-
fluss des Systemparameters Tg, durch Änderung der Geschwindigkeit beim Einfrieren bei
verschiedenen Temperaturen, untersucht. Dabei wurde nach der Erstellung der Phasen-
diagramme das entsprechende FT Protokoll durchgeführt. Hierfür wurden die Platten
auf eine Kühlapparatur gelegt und das jeweilige FT Protokoll angepasst. Anschließend
wurden die Platten in einer Inkubationskammer für 40Tage bei 20℃ gelagert. Die für
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die Proteinstabilität relevanten Parameter, Phasenverhalten, Kristallmorphologie und
Proteinlöslichkeit, wurden anschließend verwendet um den Einfluss der verschiedenen
getesteten Rampen zu bewerten. Der Einfluss von Einfrierrampen auf die Proteinstabilität
war ausgeprägter als von Auftaurampen, wobei schnellere Rampen weniger stressbed-
ingte Instabilitäten hervorriefen. Dementsprechend wurde davon ausgegangen, dass die
Gefrierkonzentration, und nicht die Bildung der Wasser-Eis-Grenzfläche, das Hauptprob-
lem beim Einfrieren von Lysozyme ist. Darüber hinaus war die Gesamtzeit, in der das
Protein kalten Temperaturen ausgesetzt war, bzw. die Lösung nicht Tg überschritten hatte,
kritisch. Je später die Temperatur der Einfriergeschwindigkeit von schnell auf langsam
geändert wurde, desto weniger Proteininstabilitäten wurden durch das Einfrieren/Auftauen
verursacht.
Um noch mehr Erkenntnisse über den Einfrier- und Auftauprozess bei Verwendung der
entwickelten Methode zu erhalten, wurde der Aufbau durch eine Kamera erweitert. Die
Platten wurden beim Einfrieren und Auftauen gefilmt um den Prozessparameter Tcloud
zu bestimmen. Ausgenutzt wurde dabei der Effekt, dass bei Tcloud die Lösung durch
die Bildung von wässrigen Zweiphasensystemen (liquid–liquid phase separation, LLPS)
trüb wird. Darüber hinaus wurde Tcloud als Funktion der Lysozymkonzentration, des
Ionentyps, der Ionenstärke und des FT Stresses bestimmt. Dabei wurde die Korrelation
des Kurzzeitparameters Tcloud und der Langzeitstabilität von Proteinen durch die Erstel-
lung von Phasendiagrammen in einer Fallstudie untersucht. Die Reproduzierbarkeit der
Methode und eine Korrelation der ermittelten Tcloud Werte mit Literaturdaten wurden
ebenfalls überprüft. Bezüglich der Reproduzierbarkeit konnte eine geringe absolute Ab-
weichung vom Median (median absolute deviation, MAD) von 0,2℃ innerhalb von 60
Proben erreicht werden. Darüber hinaus wurde eine hohe Korrelation zu Literaturdaten
mit einem Pearson Korrelationskoeffizienten (Pearson correlation coefficient, PCC) von
0,996 gezeigt werden. Die anschließende Fallstudie wies eine partielle Korrelation zwis-
chen dem gemessenen scheinbaren Tcloud–Wert und der langfristigen Proteinstabilität als
Funktion der Lysozymkonzentration, des Ionentyps, der Ionenstärke und des FT Stresses
auf. Die getesteten Lysozym– und/oder Salzkonzentrationen waren jedoch zu niedrig, um
bei Zugabe von den Additiven Natriumsulfat und Ammoniumsulfat eine Aggregation zu
erzeugen. Demnach konnten auch keine Tcloud vor dem Einfrieren der Lösung detektiert
werden. Mit Natriumchlorid und Ammoniumchlorid fand eine Aggregation statt. Zudem
konnte Tcloud bei den Formulierungen mit Natriumchlorid bestimmt werden. Für diese
Formulierungen konnte das Auftreten von Tcloud bei Temperaturen um die -10℃ mit
langfristigen Instabilitäten korreliert werden.
Um Stabilisierungsparameter aber auch die Reversibilität von FT Stress–induzierten In-
stabilitäten zu untersuchen, wurde im letzten Abschnitt der Arbeit die Reversibilität
als Funktion verschiedener Gefrierschutzstoffe (Saccharose, Glycerin, PEG200, Tween20)
beurteilt. Dabei wurde der Einfluss der verschiedenen Gefrierschutzstoffe auf das Phasen-
verhalten von Lysozym und dem Fällungsmittel Natriumchlorid ohne FT Stress und mit
bis zu drei FT Zyklen untersucht. Um die Reversibilität der induzierten Instabilitäten
zu untersuchen, wurde ein Wärmeschritt hinzugefügt, bei dem das Phasendiagramm auf
40℃ für 30Minuten erwärmt wurde. Darüber hinaus wurden die Proteingröße und die
Proteinstruktur ausgewählter löslicher Proben unmittelbar nach der Verarbeitung des
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Stressprotokolls durch Dynamische Lichtstreuung (dynamic light scattering, DLS) bzw.
FTIR bestimmt. Diese Kurzzeit–Parameter wurden dann mit der Langzeitstabilität der
Proteine nach 40 Tagen und dem angewandten FT Stress korreliert. Um die Stabilisierung
durch Gefrierschutzstoffe und die Reversibilität durch Wärme zu bewerten, wurden, wie
zuvor beschrieben, Änderungen des Phasenverhaltens, der Kristallmorphologie und der
Proteinlöslichkeit berücksichtigt. Um die Stabilisierungseffekte zu beurteilen, wurden die
Formulierungen mit Gefrierschutzstoffen mit denene die nur Natriumchlorid enthielten,
verglichen. Mit dem Vergleich der gestressten und nicht gestressten Systeme konnte die
Reversibilität beurteilt werden. Bezüglich der Stabilisierung von Lysozyme hinsichtlich
FT Stress, zeigten die Osmolyten Saccharose und Glycerol verglichen zu den anderen
getesteten Formulierungen die wenigsten Instabilitäten. Außerdem zeigten sie eine gute
Reversibilität. Die Formulierungen mit dem getesteten Polymer PEG200 zeigten keine
Stabilisierung/Destabilisierung, wenn die Proben gestresst wurden. Die Reversibilität war
ohne den Zusatz von PEG200 höher, was vermutlich auf die Bildung von Proteinaggre-
gaten mit stärkeren Protein–Protein–Wechselwirkungen, bei Anwesenheit von PEG200,
zurückzuführen ist, die durch Hitze nicht gelöst werden konnten. Das Tensid Tween20, von
dem bekannt ist, dass es sich an Wasser-Eis-Grenzflächen anlagert um das Protein vor
Denaturierung zu schützen, zeigte eine destabilisierende Wirkung, wenn die Formulierun-
gen durch Einfrieren und Auftauen gestresst wurden. Darüber hinaus konnte durch das
Erwärmen der Platten auf 40℃ nahezu keine Reversibilität erreicht werden. Hier wurde
angenommen, dass die Wasser-Eis-Oberfläche die Proteinstabilität nicht beeinflusst sondern
die Interaktion zwischen Protein und Tween20 zu den Instabilitäten führt. Für alle For-
mulierungen konnte ein destabilisierender Effekt durch Erhöhung der Zyklenzahl beobachtet
werden, während bei Tween20 der Unterschied zwischen einem und drei Zyklen geringer
war. Hier wurde angenommen, dass der Grad der Destabilisierung nach einem Zyklus so
groß war, dass keine zusätzliche Destabilisierung durch weitere Zyklen stattfinden konnte.
Bezüglich der Korrelation der Kurzzeit–Parameter Größe und Struktur zur Langzeitstabil-
ität der Proteine konnte keine Abhängigkeit festgestellt werden. Weder die Größe, noch
die Struktur wurden durch die Zugabe von Gefrierschutzstoffen, der Anwendung von FT
Stress oder der Wärmebehandlung beeinflusst.
Zusammenfassend lässt sich sagen, dass eine phasendiagrammbasierte Methode zur Un-
tersuchung von FT Stress–induzierten Proteininstabilitäten entwickelt wurde. Mit dieser
Methode ist eine parallele Erforschung und Entwicklung von Formulierungs- und Prozess-
parametern und deren Einfluss auf die Protein–Langzeitstabilität möglich. Darüber hinaus
wurde die Bestimmung eines Systemparameters, dem Trübungspunkt Tcloud, beim Ein-
frieren und Auftauen entwickelt um noch mehr Informationen über den FT–Prozess zu
generieren. Zum Schluss wurde die Stabilisierung durch Gefrierschutzstoffe hinsichtlich der
FT Stress–induzierten Instabilitäten und deren Reversibilität durch Wärme mit Hilfe der
entwickelten Methode untersucht.
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Abstract
The general purpose of this thesis is the development of a simple, time–saving high–
throughput screening (HTS) method to investigate the impact of freeze/thaw (FT) stress
on the long–term stability of recombinant proteins. Recombinant proteins are biological
macromolecules, which have a highly specialized functionality, and their long–term stability
plays a crucial role in the biotechnology product and process development. During the
upstream process (USP) and downstream process (DSP) of recombinant proteins, one or
more FT steps are necessary, for storage, transportation, or for intermediate storage due
to bottlenecks during purification. Within the FT step, the protein stability should be
guaranteed as well as the shelf life of the proteins should be increased. In general, the
protein stability has to be guaranteed, during USP, DSP, and freezing/thawing. The protein
stability, including conformational and colloidal stability, is very sensitive to environmental
changes, such as temperature, solute type and concentration, and pH value. A loss of
the protein stability results in the loss of the protein functionality. This is problematic
both in terms of effect and safety. The sensitivity of the protein stability to environmental
conditions is challenging especially at the end of purification when recombinant proteins
are formulated. By the formulation, a protein long-term stability shall be ensured for at
least 18-24 months. Within the formulation development, the protein stability over time
as a function of different environmental conditions has to be studied. This is very complex
due to the fact that all factors influence each other. Especially during freezing and thawing,
both formulation parameters (pH value, additive and buffer system) and process parameters
(FT ramp, sample volume, storage time and temperature) have an influence on the protein
stability. In addition, system parameters, such as the glass transition temperature (Tg)
or the cloud point (Tcloud), are influenced by the formulation and process parameters and
have, in turn, also an influence on protein stability. Therefore, it is important to generate
an overall understanding of the relationship of all these parameters and their influence
on long–term stability to ensure a high level of protein stability after one or more FT
steps. Different analytical methods can be used to characterize the protein stability during
pharmaceutical formulation development. For example, size measurements using size
exclusion chromatography (SEC), structure measurements using Fourier–transform infrared
spectroscopy (FTIR), or activity measurements using activity assays, are performed. These
methods are time-consuming, expensive, and the correlation of the data is complex and
not always obvious. To investigate the effects of formulation parameters on the protein
long–term stability, protein phase diagrams are used exemplarily. Here, the high flexibility
and freedom by creating the phase diagrams is a huge benefit. With this background, in
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a first step of this work the development of a phase diagram–based method was aimed
to create the possibility of a simple, time–saving high–throughput (HT) screening of
different formulation and process parameters, and the detection of system parameters.
When creating the phase diagrams using a liquid handling station, the protein and salt
concentrations were varied, and the influence on the phase behavior was investigated as
function of different formulation parameters (buffer systems, buffer capacities, pH value,
ionic strength). Here, the phase diagrams were created using the model protein lysozyme
from chicken egg white and the precipitant sodium chloride. The evaluation of the FT
stress–induced instabilities showed, that changes in phase behavior, crystal morphology,
and protein solubility after 40–day storage at 20℃ in an incubation chamber, are sensitive
parameters. The phase behavior and the crystal morphology were rated visually, and
the protein solubility was calculated using the protein concentration in the supernatant,
measured by UV-vis spectroscopy. This study in a first view focused on the influence
of different formulation parameters as a function of the number of FT cycles. Thereby,
the plates were frozen in a freezer to -80℃ and thawed at 20℃. The results showed an
influence of FT stress on all parameters (phase behavior, crystal morphology, and protein
solubility), whereas this influence increased by the increase in the number of FT cycles, no
matter which pH or buffer system was used. Increasing the number of cycles resulted in
smaller regions in which the protein stayed stable/soluble, in smaller and more complex
structured crystals, and in lower protein solubilities, which overall represented an increased
degree of instabilities. These trends were always rated to represent more instabilities. The
effect of FT stress was found to be dependent on the buffer component and pH value. If the
proteins were already destabilized by the pH value (e.g. pH 3), a smaller influence of FT
stress was observed than in the case of proteins which were not assumed to be destabilized
by the pH value itself (e.g. pH 5). Formulations with buffer components, which are known
to interact with the protein itself, showed a higher degree of FT stress–induced instabilities.
Considering the observed possibilities to rate the influence of different formulation pa-
rameters during freezing and thawing, the applicability of the developed method was
verified by varying the process parameters. Here, different freezing and thawing ramps were
tested while one ramp was kept constant to separate the freeze and thaw influences from
each other. In addition, the influence of the system parameter Tg by changing the speed
during freezing at different temperatures was investigated. The respective FT protocol
was performed after the phase diagrams were created. Here, the plates were placed on
a cryogenic device and the respective FT protocol was adjusted. Afterwards, the plates
were stored in an incubation chamber at 20℃ for 40 days. Parameters relevant for protein
stability, phase behavior, crystal morphology, and protein solubility, were used to evaluate
the influence of the different tested ramps. The influence on the protein stability of freezing
ramps was found to be more pronounced than on thawing ramps, where faster freezing
ramps showed less FT stress–induced instabilities. According to this, it was assumed
that freeze concentration and not the creation of the water–ice interface is the main issue
when lysozyme is frozen. Furthermore, the overall time where the protein is exposed to
cold temperature or the solution did not cross Tg, was critical. Consequently, the later
the temperature of the freezing speed was changed from fast to slow, the less protein
instabilities were induced by freezing/thawing.
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To generate even more knowledge about the freezing and thawing process while using the
developed method, the setup was extended by a camera. The plates were recorded during
freezing and thawing to determine the process parameter Tcloud. The effect was exploited
that the solution at Tcloud becomes turbid through the formation of liquid–liquid phase sep-
aration (LLPS). In addition, Tcloud was determined as a function of lysozyme concentration,
ion type, ionic strength, and FT stress. Here, the correlation of the short–term parameter
Tcloud and the long–term protein stability, by creating phase diagrams, was investigated
in a case study. Reproducibility of the method and a correlation of the determined Tcloud
values to literature data were checked as well. Regarding the reproducibility, a small
median absolute deviation (MAD) of 0.2℃ within 60 samples was shown. In addition, a
high correlation to literature data with a Pearson correlation coefficient (PCC) of 0.996
was demonstrated. The subsequent case study demonstrated a partial correlation between
the obtained apparent Tcloud parameter and long–term protein stability as a function of
lysozyme concentration, ion type, ionic strength, and FT stress. However, the tested
lysozyme and/or salt concentrations were too low to create aggregation when the additives
sodium sulfate, and ammonium sulfate were added. Subsequently, Tcloud did not appear
either before the solution froze. With sodium chloride and ammonium chloride, aggregation
took place. In addition, Tcloud could be determined for formulations containing sodium
chloride. For these formulations, the appearance of Tcloud at temperatures around -10℃
could be correlated with long–term instabilities.
In order to determine stabilization parameters as well as the reversibility of FT stress–
induced instabilities, the reversibility as a function of different antifreeze substances was
investigated in the last section. The influence of the different cryoprotectants on the
phase behavior of lysozyme and the precipitant sodium chloride without FT stress and
with up to three FT cycles was researched. To investigate the reversibility of the induced
instabilities, a heat step where the phase diagram was heated to 40℃ for 30minutes, was
added. In addition, the protein size and the protein structure of selected soluble samples
were determined right after the stress protocol was processed by dynamic light scattering
(DLS) and FTIR, respectively. These short–term parameters were then correlated to the
long–term protein stability after 40 days and to the applied FT stress. To evaluate the
stabilization by cryoprotectants and the reversibility by heat, changes in phase behavior,
crystal morphology, and protein solubility were considered, as described before. Here, the
formulations containing cryoprotectants were compared to the formulations containing only
sodium chloride when investigating the stabilization effect. To evaluate the reversibility, the
stressed systems were compared to the non–stressed systems. The osmolytes, sucrose and
glycerol, were found to stabilize lysozyme regarding FT stress compared to the other tested
formulations. Moreover, they showed a good reversibility. The formulations containing
the tested polymer PEG200 showed no stabilization/destabilization effect when stressed.
Reversibility was higher without the addition of PEG200, presumably due to the formation
of protein aggregates with stronger protein–protein interactions in the presence of PEG200,
which could not be resolved by heat. The surfactant Tween20, known to stabilize against
denaturation on water–ice interfaces, showed a destabilizing effect when the formulations
were stressed by freezing and thawing. In addition, nearly no reversibility could be induced
by heating the plates to 40℃. Here, it was assumed that the water–ice interface does not
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influence the protein stability, but that the interaction between protein and Tween20 leads
to instabilities. For all formulations, a destabilizing effect by increasing the number of cycles
could be reported, whereas with Tween20, the difference between one and three cycles was
less. Here, it was assumed that the degree of destabilization was too significant after one
cycle and no additional destabilization could take place through further cycles. Regarding
the correlation of the short–term parameters, size and structure to the long–term protein
stability, no correlation could determined. Neither the size nor the structure were influenced
by the addition of cryoprotectants, the application of FT stress, or heat treatment.
In summary, a phase diagram–based method to investigate FT stress–induced protein
instabilities was developed. Using this method, a parallel research and development of
formulation and process parameters and their influence on protein long–term stability is
possible. In addition, the determination of a system parameter Tcloud during freezing and
thawing was developed to gain even more information on the FT process. At the end, the
stabilization by cryoprotectants regarding the FT stress–induced instabilities and their
reversibility by heat were investigated by using the developed method.
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1. Introduction
Proteins are complex biomolecules which fulfill essential tasks in living organisms. The
unique three–dimensional structure defines the functional property of acting as antibody,
enzyme, hormone or structural cell component. One of the main groups of the biophar-
maceutical industry is the production of recombinant proteins [1]. Recombinant proteins
are expressed by organisms modified with recombinant DNA. For example, as expression
system for human insulin, bacterial cells are used [2]. Several criteria have to be fulfilled
to obtain a successfully developed recombinant protein. The safety and efficacy for the
patient have to be guaranteed, and a long–term stability of at least 18–24 months has to
be proven. Furthermore, the production process has to be scalable and economical [3, 4].
Due to the complex structure and the specific functionality, the protein stability is very
sensitive to environmental changes. These changes might result in unfolding of the protein
or aggregation, both of which might result in a loss of the protein functionality [5]. There-
fore, it is necessary to investigate the environmental changes during production (USP),
purification (DSP), and final formulation [6]. When this is not guaranteed, an insufficient,
excessive, or defective recombinant protein production can lead to serious diseases, such as
diabetes [7], Alzheimer’s disease or Parkinson [8, 9].
To avoid these issues, an understanding of the impact of environmental changes on the
protein stability as well as the long–term stability is required. In the following sections, a
theoretical background of protein structure, protein stability, and their influencing factors is
presented. The focus is laid on the impact of freeze/thaw stress. Furthermore, an overview
is given of the used analytical techniques to monitor protein stability.
1.1. Protein conformation and interactions
The unique three–dimensional conformation of proteins is based on an amino acid sequence.
The amino acids are linked by peptide bonds, thus forming an individual polypeptide chain.
This chain is called the primary structure; is is built up of combinations of 20 different
proteinogenic amino acids, see Figure 1.1 a. The number of amino acids defines the molecular
weight and varies between the biopharmaceutical proteins. The molecular weight range is
between 5 kDa (insulin) and 150 kDa (mAbs). The amino acids have different characteristics
and are either basic, acid, hydrophobic (non-polar), or hydrophilic (polar) [10]. This results
1
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in electrostatic, hydrophobic, van der Waals interactions or hydrogen bonds and disulfide
bonds between the amino acids. These intermolecular interactions create the secondary
structure of proteins, where α–helix, β–sheet, or β–sheet anti parallel conformations are
created by hydrogen bonds between carbonyl and amino groups, see Figure 1.1 b. Through
intermolecular interactions, like hydrophobic and hydrophilic interactions as well as disulfide
bonds, the protein is folded even more in a specific three–dimensional conformation, called
tertiary structure, see Figure 1.1 c. There, hydrophobic interactions are the most dominant
ones. To stabilize the folded native state, most of the peptide groups and non–polar side
chains (∼ 80%) are covered in the inside of the molecule to avoid contact with water. The
polar side chains are present on the protein surface, and by building stable hydrogen bonds,
the protein conformation is stabilized. Larger and more complex proteins are built of more
than one polypeptide chain; the subunits aggregate and create a protein molecule. This
structure is called quaternary structure, see Figure 1.1 d [11–16]. The protein stability is
Figure 1.1.: The different protein structures are shown. The primary structure is shown in
a), whereas the amino acid are represented by the circles. The secondary structure possibilities,
α–helix (left), β–sheet anti parallel (right up), and β–sheet (right down) are displayed in b),
whereas interactions between the chains are presented schematically by dotted lines. The
tertiary structure is shown in c), and the quaternary structure with two subunits (grey and
black) in d).
directly related to the protein conformation (conformational stability). Environmental
changes influence the intermolecular interactions, which might cause conformational changes
and results in the loss of protein stability and activity. These factors are explained in more
detail in Section 1.3.
By folding the polypeptide chain into a tertiary (or quaternary) structure, a protein surface
is created. As described before, mainly charged side chains are present at the surface
and due to electrostatic interactions with water molecules the protein is stabilized in
solution [17]. These interactions influence the intermolecular protein–protein interactions.
Long–range repulsive interactions take place when both molecules are similarly charged
[18]. Besides, attractive short-range protein–protein interactions might also occur. Next to
the electrostatic interactions, additionally van der Waal, hydrophobic, and steric (excluded–
volume) interactions influence the aggregation tendency (colloidal stability) of the protein
[14, 19, 20]. Depending on the environmental conditions the protein surface charge as well
as the aggregation tendency are affected; both are described in more detail in Section 1.3.
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1.2. Lysozyme from chicken egg white
In this study, the model protein lysozyme from chicken egg white is used. Lysozyme has
a molecular weight of 14.6 kDa and the polypeptide chain exist of 129 amino acids [21,
22]. The isoelectric point (pI) of lysozyme is at ∼11.35 [23]. The native conformation is
displayed in Figure 1.2.
Figure 1.2.: The native protein conformation of lysozyme from chicken egg white from two
perspectives. The alpa–helix structures are presented in blue and the beta–sheet structures
are displayed in red.
1.3. Protein aggregation
Protein aggregates occur due to the loss of colloidal stability, which might be induced by
the loss of conformational stability. The protein aggregates are classified into different
categories [24, 25]: a) The type of bond: non–covalent aggregates are bound by electrostatic
interactions, whereas covalent aggregates are bond by disulfide bridges. b) Depending on
the type of bond, the reversibilities differ: non–covalent aggregates are reversible, and
covalent bond aggregates are irreversible. c) The aggregate size: there are small soluble
oligomers (dimers, trimers, etc.), large oligomers (≥ 10-mer oligomers), aggregates from
20nm to 1µm, insoluble aggregates up to 25µm, and visible aggregates (> 100µm). d)
The protein conformation: native aggregates and non–native aggregates, where the proteins
lost their activity.
There are different aggregation mechanisms, depending on the initial protein state (native/-
non–native), and the reason for aggregation (environmental changes or applied stress)
[24, 26]. A classification of the five most common mechanisms are published by Philo
and Arakawa [26], and is schematically shown in Figure 1.3. Mechanism1, describes the
aggregation of native monomers, here the oligomerization is reversible and the creation of
higher oligomers might be irreversible. Mechanisms 2 and 3 show aggregation of non–native
(2) or chemically modified (3) proteins. The chemical modification is irreversible, like
the higher oligomers which are created for both mechanisms. The mechanism4 shows
the attachment of native proteins to critical nuclei, created out of protein aggregates or
3
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Figure 1.3.: Schematic illustration of five common aggregation mechanism, adapted from
[26].
contaminants. While attaching of the proteins to the nuclei surface, partial unfolding of
the protein might take place. As a consequence, visible particles or precipitate are created,
which are irreversible. Mechanism 5 describes the process of adsorption of native monomers
to the container or air–water surfaces which promotes partial unfolding, resulting in protein
aggregation.
1.3.1. Aggregation process and morphologies
The assembly of protein monomers to form multimers because of attractive protein in-
teractions result in the appearance of different crystal shapes, precipitate types, or gel
formation. The aggregation process is thereby split into two main steps: nucleation and
crystal growth. First, an energetic barrier (∆G∗) has to be overcome to create critical
nuclei. Therefore, the attractive interactions have to be significantly high, see Figure 1.4
[27]. The theoretical background of ∆G∗ is explained in the following. The nucleation
of protein crystals is based on the classical nucleation theory developed in 1926 for the
condensation of a drop from its vapor [29]. The applicability for protein crystallization
was then forwarded by Feher and Kam [30]. The formation of a spherical nucleus with
the radius r is described by the Gibbs free energy ∆G(r), and the calculation is shown in
Equation 1.1. The first summand describes a volume term and a surface term is described
in the second summand, see Figure 1.4 (left) [27, 28].
∆G = −43pir
3kbT
ν
lnSsat + 4pir2γ (1.1)
The interfacial free energy between the crystal nucleus and the bulk solution is described
by γ. The radius r describes the size of the nucleus. kbT/ν lnSsat describes the free energy
difference between a protein molecule in solution and attached to the crystal, ν represents
4
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Figure 1.4.: Gibbs free energetics (∆G) of nucleus formation as a function of the nucleus
radius (r)(left) and the variation of the energetic barrier as a function of supersaturation (Ssat)
(right), adapted from [28]
the occupied molar volume of one protein molecule, Ssat the supersaturation in the solution,
kb the Boltzmann constant, and T the absolute temperature. The maximal ∆G value
calculated with Equation 1.1, describes the nucleation barrier ∆G∗ with the radius r∗ of
the critical nucleus. This is defined by(δ∆G(r)
δr
)
Ssat,T
= 0 (1.2)
resulting in
r∗ = 2νγ
kbT lnSsat
(1.3)
To calculate the nucleation barrier ∆G∗, r∗ (Equation 1.3) has to be inserted into Equa-
tion 1.1. Both parameters, r∗ and ∆G∗, are strongly dependent on the supersaturation
Ssat. As illustrated in Figure 1.4 (right), the higher the supersaturation Ssat, the lower r∗
and ∆G∗, consequently the easier the nucleation barrier is overcome [27, 28].
Using the supersaturation Ssat, the metastable and the labile zones, which are created
in a phase diagram (Figure 1.8), can be differentiated. In the metastable zone, ∆G∗ is
not reached, due to the low supersaturation, e.g. the contribution of the surface term
(second summand in Eq. 1.1) is too high and therefore is not exceeded by the volume term
(first summand in Eq. 1.1). Consequently, nucleation does not take place, but existing
crystals continue growing. Increasing the supersaturation, the volume and surface term
counterbalance each other at the borderline between metastable and labile zone before
the supersaturation is so high that nucleation starts. Once a critical nucleus of size r∗ is
created, the crystal continues growing [27]. The nucleation rate is dependent on the kinetics
of monomers attaching to the nucleus and hence dependent on the solution viscosity and
density [28, 31].
The nucleation process controls the aggregation type. The differences between crystalliza-
tion and precipitation are dependent on the level of the nucleation barrier. Precipitation
occurs only for very high supersaturation. Accordingly, the critical nucleus size r∗ becomes
smaller than the smallest structural unit (e.g. size of a protein monomer), and the nucle-
ation barrier disappears [27, 28]. Besides, the nucleation structure controls the structure of
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the crystalline phase and subsequently the size of the crystals [30, 32].
Depending on several parameters (e.g. solution condition, supersaturation degree, tem-
perature, additive, etc.), protein aggregation may lead to different morphologies, such as
the creation of precipitate, crystals or gelation [24, 33, 34]. Precipitation is known to be
spontaneous and fast. Two types of precipitate are acknowledged: amorphous precipitate
and cloudy precipitate. According to [34, 35], amorphous precipitate corresponds to incom-
plete gelation. Gelation is the formation of network–like and associated spacious structures
with increased viscosity [36–38]. Cloudy precipitate appears when LLPS takes place [35,
39]. Precipitate, in general, is associated with the loss of conformational stability of the
protein monomer [36]. This results in the loss of the protein native state, and non–native
aggregation occurs [14]. However, native precipitation has been observed as well [40].
Crystallization describes well–structured protein aggregation [41], and is assumed to be
native aggregation [26, 42]. The nucleation steps control also the structure of the crystalline
phase and the number and subsequently the size of the crystals [30, 32]. Due to the influence
of solution conditions as well as environmental parameters (e.g. temperature, pressure) on
the nucleation process [35, 43, 44], changes in morphology could be used as an indicator
for changes in the system [45, 46]. For example, increasing supersaturation increases the
nucleation rate, resulting in smaller crystals [47]. Consequently, the morphology can be
used to generate a better understanding of complex processes in the solution while it is,
for example, frozen.
1.3.2. Parameters affecting stability
During the production and storage of biopharmaceutical proteins, protein aggregation
may occur. Changing the solution conditions during purification, like pH value, ionic
strength, buffer system, and/or addition of additives, might destabilize the colloidal and
conformational stability. In addition agitation stress due to pumping, stirring, or shaking
influences the protein stability as well [6, 14, 24, 33, 48]. Subsequent to purification, during
the formulation process the protein is concentrated. The protein concentration itself is
known to influence the protein stability [24]. During storage, the long–term protein stability
has to be ensured, and therefore, most of the time the protein solutions are frozen [49, 50].
These stability–affecting parameters are explained in more detail in the following.
pH value
Varying the pH value of the formulation, the protein interactions change the type and the
distribution of charges on the protein surface. This affects the colloidal and the conforma-
tional protein stability [24, 33]. At pH values with a high distance to the pI, the protein is
strongly charged. When the pH value is higher than the pI, the protein is charged negatively,
hence in formulations with pH values below the pI the protein is charged positively, see
Figure 1.5. These differences in charge influences the electrostatic interactions inside of
6
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and between protein molecules. When the protein surface is charged similarly, protein
Figure 1.5.: The influence of the pH value on the surface charge of proteins (adapted from
[51]).
aggregation from an energetic perspective is not preferred, and repulsive interactions take
place. When the charge density is high, inter– and intra–molecular interactions increase,
which results in a partial unfolding of the protein. Hence, the hydrophobicity arise at the
protein surface, which increases the aggregation tendency. At the pI, the surface net charge
is zero i.e., the same amount of positive and negative charges are present. This results in
attractive dipole interactions. Consequently, the solubility decreases while the aggregation
tendency increases [14, 33, 52].
Ionic strength
Besides the pH value, the ionic strength influences the protein stability as well. This influ-
ence is protein–dependent and differs according to the buffer systems and concentrations
used in the formulation [33, 53–55]. Protein aggregation is inhibited due to the shielding
of electrostatic interactions. However, a decrease in these interactions might cause protein
destabilization. Subsequently, hydrophobic groups expose and lead to attractive protein
interactions [14, 56].
Protein concentration
The protein stability is also dependent on the protein concentration. The distance between
the protein molecules influences the strength and occurrence of protein interactions [24, 53].
Huge intermolecular molecule distances appear in diluted protein solutions. Long–range
interactions are present and the protein is stabilized in the solution [57, 58]. The distance
between the molecules decreases, when the protein concentration increases. Consequently,
attractive short–range, van der Waals and hydrophobic interactions become significant [58,
59].
7
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Buffer components
Buffer components are used to control the pH value of the solution, including e.g. citrate,
acetate, phosphate, glycine, and Tris to adjust pH values between 2–10 [60]. Different buffer
components might have an impact on the protein stability, stabilizing or destabilizing, as
explained in more detail in Section 1.3.2 (Additives). This might limit the choice of the
buffer system. In addition, some buffer components, e.g. Tris or phosphate are known to
change the solution pH value with temperature or upon freezing, respectively [60]. The
effect of freezing is explained in more detail in Section 1.3.4 (Stress types). To avoid these
problems, buffer component which do not influence the protein stability and do not show
temperature dependencies are preferred. In previous studies, synthetic buffer components,
such as AMPSO or MES, were shown to have no impact on protein stability [61].
Additives
Additives or excipients are substances added to the formulation, next to proteins or buffer
components. They are used in the biopharmaceutical industry to stabilize/destabilize the
conformational as well as the colloidal protein stability [62, 63]. The common used additive
classes are salts, polyols, sugars, surfactants, polymers and amino acids [14, 62–65].
The influence of these excipients is based on two theories: preferential interaction/binding
and preferential exclusion/hydration [66]. When preferential interaction/binding takes
place, the excipient prefers to bind to the protein surface, which results in a destabilizing
effect [14, 63]. In contrast, when preferential exclusion/hydration takes place, the protein is
stabilized. Here, the excipients are excluded from the proximity environment of the protein.
Consequently, the protein surface is hydrated, which stabilizes the protein conformation
[67–69]. Depending on the size, concentration and functional group of the excipient,
preferential interaction/binding or preferential exclusion/hydration are the mechanisms of
choice.
Salts influence the colloidal and conformational protein stability. The salt concentration as
well as the salt type have an impact on the protein stability [14, 70]. The colloidal stability
is destabilized at low salt concentrations due to the shielding of protein surface charges and
covering repulsive electrostatic forces [71]. At higher salt concentrations the conformational
stability might be influenced due to preferential binding of the salt ions to the molecule.
This results in a decrease in the thermodynamic stability of the native conformation [14].
Depending on the salt type, the salt ion is preferentially excluded or preferentially bound
to the protein molecule. Preferentially excluded salt ions stabilize the protein conformation
whereas preferentially bound salt ions destabilize the protein conformation [70]. The
influence of the different salt ion types is summarized in the Hofmeister series [72], and is
ordered according to their ability to aggregate proteins. The Hofmeister series is split into
anions and cations and is ordered according to their salting–out (increasing precipitation)
or salting–in (stabilizing) effects. The order of the Hofmeister series (direct or inverse)
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is dependent on different factors, like the protein charge, the salt concentration, as well
as the pH value. The solution pH value influences the impact of anions on the colloidal
protein stability. This is presented in the direct Hofmeister series [72]. Furthermore, the pI
of the protein has an impact on the order of the series. Above the pI a direct order and
below the pI an inverse order of the Hofmeister series was found [73]. It was also reported
that the salt concentration has an impact on the Hofmeister series order. For example,
positive macromolecules show direct Hofmeister behavior at low salt concentrations, but
revert to an inverse Hofmeister series when salt concentration increases [74].
Sugars, polyols, and amino acids are known to stabilize native protein state and reduce
aggregation propensity [75, 76]. Sugars and polyols are known to be preferentially excluded,
which promotes conformational stability [33, 43, 69]. While stabilizing the conformational
stability, the energy gap between the native and non–native state is increased [77]. This
decreases the free energy, due to a self–association which lowers the colloidal stability [62].
Whereas amino acids stabilize proteins with a variety of mechanisms, either preferential
interaction or exclusion, and their buffering capacity or chemical degradation prevention,
like oxidation, increase the protein stability [65, 78, 79].
Surfactants (non–ionic) prevent protein aggregation due to their ability to compete with
protein molecules for hydrophobic surfaces, like air–water interfaces [80]. They interact not
only with hydrophobic surfaces but also with hydrophobic regions on the protein surface
[81, 82]. The two frequently used surfactants are polysorbate 20 and polysorbate 80 [83].
Polymers, like polyethylen glycol (PEG) do also influence protein stability, whereas it
is strongly dependent on polymer molecular weight [84] and concentration [85]. Steric
shielding of attractive protein–protein interactions might induce protein stabilization, when
only low PEG molecule weights and concentrations are added to the formulation. Higher
molecular weight and concentrations, however, induce protein destabilization. The reason
is steric exclusion of the protein molecules from the solvent occupied by PEG molecules.
Consequently, the proteins are concentrated and precipitate as soon as the solubility limit
is exceeded [85–87].
Additives/excipients which are used to aggregate proteins are called precipitants, e.g.
sodium chloride. Some additives, called cryoprotectants, are useful to stabilize the protein
against freeze/thaw stress, e.g. sucrose [88, 89] or Tween20 [90, 91].
Mechanical stress
During processing and purification, proteins are exposed to mechanical stress, including
stirring, pumping or shaking. This has an influence on protein interactions and stability.
Here, mainly the conformational stability is assumed to be influenced by induced shear,
interfacial effects, cavitation or local thermal effects [43, 92–94].
Temperature
The surrounding temperature the protein is exposed to influences the protein conformational
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and colloidal stabilities significantly. As presented in Section 1.3.1, the colloidal stability
is dependent on the amount of Gibbs free energy needed to create aggregates. The
conformational stability is also described by the Gibbs free energy G. The native structure
of the protein is stable under physiological conditions when the Gibbs free energy is at a
global minimum [95, 96]. Changing to non–physiological conditions, molecular interactions
are changed, and a transition from the native to an unfolded state is favored. The Gibbs
free energy is defined as a function of the enthalpy H, the entropy S, and the temperature
T , see Equation 1.4.
G = H − T ∗ S (1.4)
The change of the Gibbs free energy is described by Equation 1.5:
∆G = ∆H − T ∗∆S (1.5)
While unfolding, the protein conformation changes. This results in a change of interactions
with the surrounding water. This influences the entropy S. The entropy is low when the
protein state is folded/native, since the attractive molecular interactions hold the protein
atoms in a well–defined geometry. Conformational changes result in an increase in entropy
due to the loss of interactions and the higher degree of freedom for each amino acid residue.
While the entropy of the protein increases, the enthalpy of the solvent relatively to the
folded state decreases. The reason are the compensation of the water molecules due to
their ordered conformation to reduce the contact with non–polar side chains [97]. The
energy due to the disruption of molecular interactions (hydrogen bonds, ionic salt bridges,
and van–der–Waals interactions) and the hydration of buried groups in the native state
which expose to the solvent upon unfolding, are reflected by the change of enthalpy ∆H
[98].
∆G is dependent on the temperature, according to Equation 1.4. An increase or decrease
Figure 1.6.: Gibbs free energy as function of temperature (adapted from [33, 99])
in the temperature, decreases the amount of energy needed to unfold the protein (∆Gunf ).
∆Gunf describes the difference between the Gibbs free energy of the unfolded and native
10
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state [100]. The highest value of ∆Gunf is reached at the temperature T∆G=max when the
native state of the protein appears, see Figure 1.6 [101]. The higher the difference of the
surrounding temperature to T∆G=max, the lower the protein stability up to a point where
the entropy term becomes greater than the enthalpy term and ∆G becomes negative, thus
resulting in protein unfolding. Already small temperature changes might result in the
disruption of molecular interactions [48]. It was also shown that this is pH–dependent [102].
In the two following subsections temperature increase (heating) and decrease (freezing) are
presented in more detail.
1.3.3. Heating
When T∆G=max is crossed, applying heat causes protein denaturation as described in
Section 1.3.2 (Temperature). However, when T∆G=max is not crossed, protein aggregates
can be reversed to monomers when heat is applied [25, 33]. Only non–covalent weak
protein–protein interaction can be reversed by heat [25]. To keep the proteins stable after
the temperature is decreasing again, the conditions which have induced the aggregates
have to be changed [5, 33] .
1.3.4. Freezing
During freezing and thawing, the protein is applied to different types of stress [103]. On the
one hand, as mentioned in Section 1.3.2 (Temperature) the cold temperatures might result
in cold denaturation [104]. On the other hand, freeze concentration might occur. Here,
the solutes (like buffer, excipients, and buffer components) are concentrated [105–108]
as a result of ice formation. Additionally, when ice crystals grow, a water–ice surface is
created which might cause protein destabilization [90, 109]. To minimize the destabilizing
effects, formulation, process and/or system parameters can be adjusted. In the following,
the different stress types as well as different stabilizing parameters are explained in more
detail.
Stress types
Cold denaturation
As mentioned in Section 1.3.2 (Temperature), low temperatures (below 0 ℃) might result
in protein denaturation [104]. The cold denaturation temperature is dependent on the pH
value of the solution, concentration of the protein, the presence of additives such as sugars,
and pressure [102, 110–112].
While the temperature decreases Privalov and Jaenicke published that hydrophilic interac-
tions are stabilized and hydrophobic interactions are destabilized [104, 113]. In addition, it
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was assumed that only the quaternary structure of proteins is affected by cold denatura-
tion, probably due to the ionization of essential groups which results in an unfolding of
the compact structure [104]. When cryoprotectants are preferentially excluded from the
protein surface, a stabilization against cold denaturation is not possible, due to preferential
hydration of the protein and the creation of a "cover". The water in the "cover" starts to
create even more hydrogen bonds when the temperature decreases. This supports protein
unfolding [112].
Ice formation
The appearance of ice crystals causes the major change in the formulations. Due to this,
other stress types are resulting e.g. the freeze concentration of solutes, which is explained
in the next paragraph (Freeze concentration) in more detail. Besides, a water–ice surface
is created which might lead to protein denaturation. The appearance of ice crystals is
strongly dependent on the degree of supercooling and the freezing rate. Lindenmeyer
et. al published that the ice crystal growth is proportional to the degree of supercooling
[114]. When the supercooling and the freezing rate are too high, a lot of small ice crystals
are created which form a huge ice surface [103]. This promotes denaturation of protein
molecules on the ice surface [90, 109, 115, 116]. In addition, not only the appearance
of ice crystals but also the ice structure is dependent on the degree of supercooling and
the freezing rate. Fast freezing and supercooling support the growth and amount of ice
dendrites, which have a high ice–surface [109, 115, 117]. However, the huge benefit of
ice dendrites is the creation of interdendritic spaces. In these spaces, solutes (additives,
proteins, buffer components) are trapped, and extensive freeze concentration is hindered
[118]. Due to the significant influence of supercooling on the ice crystal growth, it might
be beneficial to separate the cooling and freezing step from each other to simultaneously
freeze the samples, show reproducibility and generate a better understanding of the cooling
and freezing processes [119]. Therefore, a seeding step has to be added while cooling. Here,
different seeding methods can be used. In previous studies, small ice crystals [120, 121] or
chemical nucleants [122–124] were added to the supercooled sample. The addition of seeds
might lead to contamination. Furthermore, the chemical nucleants are not biocompatible
[119]. To avoid these problems, externally applied seeding methods are preferred. Exem-
plary electrofreezing, mechanical methods, shock cooling/cold spot creation, or a pressure
shift can be listed here. Electrofreezing implies the application of high voltage to a metal
electrode in a supercooled solution to induce ice formation [125]. Different mechanical
methods, like shaking, taping, and the application of ultrasound, can be used to effectively
induce ice in supercooled solutions [126].To induce ice nucleation from the outside, also a
cold spot at the cryocontainer can be created from where the ice crystal growth starts. To
standardize this method, commonly a step during freezing is added where the temperature
is held constant below 0℃ for a certain time to create a nucleation plateau [119]. To
create this cold spot, shock cooling can be performed. Here, the initial slow cooling ramp
is changed to a rapid ramp. Thereby, a cold pot is formed at the wall of the container [127,
128]. Reducing the pressure significantly (∼1 psig) also induces ice nucleation [129].
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Freeze concentration
Due to ice crystal growth the solutes in solution are concentrated. This results in different
effects. The concentration of the solutes, like protein, additive, buffer component, might
result in aggregation of the different components. (1) Protein aggregation might take place
due to the increased protein and/or additive concentration [130]. (2) Crystallization of
buffer components might result in a pH shift which probably leads to a protein desta-
bilization [103]. The appearance of buffer salt crystals is dependent on the nature and
concentration of the buffer components as well as the presence of other solutes, like salt
in the solution. A huge pH shift (∼3-4 pH units) was shown for sodium and potassium
phosphate buffer systems [131, 132]. The temperature decrease might also cause a pH
shift, but this shift is very low (<0.5 pH unit) [103]. (3) The high concentrations of
proteins and additives might result in LLPS which might be created also due to decreasing
temperature [35, 41, 133]. This phase separation might result in a separation of proteins
and cryoprotectants which increase protein denaturation [107, 108, 134]. The appearance
of LLPS is indicated by two glass transition temperatures (Tg) [105, 135–137]. And fourth
due to the temperature decrease as well as the solute concentration increase the solution
viscosity increases [138, 139]. Concerning the increased viscosity the protein is stabilized
due to the lowered molecule moving in solutions [33].
Stabilizing parameters
The influence of the mentioned effects on the protein stability is complex and depends on
formulation parameters (buffer, excipient and protein type and concentration, pH value),
system parameters (freezing and thawing point, Tg, and Tcloud temperature), and process
parameters (cycle number, freezing/thawing ramp, storage temperature and time, and
volume) [41, 103, 109, 117, 133, 140]. All parameters influence each other and, therefore, all
parameters have to be taken into account when a freezing/thawing step has to be included.
Each parameter and the correlations to each other are explained in the following.
Formulation parameters
The formulation parameters include additives (precipitant and/or cryoprotectants), buffer
system and buffer capacity, the pH value and the solute concentration. All these parameters
have an influence on the degree of freeze concentration, the ice structure, and, in general,
the protein stability during freezing [35, 103, 118, 130, 133].
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Cryoprotectants
As mentioned in Section 1.3.2 (Additives) additives are used as cryoprotectants. They are
specifically known to stabilize the protein against FT stress [33, 103, 133]. On the one
hand, there are additives which stabilize the native structure of proteins, e.g. osmolytes
[141–143], on the other hand, attractive protein–protein interactions are shielded, e.g. by
polymers [85, 87]. Furthermore, there are excipients which prevent protein molecules from
interactions with interfaces. Here, the water–air interface, the container wall as well as the
water–ice interface are included. An example of these excipients are surfactants [80, 90,
91].
Buffer systems, buffer capacity and pH value
The choice of the buffer systems is even more important when an FT step is included.
Because of the low temperature and freeze concentration, buffer substances might crystallize
and the pH shifts during freezing, which destabilizes the protein. Phosphate buffers are
known to crystallize during freezing and result in a pH shift [118, 144, 145]. The degree
of the shift is dependent on the buffer capacity. The lower the buffer capacity, the lower
the pH shift [103], due to the lower crystallization degree of buffer components [145].
Additives, the sample volume, and the freezing rate change the crystallization grade of
buffer components and have to be taken into account when the formulation is developed
for the FT step [130, 131, 145].
Solute concentrations
The initial solute concentration influences the degree of freeze concentration as well as the
appearance of solute aggregation. Higher concentrations lead to a higher viscosity, a higher
degree of freeze concentration, a decrease in the freezing point, and probably to a higher
degree of aggregation and LLPS creation [103, 133].
System parameter
System parameters, which influence protein stability, are the freezing and the thawing
point, the glass transition temperature (Tg) and the eutectic point (Teu), as well as the
cloud point (Tcloud). These points ar dependent and adjustable through formulation and
process parameters.
Glass transition temperature (Tg) and eutectic point (Teu)
While cooling down a protein solution, depending on the temperature and solute concen-
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tration different states can be reached, see Figure 1.7. The temperature, where the solution
reaches a glassy state is called Tg. Here, the viscosity is so high that molecule movement
is hindered, conformational changes of proteins do not take place any more [146]. Before
this point is reached, the eutectic point (Teu) might be crossed. Here, the components of a
homogeneous mixture crystallize next to each other when the temperature is decreased. If
the mixture varies from the mixture at Teu, the components do not crystallize in parallel,
and the component with a higher proportion than at Teu crystallizes first [147]. However,
the crystallization of the components is mostly hindered by the high viscosities in these
systems. Due to this, Tg is concentration–dependent for concentrated solutions, while Tg is
concentration–independent for dilute systems [133].
Figure 1.7.: Overview of the dependence of Tg and Teu on temperature and solute concentra-
tion (adapted from [133, 148]).
Freezing and thawing points
The freezing point is defined as the point where ice crystals start to grow, and the thawing
point is defined as the point where all ice crystals melt. At these points, the solution states
change and next to the low temperature, a water–ice surface is created or disappears, which
influences the protein stability [90, 104, 109, 115, 116]
Cloud point (Tcloud)
The Tcloud temperature is defined as the temperature where LLPS takes place, as mentioned
in Section 1.3.4 (Freeze concentration). LLPS formation results in a turbidity increase due
to the creation of protein–rich droplets in a protein–poor liquid phase, and therefore this
point is called cloud point. The formation of the LLPS is dependent on the strength of
protein–protein interactions, stronger interactions lead to a shift of LLPS to higher temper-
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atures [149]. Due to the dependency of Tcloud and protein–protein interactions, Tcloud was
found to be a respective parameter for colloidal stability [140, 149–151]. Furthermore, this
parameter might be a factor that influences protein stability during freezing and thawing
due to the fact that formulations with low protein and salt concentrations show LLPS
creation at sub–zero temperatures [150].
Process parameters
The process parameters, including cycle number, freezing/thawing rate, final storage
temperature and time, and sample volume, influence the protein stability significantly.
The optimal process is mainly formulation-, protein- and volume–dependent and must be
carefully investigated. All parameters and their correlations are explained in the following.
Cycle number
Increasing the amount of FT stress applied to the sample by freezing and thawing the
sample several times, e.g. during production and then for storage, the mentioned stress
types described in Section 1.3.4 (Stress types) are repeated, and the protein stability might
be destabilized even more [152]. Consequently, it is important to investigate which FT
step is necessary and which one can be skipped.
Freezing and thawing rates
The selection of the freezing rate has a major influence on the time during which the protein
is exposed to low temperatures and on the growth of the ice crystals (structure and size).
Optimization of both influencing factors is not possible. To minimize the overall time, the
protein is subjected to potential damage states, (receptively cross Tg) as fast as possible,
the rate has to be maximized [145, 153]. This, however, that would maximize the ice crystal
surface, due to the creation of many small ice crystals. Consequently, protein denaturation
on the ice surface is promoted [90, 109, 115, 116]. As mentioned in Section 1.3.4 (Ice
formation), the freezing speed not only influences the size of the ice crystals, but also the
structure. The steeper the freezing rate, the more supercooling takes place (when there
is no seeding) and the more ice dendrites are created, which maximizes the ice surface.
However, the creation of ice dendrites minimizes the degree of freeze concentration [109,
115, 117].
The choice of the thawing rate is critical as well due to the period of time the protein
is exposed to cold temperatures or rather in the non–glassy state (above Tg). But also,
Ostwald ripening, i.e. the simultaneous ice crystal melting and growing into bigger crystals,
also called recrystallization, should be avoided [118, 154].
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Final storage temperature and time
The choice of the final storage temperature is important to the long–term protein stability.
A storage below Tg is necessary to ensure long–term stability. Above Tg, still molecule
movement is possible and consequently, long–term stability cannot be ensured [103, 133,
145, 153]. The storage of all proteins at -80℃, no matter where Tg is, is economically
ineffective due to the fact that a lot of energy is used which does not necessary ensure
long–term protein stability.
Sample volume
The sample volume influences the freezing point, thawing point, degree of freeze concentra-
tion and, consequently, the crystallization grade of, e.g. buffer components. In addition,
the ice crystal growth and structure, due to the creation of an ice front through the sample
container, is influenced as well [130, 131, 133]. Due to the creation of this ice front, a
scale–up is not trivial. The development of different FT ramps as well as the formulation
might be necessary depending on the sample volume and the cryogenic device. Furthermore
it is very important to take into account the shape and cooling mechanism of the cryogenic
device [103, 133]. In this study, the sample volume is maximal 30µL and, therefore, the
creation of an ice front has not been taken into account.
1.4. Analytical techniques
1.4.1. Phase diagrams
For the development of the protein purification and formulation process, it is important to
have information about the protein phase behavior, one the one hand, to avoid undesired
phase transition during processing, and on the other hand, to apply phase transition to the
purification process (e.g. precipitation). When phase transition occurs, conditions with
soluble protein molecules show aggregation (or the other way around). Aggregation might
result in crystallization, precipitation, gelation, LLPS, or skin formation [155]. To visualize
and investigate the protein phase behavior as function of different environmental param-
eters (pH value, buffer system, protein concentration, additive type and concentration,
and temperature), phase diagrams are created, see Figure 1.8. Usually two parameters
are varied, e.g. protein concentration (cprotein) and precipitant concentration (cprecipitant),
while the other parameters, like the pH value, remain constant. Further possibilities
are: protein concentration as a function of temperature (see [39, 156, 157]) or protein
concentration as a function of a protein interaction parameter, like the second osmotic
viral coefficient (B22) [155]. Consequently, phase diagrams present an option to screen the
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influence of a wide range of environmental parameters to investigate the long–term protein
stability. To keep the material usage and the experimental workload low, a method in a
HT format with microbath experiments has been optimized by Baumgartner et al. and
used in this study [158].
The phase diagrams used in this study are shown in Figure 1.8. The protein concentration
Figure 1.8.: Phase diagram with increasing protein and precipitant concentration, adapted
from [41].
and precipitant concentration were varied. Thereby, two main zones are created, which
are separated by the solubility line: the undersaturated and the supersaturated zone. At
concentrations below the solubility line the protein stays soluble. The solubility line has
to be crossed to reach phase transition and thus create protein aggregates. The solubility
describes the equilibrium between aggregated and monomer proteins. Crystals appearing
in the supersaturated zone are growing as along as the supersaturation in the supernatant
is still high and stop when the supernatant is saturated. At this point, the crystal and
supernatant composition remain constant [41, 159]. Starting with under– or supersaturated
solutions, crystallization occurs when the supersaturation is high enough, and crystal
growth will stop when the equilibrium between aggregated and monomer crystals is reached
[160, 161](see Section 1.3.1). Then, the supernatant of crystalline solution is saturated and
the protein concentration in the supernatant thus reflects the protein solubility [41, 162,
163]. Based on this, the solubility line can be determined when performing micro–bath
experiments. Galm et al. developed a method to determine the solubility line by measuring
the protein concentration in the supernatant of crystalline suspensions after 40 days [164].
This method was also used in this study, to combine HT microbatch protein diagram
experiments with the determination of solubility lines.
When the solubility line is crossed, the supersaturated zone is created and protein crystal-
lization, precipitation, and other phase transitions occur [41, 159]. The driving force for
this phase transition is a thermodynamic imbalance, because of unfavorable interactions
between the solvent and exposed side chains which are minimized by attractive protein
interactions, which is also referred to as supersaturation [13, 14]. This zone is split into
three zones: the metastable zone at the border to the undersaturated zone, the labile
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zone, and, at very high supersaturation, the precipitation zone. In the metastable zone, no
crystals are created, but existing ones will grow. In the labile zone, crystal formation and
growth occur. Precipitate is created in the precipitation zone [27], see also Section 1.3.1.
1.4.2. Solubility line (SL)
The solubility line describes the equilibrium between monomer and aggregated protein
molecules. The more the equilibrium is shifted towards monomer protein molecules, the
higher the protein solubility in the respective formulation. To investigate the solubility
line, the supernatant of crystalline solutions was determined. The supernatant of solutions
where crystals grow is saturated and, therefore, the measured concentrations reflect the
protein solubility [41, 162, 163]. According to the method published by Galm et. al [164], to
calculate the solubility line (SL) the supernatant concentrations for each salt concentration
are averaged, due to the fact that the initial protein concentration does not influence the
supernatant concentration of conditions where crystals have grown [41]. The averaged
values are fitted using Equation 1.6:
Ssol = S0 +A · eR0·csalt (1.6)
Here, Ssol is the protein solubility, S0 is the theoretical protein solubility when nothing is
added. A and R0 are variable parameters, and csalt describes the used salt concentration.
The determined SLs can then be used to compare different phase diagrams to each
other regarding their protein solubility [164]. Furthermore, the protein solubility is
described in many publications to directly correlate to protein–protein interactions [165–
168]. Consequently, no change in the solubility lines implies no influence on protein–protein
interactions.
1.4.3. Dynamic light scattering (DLS)
To monitor the colloidal protein stability in the formulations, DLS measurements were
performed. The Brownian motion of protein molecules results in scattered light fluctuation
which is monitored over time using DLS [169]. These fluctuations over time correlate to the
particle size. Using the decay rate (Equation 1.7, q=wave vector) and the Stokes–Einstein
equation (Equation 1.8), the translational diffusion coefficient (Dt) and hydrodynamic
radius (RH) can be calculated, respectively.
Γ = q2Dt (1.7)
Dt =
kb ∗ T
6pi ∗ η ∗RH (1.8)
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The decay rate Γ describes the analysis of the auto correlation of the fluctuation of the
scattered light intensity, namely the similarity of the function to itself after a certain time
increment. Smaller particles diffuse faster and the light fluctuation function is only shifted
slightly before it does not correlate to itself any more. Consequently, the decay rate Γ is
small. For bigger molecules it is the other way around. Using the Stokes–Einstein equation
(Equation 1.8) to calculate the hydrodynamic radius RH , the viscosity η, the temperature
T , and the Boltzmann constant (kb=1.281 ∗ 10−23[J/K]) have been taken into account
[169–171]. Besides these parameters, protein–protein interactions also influence RH [172].
Attractive interactions reduce the movement in the solution and therefore a bigger RH is
calculated. Therefore, DLS measurements calculate more an apparent RH for non–diluted
formulations [173]. For this work, the appearance of only large protein species was taken
into account.
1.4.4. Fourier transform infrared spectroscopy (FTIR)
Using FTIR, the unique stretch vibrations or molecular bonds are used to identify the
secondary structure, like α–helix, β–sheet, or β–sheet anti parallel (see Section 1.1) [174].
The stretch vibrations are induced by the infrared radiation absorbance, and are a result
of changes in dipole moments of molecular bonds. Here, the carbonyl group (C–O) shows
the most distinct stretch vibration for proteins [175, 176]. These changes are measured
in a wavenumber range from 1700 cm−1 to 1600 cm−1, also called the Amide I band [177].
In accordance with the position of the carbonyl groups’ differences between the different
structures and, therefore, within the Amide I, band each secondary structure corresponds
to a specific range: α-helix (1650 - 1685 cm−1), β-sheet (1615 - 1635 cm−1), and β-sheet anti
parallel (1670 - 1685 cm−1).
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The production of recombinant proteins is complex and split into an upstream (USP) and
downstream (DSP) part. Within USP the product is produced by e.g. modified bacteria
or cells. In DSP and formulation the product is purified and formulated for the final appli-
cation to the patient. DSP exists out of several purification steps using chromatography,
virus inactivation, and buffer exchange steps. During production, purification, storage and
transportation the protein stability has to be guaranteed [6]. To prolong protein stability
throughout these steps the solution is frozen and when needed thawed again. Even when
there is no bottleneck within the production process, for storage and transportation prod-
ucts are often frozen to increase the shelf life [133]. The development and optimization of
the FT step is dependent on formulation parameters (pH value, buffer system and capacity,
additives, solute concentration), system parameters (glass transition point Tg, freezing and
thawing point, cloud point temperature Tcloud), and process parameters (freeze and thaw
ramp, storage temperature, storage time, cycle number, volume) [103, 133]. To characterize
the effect of the FT step concerning the protein stability, different analytical methods
are used to investigate short– and long–term protein stability. These analytical methods
include for example SEC to determine protein size, UV-vis spectroscopy to identify protein
concentration, osmolality and pH value to determine the solute distribution of additives and
buffer components, and activity assays to study protein activity [152, 178]. Furthermore,
the appearance of Tg and Tcloud is identified, by differential scanning calorimetry (DSC) or
refractometry, respectively [179–181]. However, these methods are expensive, complex and
time consuming, due to the often missing ability of HTSs, and data handling. Furthermore,
to find a correlation between induced stress and protein properties is often not obvious and
straight forward. In addition, to study the long–term stability samples have to be stored
over at least 18-24 months [3, 4]. To speed up the characterization of the formulation
step regarding long–term protein stability, the creation of phase diagrams can be used
to indicate the influence to different formulation parameters [158]. In addition, these
observation can be correlated to short–term parameters like viscosity, rheological behavior,
and structure changes [164, 182–185]. Missing however, is the investigation of the influence
of temperature to the phase behavior.
This work focusses on the investigation of FT stress–induced instabilities using phase
diagrams. Here, the flexibility of phase diagrams is used to study the influence of formu-
lation parameters, which can be varied while the phase diagram is created, and process
parameters, which can be varied while handling the phase diagram. In addition, the
setup of the freezing and thawing is used to determine system parameters in parallel. By
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doing so a toolbox will be generated where a simple, time–saving HT screening of different
formulation and process parameters and the detection of system parameters is possible to
generate a larger understanding of the influence of freezing/thawing on long–term protein
stability. As a consequence, the present work concentrates on three subsections dealing
with the development, verification and extension of a phase diagram–based method to
enable access to a better understanding of the influence of formulation, process, and system
parameters on the long–term protein stability when freezing and thawing. In addition,
the fourth subsection focussed on the reversibility of the FT stress–induced instabilities as
function of cryoprotectants.
The first subsection aims on the development of a phase diagram–based method to inves-
tigative the influence of FT stress. The phase behavior [41, 158], the crystal morphology
[35], and the solubility line [164] are known to be sensitive to environmental changes.
Hence, the evaluation of FT stress–induced instabilities focusses on these parameters. Next
to the method development, the study deals with the influence of different formulation
parameters, like buffer systems and pH value, on the long–term protein stability while
freezing and thawing. Furthermore, the influence of the different formulation parameters
will be studied as function of the process parameter cycle number. In order to verify
the possibilities of the developed method, the second subsection aims on the influence of
varying process parameters due to the known influence of e.g. the freezing rate on the
protein stability [103, 133].
Next to the influence of the formulation and process parameters on the protein stability, the
position and appearance of the above listed process parameters, like Tg or Tcloud, are known
to affect protein stability [133]. Hence, the third section aims to extend the developed
method by the possibility to detect Tcloud in parallel using video analysis while the plates
are frozen/thawed. Here, the ability to find a correlation between short–term parameter
Tcloud and the protein long–term stability influenced by FT stress will be investigated.
Based on the correlations between short–term and long–term protein stability made before
using the protein structure, solution viscosity or the rheological behavior [164, 182–185],
it is also figured out whether Tcloud is also a suitable parameter for such correlations. In
addition, the method extension will be validated by the influence of different additives.
Even when instabilities are induced by FT stress the fourth subsection aims a method to
reverse these instabilities. Reversibility of protein aggregates by e.g. heat is well known,
whereas the aggregate type is important (reversible/irreversible, strength of protein–protein
interactions) [13, 25, 26, 33, 43]. The reversibility of aggregates in this study will be
investigated as function of different cryoprotectants. In addition, again a correlation
between short–term parameters (size and structure) and long–term protein stability is
aimed, influenced by FT.
In summary, this work aims to develop a phase diagram–based methodology to investigate
FT stress–induced protein instabilities, in which the parallel research of formulation and
process parameters as well as the detection of a system parameter is possible. Further-
more, a possibility to reverse FT stress–induced protein instabilities will be presented. In
any experimental method the sample volume will be minimized in order to save product
consumption. Furthermore, the potential of HT methods will be used, whenever possible,
to reduce time consumption. As method development and applicability are protein con-
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suming, the model protein lysozyme from chicken egg white will be used. Nevertheless, the
developed method can be transferred to any biopharmaceutical protein of interest, such as
monoclonal antibodies.
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Chapter 4: Analysis of phase behavior and morphology during freeze/thaw
applications of lysozyme
Anna K. Wöll, Juliane Schütz, Jana Zabel, Jürgen Hubbuch
This article present the development of a toolbox to investigate FT stress. The influence
of different formulation parameter – buffer system, buffer capacity and pH value, in
combination with varying the process parameter – number of FT cycles – were investigated.
Therefor, to determine the long–term stability of lysozyme, phase diagrams were created
by using the method published by Baumgartner et al. [158]. These phase diagrams were
stressed up to five times with the following FT protocol: freezing for 30minutes in a -80℃
freezer and thawing for 30minutes at 20℃ in an incubation chamber. As reference an
unstressed plate fo each formulation was prepared. Afterwards, the long–term protein
stability was evaluated by determining the protein solubility, the phase behavior and the
crystal morphology. The buffer systems and the pH value had an influence on the degree
of FT stress–induced instabilities. The formulations were more stable at pH5, whereas
the buffer systems with acetate and citrate showed more instabilities compared to the
multi–component buffer (MCB) buffers. Increasing the number of FT cycles resulted in a
decrease of the soluble zone and crystal size, and the appearance of sea urchin crystals in
the high concentrated region.
published in: International Journal of Pharmaceutics (555), 2019, 153-164
DOI: 10.1016/j.ijpharm.2018.11.047
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Chapter 5: A phase diagram–based toolbox to assess freeze/thaw ramps
on the phase behavior of lysozyme from chicken egg white
Anna K. Wöll, Monika Desombre, Lena Enghauser, Jürgen Hubbuch
In this study, the developed method presented in Chapter 4 was extended by varying the
process parameters such as freezing/thawing ramp and number of FT cycles, whereas the
formulation parameters were kept constant using a MCB at pH5. Different freezing ramps
with constant thaw ramps, as well as the other way around, were tested to investigate the
destabilizing freezing and thawing effects separately. Besides, combination of the best and
worst ramps were investigates as well. To do so the created phase diagram were placed
on a cryogenic device, where it was able to adjust the respective ramps. To evaluate the
differences between the ramps, the long–term protein stability of lysozyme was determined
by checking the protein solubility, the phase behavior, and the crystal morphology. Freezing
ramps had a more significant impact on the long–term stability of lysozyme than thawing
ramps. Whereas, fast freezing resulted in less instabilities. The influence of the cycle
number seen in Chapter 4 could be verified in this study.
published in: Bioprocess and Biosystems Engineering (43), 2020, 179-192
DOI: 10.1007/s00449-019-02215-5
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Chapter 6: Application of a cryogenic device for high-throughput low
volume sub-zero cloud point temperature determination by means of au-
tomated video analysis
Marieke Klijn1, Anna K. Wöll1, Jürgen Hubbuch
1 These authors contributed equally to this work
This publication presents an expansion to the developed method (see Chapter 4 and 5) to
determine the system parameter – cloud point (Tcloud). The image-based method with
an automated image acquisition system was evaluated by means of robustness, validation
and a case study. The robustness study showed that the point detected (TCE) with the
developed method represents Tcloud. The applicability of this parameter was verified in
the validation study where eight lysozyme concentrations were measured and compared
to literature data. In the case study the correlation between Tcloud and the long–term
stability of lysozyme was evaluated. Thereby the influence of the lysozyme concentration,
the ion type, the ionic strength and FT stress were studied. A partial correlation could be
established. Formulations which showed long–term instabilities showed also an increasing
Tcloud value by increasing the supersaturation. Ammonium chloride formulations were
sensitive to FT stress and showed higher Tcloud values compared to formulations which
stayed stable over time, even when FT stress was applied.
published in: Bioprocess and Biosystems Engineering (43), 2020, 439-456
DOI: 10.1007/s00449-019-02239-x
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Chapter 7: Investigation of the reversibility of freeze/thaw stress-induced
instability using heat cycling as a function of different cryoprotectants
Anna K. Wöll, Jürgen Hubbuch
This manuscript aims to investigate the reversibility of FT stress–induced instabilities
of lysozyme by the application of heat (40℃) as a function of different formulation
parameters – cryoprotectants (sucrose, glycerol, PEG200, and Tween20). In addition, a
process parameter – number of FT cycles, was varied as well. Phase diagrams were created
to investigate the long–term stability and additionally short–term stability analysis were
performed. Therefor, the colloidal and conformational protein stability were studied, by
performing DLS (size) and FTIR (structure) measurements. All formulations containing
additionally cryoprotectants were compared to formulations including only NaCl. The
phase behavior, protein solubility, aggregation kinetics, and crystal morphology differed
between the formulations with and without any stress (freezing/thawing or heating). All
formulations showed FT stress–induced instabilities, which increases with a higher number
of FT cycles. The degree of instabilities were dependent on the cryoprotectant, as well
as the degree of reproducibility. Sucrose and glycerol showed a significant stabilization
effect regarding FT stress and the degree of reproducibility by heat was very high. Nearly
the same behavior, solubility and crystal morphology could be reached compared to the
formulations where no stress was applied.
accepted by: Bioprocess and Biosystems Engineering, 2020
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Abstract
Knowledge of protein behavior/stability during FT operations is essential for storage
and production processes in the biopharmaceutical industry. FT stress involves freeze
concentration, cold denaturation, and ice crystals formation which can result in protein
aggregation. Therefore, it is important to understand the ongoing FT processes, and
the influence of different solution parameters. In order to evaluate the ongoing processes
during FT (up to -80℃ ), phase diagrams with lysozyme from chicken egg white and
sodium chloride were generated. Thereby, three different buffer systems with varying buffer
substances and ionic strengths at pH3 and pH5 were investigated. As indicators for the
ongoing FT processes, the phase behavior, crystal morphology and solubility were used. An
increased number of cycles led, for example, to the formation of micro crystals, sea urchin
crystals – indicating LLPS and/or high supersaturation – and precipitate. Furthermore,
the buffer substances had a more distinct influence on the phase behavior and morphology
compared to the ionic strength differences. The solubility line itself was only shifted
when distinct changes in the phase behavior could be observed. In summary, a tool was
developed for using the phase behavior and especially the crystal morphology as indicator
for underlying processes during FT operations.
Keywords: phase diagrams, temperature, cycles, sodium chloride, precipitant
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4.1. Introduction
Stability of biopharmaceutical proteins during and after the production process is essential.
Important factors of impact on protein stability are mostly chemically (pH, additives, etc.)
and mechanically induced stresses (pumps, lines) [33, 48]. In order to increase stability and
enable long–term storage or transportation, protein solutions are often frozen down to -20 or
-80℃ and thawed again prior to use [49, 50]. During such freeze/thaw (FT) operations, both
chemical and physical stress is experienced by the protein in solution. While the underlying
processes leading to such stress are known, only a complex analytical toolbox allows its
detection. These underlying processes occurring can be grouped into three clusters, namely
cold denaturation [104], freeze concentration [105–108], and ice crystal formation [90, 109].
Cold denaturation describes the process of structural denaturation of the protein due to
cold temperatures. Privalov found that this process only affects the quaternary structures
of proteins [104]. During freeze concentration, water ice crystals grow and the soluble
solutes become concentrated. This includes the protein itself, buffer components, and
additives. A concentration of protein or additives may result in supersaturation [186].
The formation of ice crystals during freezing may also cause LLPS [35, 133], meaning
the demixing of the solution due to high concentrations (concentration–induced) and/or
low temperatures (temperature–induced). Thereby, LLPS might lead to a change in
concentration of formulation excipients or even a shift of the pH value [187]. Finally, ice
crystal formation, in particular the water–ice–interface, can have destabilizing effects on
the protein due to denaturation at this interface [109].
As mentioned, the FT stress introduced might have an influence on the protein stability [178,
188]. In this context, a distinction has to be made between colloidal and conformational
stability. In general, it can be differentiated between two different types of aggregation,
a fast unstructured – leading to precipitate – and a slow well–structured – leading to
crystals – aggregation [41]. Thus, depending on system composition or changes within
the system, different types and morphologies of crystals appear. One key point is the
actual concentration of protein in the liquid phase of the system. If supersaturation is low,
spontaneous nucleation does not take place within a reasonable time frame, and well–ordered
stable crystals grow best [45]. At higher supersaturation, spontaneous nucleation within
the crystallization/labile zone occurs. With the supersaturation increasing even more, the
energy barrier is easily overcome, and a precipitation zone is created [41, 186]. The whole
nucleation and growth process is further depends on parameters such as solution conditions,
the sample preparation, and the sample history [35, 43, 44]. Thus, alterations in morphology
might be used as an indicator for changes occurring in the system investigated [45, 46].
As an example, the typical morphology of lysozyme crystals with sodium chloride (NaCl)
as precipitant can be described as tetragonal [189]. An increase in protein concentration
might lead to a higher nucleation rate, which in results in a decrease in the crystal size.
Small tetragonal and micro crystals grow [47]. Furthermore, the creation of temperature–
or concentration–induced LLPS favors the growth of micro crystals [186]. Increasing the
level of stress and/or supersaturation results in the growth of the so–called flower crystals,
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needle crystals, and sea urchin crystals. The needle crystals are unstable polymorphs and
are slowly converted into tetragonal crystals [190]. For the growth of sea urchin crystals,
additionally LLPS and a very high supersaturation are necessary for needles growing fast
out of the nucleation center [35, 191]. If the growth process is too fast, because of a
excessive supersaturation, unstructured precipitation takes place [41].
Solubility as a general parameter is normally determined by supernatant measurements
of samples where crystals occur or co–occur, and the protein in the supernatant reflects
the protein solubility [41, 162, 164]. A shift in the overall solubility zone thus marks the
stability/instability of the respective system.
As mentioned above, morphology, and the parameters influencing the crystal shape, such
as supersaturation and LLPS, are sensitive to a whole set of parameters. On the one
hand to solution conditions, e.g. salt and protein type and concentration, and further
additives as well as the pH value and ion strength (IS) [35, 43–45, 151, 192–194]. On the
other hand to stress factors like FT [103]. In general, a toolbox of analytics is available
to gain some insight into processes occurring during FT operations such as size exclusion
chromatography, micro–flow image processes, activity assays, or dynamic light scattering
[24, 178, 195, 196]. Missing however are a holistic view on systems and the use of an easily
accessible signature to identify and describe the stability of given systems in potentially
ongoing processes during FT applications.
In this work, a phase diagram–based tool is developed to use the analytically easily accessible
phase behavior, the crystal morphology, and the solubility as indicators for system stability
and ongoing processes during FT applications. The applicability of the tool is shown for the
cases of changing buffer compositions, pH values, protein and precipitant concentrations as
well as for the number of FT cycles.
4.2. Materials and methods
For investigation of the impact of FT cycles on the phase behavior of lysozyme from chicken
egg white, phase diagrams are generated using different buffer systems at pH3 and pH5.
Additionally, a reproducible FT method has been established. In all studies, a protein
concentration of up to 21.75mg/mL and NaCl concentrations of up to 2.5M were used. In
the following, the preparation of buffers, protein solution, and the creation of the phase
diagrams are described. Furthermore, an explanation of the FT protocol can be found in
this section.
4.2.1. Preparation of stock solutions
Three different buffer systems were used in this study. We employed common 100mM
citrate/acetate buffer solutions. The relative buffer components were citric acid (Merck
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Figure 4.1.: Schematic visualization of the method used.
KGaA, Darmstadt, Germany) and trisodium citrate (Sigma–Aldrich, St.Louis, MO, USA)
for pH3, and for pH5 acetic acid (Merck KGaA) and sodium acetate (Sigma–Aldrich).
In addition, a 20mM multi–component buffer (MCB) system was used. The preparation
differs. Both MCB were created for a pH range from 3 to 9 using the tool published
by Kröner et al. [197]. For both MCB systems, the following buffer components were
used: AMPSO (Sigma–Aldrich), TAPSO (Sigma–Aldrich), MES (AppliChem GmbH,
Darmstadt, Germany), formic acid (Merck KGaA), and D–(+)–malic acid (Sigma–Aldrich).
An overview of the tested buffer systems is shown in Table 4.1. Besides the basic buffer
without any NaCl, for all buffer systems, two salt buffers were prepared in addition, the
low–salt buffer with 2.5M NaCl (Merck KGaA) and the high–salt buffer with 5M NaCl
(Merck KGaA). An schematic overview of the buffer systems, the basic buffers, and the
stock solutions is shown in Figure 4.1.
The pH was controlled and adjusted by means of a five–point calibrated pH meter
Table 4.1.: Buffer systems
buffer system pH buffer
capacity [mM]
NaCl
conc.
[M]
conductivity
[mS/cm]
pH3
conductivity
[mS/cm]
pH5
citrate 3
100
0 3.3 -
2.5 156.6 -
5 182.5 -
acetate 5
0 - 4.6
2.5 - 156.7
5 - 208.6
MCB
3; 5 20
0 1.541 5.144
2.5 151.9 171.6
5 193.9 221.9
MCBIS
0 10.86 10.25
2.5 153.8 176
5 193 224.4
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(HI–3220, Hanna® Instruments, Woonsocket, RI, USA) equipped with a SenTix® 62 pH
electrode (Xylem Inc., White Plains, NY, USA). The titration to the desired pH value was
done with NaOH or HCl (Merck KGaA). On the day the preparation was made, the pH
was adjusted to a value differing by up to ±0.2 pH units from the final pH value. After one
day, the buffer pH of the basic buffer was adjusted to the respective final pH value with an
accuracy of ±0.02 pH units. For the MCBIS system, additionally the ionic strength (IS) was
adjusted with NaCl (Merck KGaA) to 10.08mS/cm with an accuracy of ±1mS/cm at 24℃
±1℃ by using the conductivity meter CDM 230 (Radiometer analyticals, Lyon, France)
and the four-point calibrated conductivity cell E61M014 (Radiometer analyticals, Lyon,
France). After filtration with a 0.2µm membrane consisting of Supor® Polyethersulfone
(PES)(Pall Corporation, Port Washington, NY, USA), the buffers were stored at room
temperature and were used for up to two weeks after preparation. Additionally, a pre-test
with all basic buffers at both tested pH values was performed. Therefore, the liquid
universal pH indicator UNISOL 113 (VWR, Radnor, PA, USA) was added to the buffer
(ratio 1/250), and the solution was frozen to -80℃T˙he colors of the buffers were checked
before and while freezing, and after thawing.
The lyophilized protein lysozyme from chicken egg white (Hampton Research, Aliso Viejo,
CA, USA) was weighted and dissolved in the basic buffer of the corresponding buffer
system. The protein solution was filtered through a 0.2µm syringe cellulose acetate filter
(VWR, Radnor, PA, USA). For the removal of production–related additives, a desalting
step with PD–10 (GE Healthcare, Uppsala, Sweden) columns was performed by using
the spin protocol [198]. The concentration was controlled by a NanoDrop™2000c UV–
Vis spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). An extinction
coefficient of E1%(280 nm)=22.00 Lg-1cm-1 was used. To generate one phase diagram, 1mL
stock solution with a concentration of 43.5mg/mL ± 1mg/mL was needed. The protein
stock solution was prepared freshly every time and was not used for more than one day.
4.2.2. Phase diagrams
Phase diagrams with lysozyme concentrations between 2.5 and 21.75mg/mL and NaCl
concentrations between 0 and 2.5M at pH3 and pH5 were created applying the method
published by Baumgartner et al. [158]. A Freedom EVO® 100 fully automated liquid
handling station (Tecan Group Ltd., Männedorf, Switzerland) equipped with fixed tips
and 250µL dilutors was used. It was controlled by Freedom EVO® 2.4 SP3 (Tecan Group
Ltd.). Both NaCl and protein concentration rows were prepared with the liquid handling
station. Therefore, the stock solutions of protein with 43.5mg/mL and NaCl buffers with a
concentration of 2.5M and 5M NaCl were placed onto the liquid handling station platform.
The dilution rows were mixed in a Deepwell PP plate (Greiner Bio–one, Frickenhausen,
Germany). Afterwards, the phase diagram was generated by mixing 12µL protein with
12µL of the respective buffer in a MRC Under Oil 96 Well Crystallization Plate (SWISSCI
AG, Neuheim, Switzerland), schematically shown in Figure 4.1. To avoid evaporation, the
plate was sealed with Duck® Brand HD Clear sealing tape (ShurTech® brands, Avon, OH,
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USA). Before the phase diagrams were placed in the incubation chamber RockImager54
(Formulatrix, Bedford, MA, USA) at 20℃ for 40 days, they had to pass the respective FT
protocol, which is described in the next section. During the 40 days, pictures were taken
from each well automatically and were scored after 40 days concerning phase states and
morphology. Whereas the magnitude was the same for the whole scoring.
4.2.3. Freeze/thaw method
From each buffer system, four plates were created. One of them was directly placed in the
incubation chamber, the other plates were frozen and thawed one, three or five times. For
freezing, they were placed into the -80℃ freezer (Skadi by Telstar, Terassa, Spain) for
30min. Subsequently, the thawing took place under temperature–controlled conditions
at 20℃ for another 30min in the temperature cupboard WBK200/120 (Mytron, Heilbad
Heiligenstadt, Germany). If a higher cycle number was performed after the thawing, the
phase diagram was directly placed in the freezer. After the respective number of cycles, the
plates were placed into the incubation chamber at 20℃ and the phase behavior developing
over 40 days was monitored (see Figure 4.1).
4.2.4. Solubility line
After 40 days, the supernatant of each well was measured in triplicate with the NanoDrop™
2000c to evaluate the solubility line. Therefore, 3µL of the supernatant were carefully
pipetted on the NanoDrop™2000c. Attention was paid not to pipette visible aggregates.
To evaluate the solubility line, the method described by Galm et al. was used [164]. The
averaged values from the measurements were fitted using Eq. 4.1, where Ssol is the protein
solubility, S0 is the theoretical protein solubility for 0M NaCl, A and R0 are adaptable
parameters, and cNaCl describes the NaCl concentration.
Ssol = S0 +A · eR0·cNaCl (4.1)
It is known that the supernatant concentrations of conditions where crystals grew are
always around the same value no matter which initial protein concentration was chosen
[41]. This being said, when precipitation occurs, the initial protein concentration has an
influence on the supernatant measurement [199]. Nevertheless, in this work, the supernatant
concentration of conditions with crystals, and combinations of crystals and precipitates
were taken into account for the solubility line.
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4.3. Results
The general goal of this study is the evaluation of different systems varying in the spread
and occurrence of their solubility, crystallization and precipitation zone as well as in the
morphology of the underlying aggregation as a function of FT cycles. To evaluate the
phase behavior and influencing factors of lysozyme after FT operations with NaCl as a
precipitant, three different buffer systems at pH3 and pH5 and increasing numbers of FT
cycles (FT cx; x=0, 1, 3, 5) were investigated. The tested buffer systems differed in their
buffer components and ionic strength (IS). All in all, 24 phase diagrams were created and
in the following, the results concerning the solubility line, the phase behavior, and the
aggregate morphology are presented.
4.3.1. Solubility line
The changes of the course of the solubility line and thus spread of the solubility zone
were investigated and are shown in Figure 4.2 at pH3 and pH5. The solubility lines were
calculated from supernatant measurements according to Eq. 4.1 (see Section 4.2.4). For
each curve, the associated parameters are listed in the Supplementary material, TableB.1.
pH3
Generally, highest solubility is seen for FT c0. For the citrate system, a slight change of
the solubility line between two subsequent cycles is mainly seen between FT c0 and FT c1.
The MCB system showed the strongest variations both between FT c0 – FT c1 and FT c1 –
FT c3 – FT c5. For the MCBIS,pH3 system, a solubility line could be only created for the
initial system at FT c0.
pH5
At pH5 with the acetate buffer, a shift in the region lower than 0.91M NaCl could be
detected. The lines of FT c1 and FT c3 are shifted to lower protein concentrations, while
FT c0 and FT c5 were nearly identical. Due to the difference of only one measurement point
at each line, the shift is not really informative and should be handled carefully. With the
MCBpH5 system small differences are detectable, see Figure 4.2. Only with the MCBIS,pH5
system, a clear shift from FTc0 to FT c1 is pictured in Figure 4.2. The other cycles did
not show a further shift to lower lysozyme concentrations.
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Figure 4.2.: Solubility line of all tested buffer systems at pH3 (left) and pH5 (right) at
different cycle numbers. The solid lines are fitted as described by Galm et al. [164], and the fit
parameters are listed in the supplementary material.
4.3.2. Phase behavior
The phase diagrams for the different buffer systems and pH values are shown in Figure 4.3
for pH 3 and Figure 4.4 for pH 5. In general, pH 3 is characterized by a variation of crystal-
lization, co-precipitation and precipitation zones. At pH5, most of the phase diagrams
obtained are characterized by pure crystallization zones.
pH3
At pH3, differences between the tested buffer systems could be seen and are described in
the following.
Citrate buffer
In general, at FT c0, complete lysozyme solubility was seen for NaCl concentrations at and
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below 0.45M. Following at FT c1, all NaCl concentrations at and below 0.23M showed
complete lysozyme solubility. For increasing NaCl or lysozyme concentrations, a typical
transition curve of the soluble systems is obtained showing a balance between precipitant
agent and protein concentration. For the lowest lysozyme concentration tested (2.5mg/mL),
complete solubility decreased as a function of FT cycle carried out, ranging from 1.59M
(FT c0) to 1.14M (FT c1) and 0.91M (FT c3) through to 0.68M (FT c5) NaCl, see Figure 4.3
(A left). The aggregation zone was mainly characterized by a large crystallization zone and
Figure 4.3.: In A, the phase diagrams of all tested buffer systems without and with FT stress
at pH 3 are shown. The column on the left shows the phase diagrams of the citrate buffer. In
the column in the middle, the phase diagrams of the MCBpH3 system and in the column on the
right, the diagrams of the MCBIS,pH3 system are shown. B represents the appropriate legend.
only showed an increasing co-precipitation at high lysozyme and NaCl concentrations. No
pure precipitation zone could be observed. After FT c1, this picture changed so that the
majority of systems are now characterized by co–precipitation for all cycles up to FT c5.
Scattered systems showing only light co-precipitation at low lysozyme concentrations and
a small pure precipitation zone at FT c3 and FTc5 were observed. These precipitation
zones occurred either at high lysozyme concentrations (FT c3) or low NaCl concentrations
(FT c3, FT c5), see Figure 4.3 (A left).
MCBpH 3 system
At FT c0 lysozyme showed a solubility zone for NaCl concentrations at and below 0,45M.
This picture does not remarkably change after applying FT operations. While, initially, still
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a solubility zone is seen for 0.68M NaCl and lysozyme concentrations below 10.75mg/mL,
only the lowest lysozyme concentration of 2.5mg/mL showed to be soluble under these NaCl
concentrations and FT operations, see Figure 4.3 (A middle). Concerning the aggregation
zone initially, the aggregation zone was mainly characterized by a large crystallization zone
and only showed an increasing co-precipitation at high lysozyme and NaCl concentrations.
No pure precipitation zone could be observed. After FT c1 this picture changed so that the
majority of systems is now characterized by co-precipitation for all cycles up to FT c5. Only
for low lysozyme concentrations and the complete range of added NaCl, a crystallization
region is observed, see Figure 4.3 (A middle).
MCBIS,pH 3 system
In general, lysozyme at FT c0, was soluble for NaCl concentrations at and below 0.45M.
After FT operations, the solubility zone was reduced to NaCl concentrations of 0.23M
to systems with a lysozyme concentration at and below 13.5mg/mg, see Figure 4.3 (A
right). As seen for all systems, the aggregation zone at FT c0 was mainly characterized by
a large crystallization zone and only showed an increasing coprecipitation at high lysozyme
and NaCl concentrations. No pure precipitation zone could be observed. After FT c1 the
crystallization zone moved to the lowest lysozyme concentration while at counter–clockwise
coprecipitation and at medium concentrations of NaCl, a pure precipitation zone developed.
With every FT cycle (FT c3, FT c5), the precipitation zone increases and spreads to lower
lysozyme concentrations and higher NaCl concentration. At FT c5, the crystallization zone
completely disappears leaving only a zone of co–precipitation for high NaCl concentrations,
see Figure 4.3 (A right).
pH5
In general, all investigated systems (FT c0 FTc5) for all three buffer types showed a
solubility zone over the whole lysozyme concentration range for NaCl concentrations of
0.45M (Acetate) and 0.23M NaCl for the MCB systems. Furthermore, for the lowest
lysozyme concentration of 2.5mg/mL and the whole NaCl range, all systems expressed a
solubility zone. Regarding the aggregation zone, this zone was predominantly characterized
by a pure crystallization zone. Significant co-precipitation only occurred for the MCB
systems at FT c5. The co-precipitation zone developed at high lysozyme (from 13.5mg/mL)
and medium NaCl concentrations (0.45 – 1.82M), see Figure 4.4.
4.3.3. Morphology
The above–mentioned aggregation zones only show a general picture of the solid phase
appearing. To obtain a more exact picture, morphologies within the different zones were
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Figure 4.4.: In A, the phase diagrams of all tested buffer systems without and with FT stress
at pH 5 are shown. The column on the left shows the phase diagrams of the citrate buffer. In
the column in the middle, the phase diagrams of the MCBpH3 system and in the column on the
right, the diagrams of the MCBIS,pH3 system are shown. B represents the appropriate legend.
evaluated. The obtained habits are shown in Figure 4.5 (B) and Figure 4.6 (B). Mainly
four different crystal shapes were observed, whereas the tetragonal crystals differ in size
(micro, small, and big tetragonal crystals). In general, the higher the NaCl and lysozyme
concentration and/or the FT stress, the smaller and the more complex the crystals, e.g.
flower, needle and sea urchin crystals. When no structured aggregation is possible, pre-
cipitate is growing. In the following section, the pH value, buffer system and FT stress
dependencies of the morphology are described.
pH3
When looking at FT c0, a largely homogeneous picture occurs. Close to the transition
zone from solubility zone to crystal zone, small tetragonal crystals grew. By increasing the
lysozyme and NaCl concentration, micro crystals occurred. When entering the precipitation
zone at high lysozyme and NaCl concentrations, precipitate, needle crystals (citrate buffer,
MCBIS,pH 3), flower crystals (MCBpH 3) and sea urchin crystals co-existed, see Figure 4.5
(B).
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Citrate buffer
With increasing FT cycles, the morphology changed. Everywhere in the aggregation region,
precipitation co-occurred with crystals. Additional, the shape of crystals changed from
small tetragonal crystals to micro crystals and the area of sea urchin crystals increased
with the number of cycles (see Figure 4.5 (B)). For FT c1 and FTc3, small tetragonal
crystals were only found for medium NaCl and high lysozyme concentrations. Next to this
zone, a pure aggregation zone was found for low NaCl and high lysozyme concentrations,
see Figure 4.5 (A left).
MCBpH 3 system
For increasing cycle numbers, the pure - relatively small - crystallization zone for low
lysozyme concentrations showed micro crystals. A mixture of micro crystals and co-
precipitate describes the main part of the aggregation zone. For high lysozyme and NaCl
concentrations, habits found with co-precipitation change with increasing FT cycle number
from flower and sea urchin crystals (FT c0), small tetragonal crystals (FT c1), micro and
sea urchin crystals (FT c3) to micro crystals (FT c5), see Figure 4.5 (A middle).
MCBIS,pH 3 system
Again, a small zone for low lysozyme concentrations with micro crystals was found for
FT c1 and FT c3. The latter disappeared for FT c5. The main part of the aggregation zone
could be described by a pure precipitation zone slowly replacing a zone where crystals and
precipitate were found. In this zone, at high NaCl concentration, a wide mix of habits
is found, i.e. small tetragonal, micro, needle and sea urchin crystals, see Figure 4.5 (A right).
pH5
The homogeneous picture seen in Figure 4.4 changes clearly when looking at the morpholo-
gies obtained, see Figure 6 (A).
Acetate buffer
For FT c0, the crystallization zone is characterized by tetragonal crystals followed by
sea urchin crystals for higher lysozyme and NaCl concentrations. The zone showing sea
urchin crystals is found in all phase diagrams reducing in size with increasing FT cycle
number. For FT c1, the tetragonal crystals change into small tetragonal crystals. For
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Figure 4.5.: A gives a schematic overview of the morphology with the different buffer systems
and at different FT cycles at pH3. The column on the left shows the phase diagrams of the
citrate buffer. In the column in the middle, the phase diagrams of the MCBpH3 system and in
the column on the right, the diagrams of the MCBIS,pH3 system at pH 3 are shown. The legend
of the figure is presented in B. From the left, crystal types are shown, which grow when the
nucleation rate and the supersaturation are low, e.g. tetragonal crystals (21.75mg/mL lysozyme,
0.91M NaCl, acetate buffer pH 5, FT c0), small tetragonal crystals (19mg/mL lysozyme, 0.91M
NaCl, MCBpH3, zero cycles), micro crystals (10.75mg/mL lysozyme, 2.05M NaCl, MCBpH3,
FT c0). The further on the right, the higher the supersaturation and the nucleation rate.
Hence, flower crystals (21.75mg/mL lysozyme, 2.05M NaCl, MCBpH5, FT c3), needle crystals
(13.5mg/mL lysozyme, 1.36M NaCl, citrate buffer pH3, FT c0), and sea urchin crystals
(13.5mg/mL lysozyme, 2.05M NaCl, acetate buffer pH5, FT c5) grow. The crystal types on
the right side often occur when FT stress was applied. In addition, precipitate (19mg/mL
lysozyme, 0.45M NaCl, citrate buffer pH3, FT c3) might also grow when the aggregation is
not ordered any more. This is often the case when FT operations were performed.
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FT c3 and FT c5 and low lysozyme and NaCl concentrations, the first zone is characterized
by micro crystals. The second zone - medium NaCl and lysozyme concentrations - shows
small tetragonal crystals for low and flower crystals for high lysozyme concentrations, see
Figure 4.6 (A left).
MCBpH 5 system
At FTc0, three different crystallization zones develop. For low NaCl and high lysozyme
concentrations, tetragonal crystals are found. The main part of the aggregation zone
spreading over all NaCl concentrations is described by small tetragonal crystals, and the
third zone for high NaCl and high lysozyme concentrations is a mixture of flower, needle
and sea urchin crystals. The latter zone is seen on all cycles. For FT c1 and FTc3, two
distinct zones develop. For low NaCl and low lysozyme concentrations, micro crystals and
at the medium concentration range, small tetragonal crystals are found. For FT c5, high
lysozyme concentrations led to a zone of micro crystals and co-precipitate while the lower
lysozyme concentrations are characterized by a mixture of small tetragonal and micro
crystals, see Figure 4.6 (A middle).
MCBIS,pH 5 system
At FT c0, three zones develop. The first zone is characterized by small tetragonal crystals,
the second zone by flower crystals, and the third zone - high NaCl and high lysozyme
concentrations - by sea urchin crystals. For all cycles, zone two and zone three decrease
in size with the cycle number. Zone three reveals a co-appearance of needle crystals for
FT c1 and higher. In zone one, the small tetragonal crystals move to higher NaCl and
lower lysozyme concentrations. For lower NaCl and higher lysozyme concentrations, small
tetragonal crystals develop into micro crystals. At FT c5, largely identical phase diagrams
for both MCB systems develop, showing a co-precipitation zone at low NaCl and high
lysozyme concentrations, see Figure 4.6 (A right).
4.3.4. Influence of buffer systems
A comparison of the results of the different buffer systems shows that, at both pH values,
there are differences in phase behavior, and morphology could be seen for all cycle numbers.
These differences were found to occur between strongly dependent buffer systems, like the
citrate/acetate buffer and MCB systems, as well as between rather similar buffer systems,
such as MCB and MCBIS . While the solubility lines did not show a clear trend nor
presented deeper information on buffer suitability, more information is given by changes
in aggregate morphology. At pH3, in all tested systems, tetragonal crystals in different
sizes occurred in the lower concentration region, whereas first small tetragonal and then
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micro crystals occurred. In the highly concentrated area, precipitate co–occurred with
different types of crystals in all tested buffer systems. When FT operations took place
at pH3 mainly changes in the aggregation zone and the morphology appeared. The
aggregation zone increased mainly due to the increase in the precipitation zone, where
crystals also co–appeared, with the citrate buffer to the MCB,pH 3 system. With the
MCBIS,pH 3 system, in addition, a pure precipitation zone was created at middle NaCl
concentrations. Furthermore, a pure crystallization zone appeared only for the two MCB
systems at low lysozyme concentrations, see Figure 4.5. Besides the effects mentioned
above, the area of sea urchin crystals grew with an increasing number of cycles in the case
of the citrate buffer.
At pH 5 and FT c0, both the solubility zone and the aggregate morphology differs. The size
of the solubility zone shows a trend from the acetate buffer (large) to the MCBpH 5 trough
to the MCBIS,pH 5 system (small). Regarding the morphology, big tetragonal crystals grew
with the acetate buffer and the MCBpH 5 system, whereas in the MCBIS,pH 5 system, only
small tetragonal crystals grew within the middle NaCl concentration region, see Figure 4.6.
Moreover, the zone of sea urchin crystals was the biggest when using the acetate buffer.
When FT operations were performed, the phase behavior did not changed for the acetate
buffer, with the exception of a slightly decreasing size of the solubility zone. When
increasing the cycle number, a precipitation zone with co–appearance of crystals occurs
at high lysozyme and middle NaCl concentrations at pH5 next to the decrease of the
solubility zone in both MCB systems. Regarding the morphology, all systems were found
to follow the same trend of smaller and more complex crystal structures, see arrows shown
in Figures 4.5 (B) and 4.6 (B).
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Figure 4.6.: A gives a schematic overview of the morphology with the different buffer systems
and at different FT cycles at pH5. The column on the left shows the phase diagrams of the
citrate buffer. In the column in the middle, the phase diagrams of the MCBpH5 system and in
the column on the right, the diagrams of the MCBIS,pH5 system at pH 5 are shown. The legend
of the figure is presented in B. From the left, crystal types are shown, which grow when the
nucleation rate and the supersaturation are low, e.g. tetragonal crystals (21.75mg/mL lysozyme,
0.91M NaCl, acetate buffer pH 5, FT c0), small tetragonal crystals (19mg/mL lysozyme, 0.91M
NaCl, MCBpH3, zero cycles), micro crystals (10.75mg/mL lysozyme, 2.05M NaCl, MCBpH3,
FT c0). The further on the right, the higher the supersaturation and the nucleation rate.
Hence, flower crystals (21.75mg/mL lysozyme, 2.05M NaCl, MCBpH5, FT c3), needle crystals
(13.5mg/mL lysozyme, 1.36M NaCl, citrate buffer pH3, FT c0), and sea urchin crystals
(13.5mg/mL lysozyme, 2.05M NaCl, acetate buffer pH5, FT c5) grow. The crystal types on
the right side often occur when FT stress was applied. In addition, precipitate (19mg/mL
lysozyme, 0.45M NaCl, citrate buffer pH3, FT c3) might also grow when the aggregation is
not ordered any more. This is often the case when FT operations were performed.
45
Analysis of phase behavior and morphology during FT applications
4.4. Discussion
At first glance, the study shows that the solubility, phase behavior, and morphology of
lysozyme from chicken egg white were influenced by the pH value and the NaCl concentration
as well as the initial lysozyme concentration. Furthermore, the choice of the buffer system
and the number of cycles had an influence on the phase behavior characteristics. While
these are obvious findings, the methodology of the study reveals the importance of adding
morphology as a screening parameter in order to gain a more complete and a deeper insight
when evaluating stable/soluble protein systems.
4.4.1. Solubility line
The solubility curves exhibit the lowest amount of analytical information in this study.
Changes in the course of the solubility line are not significant enough to derive deeper
conclusions – only when comparing the different buffer systems at pH5 among each other
we see significant changes – and might mainly be used to support the trends of the other
parameters. Remarkable might be that independent of FT cycles no significant changes in
the soluble region occur. Finally, changes observed result mainly from a variation of single
points in connection with the exponential fitting procedure.
4.4.2. Phase behavior and morphology
Phase behavior within the aggregation zone already reveals the general picture and volatility
of aggregation processes occurring. However, a more distinct picture on processes occurring
within the different systems is then given by the analysis of changes in morphology and
the insight into when such changes occur.
FT c0 at pH3
At pH3 and FT c0, lysozyme showed a phase transition from soluble to crystals and further
to precipitate with all used buffer systems (see Figure 4.5 A). At pH3, the distance to the
isoelectric point (pI) of lysozyme (pI is around 11.4) leads to an increase in long–range
electrostatic (stabilizing) protein–protein interactions [52, 158, 200, 201]. This stabilizing
repulsion leads generally to a higher solubility and a decrease in aggregation tendency [6,
202]. With increasing NaCl concentrations, the repulsive electrostatic forces between the
proteins decrease due to shielding by neighbouring salt ions. Hence, short–range attractive
interactions become noticeable [20, 203, 204]. These interactions can be a result of van
der Waals forces, hydrophobic or osmotic forces [18, 165]. However, at pH3, the protein
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is probably partially unfolded [205] and thus the inner hydrophobic patches are exposed
to the surface, which leads to even more hydrophobic interactions [51, 206, 207]. Thus at
least in the high concentration regime a heterogenic picture expressing both crystals and
precipitate at FT c0 results from this situation. Regarding the crystal morphology at pH 3,
tetragonal crystals of different sizes grew. The crystal size was decreasing with increasing
NaCl concentration, regardless of the buffer system used. Thus, the supersaturation and
nucleation rate were increasing [47, 208]. Accordingly, more critical nuclei were created
leading to an increase of the amount of crystals which in return resulted in a decrease in
crystal size. When supersaturation is high, the energy barrier is overcome even more easily,
which results in the growth of critical nuclei and micro crystals [186]. For the citrate buffer
and both MCBpH3 systems at pH 3, sea urchin, needle and flower crystals co–occurred with
precipitate in the high–concentration area of lysozyme and NaCl. Whereas the size of the
area differs. In the high concentration region, supersaturation seems to reach a certain level
that might promote the growth of unstable polymorph crystals with needle morphology.
Thereby, the nucleation process as well as the growth process are influenced at these
high concentrations [190]. Besides high supersaturation, temporary concentration–induced
LLPS is another prerequisite for the growth of sea urchin crystals. Needle crystals grow
fast outside the nucleus if the concentration around the nucleus is still very high [35, 191].
The state in the highly concentrated area is metastable, as precipitate co–appeared with
all mentioned crystals. Nevertheless, both phase behavior and morphology show typical
behavior with an expected sensitivity at high concentrations. This said, the morphological
observations already reveal a deeper insight is the underlying processes as it is given by
the phase behavior only.
FT operations at pH3
In all tested systems, a destabilizing effect – generation of precipitate – arising from FT
cycling on lysozyme phase behavior was detected. At FTc1, precipitation co–occurred
in the whole aggregation area. The phenomenon of precipitation with FT cycling might
be explained by an increase in concentration of solutes such as salts, buffer substances,
and the protein itself [28, 90, 105–109]. At some point, the increasing concentration of
solutes reaches a critical concentration where long–range repulsive electrostatic forces
are shielded. This phenomenon enhances the effect of attractive interaction forces under
unstressed metastable conditions, increasing the aggregation tendency. Additionally, partial
unfolding on the water–ice–surface caused by the growth of ice crystals might take place
[109]. Both effects, high supersaturation and partial unfolding, might be indicators of
precipitation [209]. This is supported by the theory that precipitate is assigned to LLPS,
whereas the latter can be caused by high concentration, or an incomplete gelation at
high supersaturation [35, 39], which is an indicator for partly denaturation of the protein
[210]. LLPS takes place when the cloud temperature (Tcloud) is crossed [140, 150, 151].
At this point, LLPS is created and highly concentrated protein drops are separated [35],
which could be observed while recording the freezing process. This induces the growth of
crystal types which are preferred when LLPS occurs, like micro crystals and sea urchin
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crystals [35, 186, 191]. However, these two crystal types were mainly observed in the
high concentration region of the obtained phase diagrams. With increasing number of FT
cycles, the morphological variety was increasing. Reason are the repetition of the FT stress
and the adding–up of the mentioned impacts of freeze concentration, water–ice interface
denaturation, and temperature–induced LLPS. Other effects such as cold denaturation or
a pH shift can be excluded here. Cold denaturation only effects the quaternary structure
[104] and lysozyme from chicken egg white does not exhibit a quaternary structure [211].
Further initial testing revealed that changes in the pH value can be ruled out (data not
shown). Additionally, the buffer substances are not known to crystallize during freezing
[118, 130, 212]. The phase behavior and morphology in more detail are dependent on buffer
system. This is explained in Section 4.4.3.
FT c0 at pH5
At pH5, the phase behavior shows only soluble and crystal conditions for all used buffer
systems at FT c0, see Figure 4.6 A. Thus, a more detailed picture can only be obtained
when looking at changes in morphology. At pH5, hydrophobicity is reduced when compared
to pH3 and no partial unfolding of lysozyme is taking place [205] leading to structured
aggregation such as crystallization. When looking at the morphology it is noticeable, that
only two sizes of tetragonal crystals grew in the lower salt region, indicating a rather
low nucleation rate. By increasing the lysozyme and NaCl concentrations, crystals grow
following the progression of shapes (see Figures 4.5 (B) and 4.6 (B)), resulting in needle,
flower and sea urchin crystals. Both are indicators of higher supersaturation and the
possibility of concentration induced LLPS [35, 190, 191]. The morphology in detail is
dependent on the buffer system. This is discussed in Section 4.4.3.
FT operations at pH5
At pH5 and FT cycles, lysozyme started to aggregated at lower NaCl concentrations.
Reasons for this might be the freeze concentration of salt and protein which generates higher
supersaturated regions, the temperature–induced LLPS which creates highly concentrated
hot spots, and also the denaturation on the water–ice interface can take a role here [90,
105–109, 150]. Regarding the influence of the increasing number of cycles, the same
trend as for pH3 could be observed. The crystal type followed the natural morphology
changes as shown in Figures 4.5 (B) and 4.6 (B). High supersaturation and appearance
of concentration– and temperature–induced LLPS might be the reason for the different
crystal types [47, 208]. Precipitation only co–occurred at FT c5 with both MCB systems.
Whereas precipitate appears in the low NaCl and lysozyme concentration area. This is
atypical of phase diagrams and was not observed before with lysozyme and NaCl [41, 158].
In general, at pH 5 significantly less co–appearance of crystal and precipitate was observed
compared to pH3 probably due to higher structural integrity of the molecule at this pH.
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4.4.3. Influence of buffer systems
Adding morphological analysis to the evaluation of system stability complements the
picture obtained during phase behavior studies. The applied buffer systems differ in buffer
components, buffer capacity, and IS (see Table 4.1). The citrate/acetate buffers only consist
of two buffer components. Citrate and acetate are both kosmotropic salts and known as
water structure makers. They are strongly hydrated ions and, as a result, have a salting
out effect [51, 213]. When compared to citrate, acetate is the more kosmotropic salt and
possibly induces a stronger salting–out effect [213]. According to Forsythe and Pusey,
acetate as buffer component affects the solubility; an increase in the acetate concentration
reduces the solubility of lysozyme [214]. The MCB systems consist of five different synthetic
buffer substances. In previous studies, it was shown that synthetic buffer components do
not show any interaction with proteins [61]. Furthermore, the MCB systems do not change
in component composition for pH3 and 5. Moreover, the buffer capacity differs between
the citrate/acetate buffer (100mM) and MCB systems (20mM).
pH3
Precipitation. At pH3 and FT c0, the smallest precipitation zone could be observed for the
MCBpH3 system. Whereas the precipitation of the citrate buffer showed approximately the
same size like the MCBIS,pH3 system (see Figure 4.3). Nevertheless, the picture did not
show significant differences for the different buffer systems.
Applying FT cycles however distinct differences develop. Concerning the phase behavior,
precipitate co–occurred with crystals for the citrate buffer and MCBpH3 system in the main
aggregation area. This can be attributed to freeze concentration and the unfolding on the
water–ice interface while FT [103] and results in high supersaturation and a partly unfolded
protein, which both induce precipitation [35, 39, 209]. For the MCBIS,pH3 system the
co–appearance only occur at the highest lysozyme and NaCl concentrations. Additionally,
pure precipitation occurred at lower NaCl concentrations, so the zones were switched (see
Figure 4.3). The level of the IS and the absence of interacting buffer substances for both
MCB systems might have an influence on the aggregation propensity itself. Because of
decreasing temperature, LLPS droplets are created in the highly concentrated region [140,
150, 151], which could be observed while recording the freezing process. With increasing
time and decreasing temperature, LLPS droplets might also occur in the lower concentration
region. During this period, freeze concentration and ice crystals formation might occur
leading to precipitation. This picture proposes that several points in time play a crucial
role: a) the point in time of the appearance of Tcloud, temperature–induced LLPS [140,
150, 151], and b) the start of ice crystal growth, point where FT stress occurs [103]. The
coincidence of these points seemed to be crucial for the appearance of crystals, precipitate
or, precipitate and crystals at pH 3. The growth of the pure precipitation phase starting at
low NaCl concentration for the citrate and MCBIS,pH3 system is remarkable, but follows
an increasing buffer IS (see Table 4.1) for low NaCl concentrations.
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Crystallization. Finally at lower lysozyme concentrations and NaCl concentrations of 1.1M
and higher a pure crystal phase exhibiting tetragonal shape is observed at FT c1 and FT c3
for both the MCBpH3 and MCBIS,pH3 system. Here, specific the interactions or the absence
of such interactions of buffer substances might be the reason. With the known interactions
of citrate [72, 213], in the zone which otherwise seems to be stable while FT stress is
applied, precipitate co–exist, while this is not the case for the synthetic (non–interacting)
components used in the MCB systems [61]. Changes in the morphology did not show
similar correlations to buffer composition. The respective degree of changes, due to the
change of crystal structure, following the row of shapes (see Figures 4.5 (B) and 4.6 (B)),
is dependent on the initial morphology.
pH5
Aggregation area. At pH5 and FTc0, the phase behavior was only influenced by the
different buffer systems in the size of the respective aggregation area. The latter was
slightly larger for the MCBIS,pH5 system compared to the other two systems. This might
be explained by the higher IS of this system. A higher IS leads to a higher supersaturation
and subsequently the energy barrier for aggregation is overcome earlier.
Precipitation. Precipitate started to co–occur at FT c3 and FTc5 in the lower NaCl
concentrated region. It can be concluded that the influence of the buffer components is
predominant here, as the conductivity is approximately the same for the acetate buffer and
theMCBIS,pH5 system, and clearly lower than for the MCBIS,pH5 system (see Table 4.1).
The influence of acetate on lysozyme seems to stabilize the phase behavior when FT
operations took place, which is a contradiction to the salting–out effect of acetate [51, 61,
213]. Compared to that the synthetic buffer components of the MCB systems are known
to not influence the protein itself [61], following the phase behavior is changing due to the
FT stress.
Crystallisation. A major difference observed in crystal morphology between the buffer
systems is seen in the size of the area expressing sea urchin crystals. For the acetate buffer
this area was largest followed by the MCBpH5 and MCBIS,pH5 systems. It is known that
acetate influences the solubility of lysozyme in higher salt regions [214]. This might be the
reason for the larger size of the area of sea urchin crystals compared to both MCB systems.
Furthermore the system with the acetate buffer only expressed tetragonal crystals and
sea urchin crystals, while no intermediate crystal type, like micro or needle crystals could
be detected (see Figure 4.6). This might be due to interactions of acetate with lysozyme
which resulted from increasing NaCl and lysozyme concentration and thus in a direct
transition from tetragonal to sea urchin crystals [214]. With both MCB systems, a zone of
intermediate crystal types was created before the zone with sea urchin crystals occur, by
increasing the concentration of NaCl and lysozyme.
Whereas, the MCBpH5 system showed the highest number of different crystal types and
the MCBIS,pH5 system clearly separated crystal zones. However, the only difference
between the systems can be pinpointed in a slightly different IS explaining the only small
differences observed. Depending on the initial IS the nucleation rate and the growing
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process is influenced. Both systems the morphology follows the order of supersaturation
(see Figures 4.5 (B) and 4.6 (B)) [35, 47, 191].
4.5. Conclusion
In order to gain a holistic view of the phase behavior of protein systems during FT cycling,
a methodology was developed based on solubility, phase and morphological data to obtain
an easily accessible signature of the underlying processes. The solubility thereby showed
the lowest amount of analytical information and can not be used for any deeper conclusion.
However, the phase behavior and especially the morphology are informative parameters to
characterize the system stability as well as ongoing processes during FT. The applicability
of the developed tool was shown with changing buffer compositions, pH value, protein
and precipitant concentrations as well as the FT cycle number. With the phase behavior
differences between buffer substances, citrate/acetate buffer systems – MCB systems, as
well as different IS, MCB – MCBIS , could be detected.
In future work, complex analytics will be performed to evaluate whether the susceptibility
to changes in the aggregation state points towards changes in the liquid phase.
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Abstract
The influence of process parameters during FT operations is essential for the preservation of
protein stability/activity during production and storage processes in the biopharmaceutical
industry. Process parameters, such as FT ramps, final storage time and temperature, affect
the occurring FT stress onto the target protein in different ways. FT stress includes cold
denaturation, freeze concentration, and ice crystal formation which can result in protein
aggregation. To visualize the impact of variations in FT ramps, analytically easy accessible
descriptors such as solubility, phase behavior, and crystal morphology were evaluated.
The phase diagram-based toolbox in combination with an HTS–compatible cryo-device
allowed the identification of suitable ramping schemes during FT operations. It could be
clearly shown that rapid operations are needed above Tg to circumvent precipitation during
FT cycles. Finally, a stability index is introduced which allows ranking of the systems
investigated.
Keywords: phase diagram, temperature ramps, stability index, lysozyme
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5.1. Introduction
Most biopharmaceutical proteins are stored and transported in a frozen state to improve
flexibility during manufacturing and long–term stability during storage [215–217]. During
manufacture, storage, and use, the proteins experience chemical–induced stress (pH value,
salt type and concentrations, buffer components, and IS [43]), mechanical–induced stress
(shear stress from pumping and mixing operations), and physical–induced stress (process
time, temperature and cycling [103, 109, 178]) [33, 48]. The different stress types might
cause protein damage, which is then mostly manifested in the formation of aggregates,
structural and/or conformational changes, or loss of biological activity [103, 139, 178,
217, 218]. Possible processes occuring during FT operation are cold denaturation [104],
freeze concentration [105–108], and/or ice crystal formation with concomitant protein
denaturation on the ice–water interface [90, 109]. The development of these processes can
be controlled by the use of cryoprotectants, adjustment of FT ramps, choice of frozen
temperature and duration as well as sample volume [109, 118, 152, 219, 220]. It is thus
mandatory, that the influence of these parameters is investigated prior to FT operations.
In this scenario, variations of FT ramping might be the most straight forward strategy
from a process engineering point of view. The choice of a freezing ramp should fulfill at
least two criteria: on the one hand Tg has to be crossed and the glassy state needs to be
reached rapidly to minimize the time the protein is subjected to potentially damaging
states [145, 153]. On the other hand, if a freezing ramp is too steep, ice-crystal interfaces
might become too large, due to the ratio between volume and surface; when a lot of small
crystals are created, protein denaturation on the ice surface is promoted [90, 109, 115,
116]. The choice of the thawing ramp is a critical parameter to counteract the possible
appearance of recrystallization where small ice crystals melt and simultaneously grow
into bigger ones (Ostwald ripening) [118, 154]. Different critical parameters, e.g. particle
size, amount of aggregates or structural changes, can be detected to be characterizing the
stability of proteins [152, 178, 196, 221–223]. These parameters, however, are difficult to
determine and the needed methods are not always available. Wöll et al. developed an easily
accessible method to characterize different systems with increasing protein and precipitant
concentrations by creating phase diagrams, and using the solubility, phase behavior, and
the morphology as indicators for ongoing FT processes [224]. In a first study, the influence
of the pH values, IS, and buffer systems on the solubility, phase behavior, and morphology
were investigated [224]. So far missing, however, is a study on the applicability of such
toolbox for investigating different ramping schemes during FT operations. In this work, the
phase diagram–based toolbox is used to show the influences of different FT ramps and FT
cycles on protein solubility, phase behavior, and crystal morphology. The influence of ramps
during FT operations on system stability was evaluated independently. In addition to
simple ramping schemes, we also introduced inflection points realizing different processing
speeds during FT operations. Finally, a ranking of the different systems according to the
processing time, and a stability index based on a classification procedure of morphological
changes were established.
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5.2. Materials and methods
To determine the influence of variations in FT ramps as well as different numbers of cycles
on the colloidal protein stability of lysozyme from chicken egg white, phase diagrams at
pH5 were generated. In the following, the preparation of stock solutions and the creation
of phase diagrams as well as the performance of the freeze/thaw protocol are described.
Furthermore, the analytical methods used are explained.
5.2.1. Preparation of stock solutions
Two different stock solutions were prepared for the creation of phase diagrams. As basic
buffer for protein dissolution and the sodium chloride stock solution (2.5M NaCl), a 20mM
MCB was prepared using a tool published by Kröner et al. [197]. The MCB included
the following buffer substances: AMPSO (Sigma-Aldrich), TAPSO (Sigma-Aldrich), MES
(AppliChem GmbH, Darmstadt, Germany), formic acid (Merck KGaA), and D-(+)-malic
acid (Sigma-Aldrich). In a final step, pH5 was adjusted with a five-point calibrated pH
meter (HI-3220, Hanna® Instruments, Woonsocket, RI, USA) equipped with a SenTix®
62 pH electrode (Xylem Inc., White Plains, NY, USA). For adjustment of the desired pH
value, NaOH or HCl (Merck KGaA) was used. The pH was adjusted on the preparation
day to a value differing by up to ±0.2 pH units from the final pH value. Prior to using the
buffer, the pH was verified again and finally adjusted to a value differing by only ±0.02 pH
units. The IS of all systems was adjusted to 10.1mS/cm with an accuracy of ±1.0mS/cm
at 24℃ ±1℃ by using the conductivity meter CDM 230 (Radiometer Analyticals, Lyon,
France) and the four-point calibrated conductivity cell E61M014 (Radiometer Analyticals,
Lyon, France) using NaCl (Merck KGaA). Finally, all buffers were filtered through a
0.2µm Supor® Polyethersulfone (Pall Corporation, Port Washington, NY, USA) filter. The
prepared buffers were stored at room temperature and not used for longer than 2 weeks
after preparation. For protein stock solution, lyophilized lysozyme from chicken egg white
(Hampton Research, Aliso Viejo, CA, USA) was used. Following dissolution of the protein,
the solution was filtered through a 0.2µm syringe cellulose acetate filter (VWR, Radnor,
PA, USA) and a desalting step with PD-10 (GE Healthcare, Uppsala, Sweden) columns was
performed by using the spin protocol [198] to remove aggregates and production-related
additives. Finally the protein concentration was adjusted to 43.5mg/mL ± 1mg/mL. To
do so, a NanoDrop™2000c UV-Vis spectrophotometer (Thermo Fisher Scientific, Waltham,
MA, USA) and an extinction coefficient of E1%(280 nm)=22.00Lg-1cm-1 was used. The
protein stock solution was prepared freshly for every experimental cycle and was not used
for more than 1 day.
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5.2.2. Phase diagrams
Phase diagrams with lysozyme concentrations between 2.5mg/mL and 21.75 mg/mL
and NaCl concentrations between 0M and 1.1M at pH5 were created, applying the
method published by Baumgartner et al. [158]. The protein and salt stock solutions
were placed onto a Freedom EVO® 100 fully automated liquid handling station (Tecan
Group Ltd., Männedorf, Switzerland) platform. The liquid handling station (Tecan
Group Ltd., Männedorf, Switzerland), equipped with fixed tips and 250µL dilutors and
controlled by Freedom EVO® 2.4 SP3 (Tecan Group Ltd.). The needed protein and salt
concentrations were prepared in a Deepwell PP plate (Greiner Bio-one, Frickenhausen,
Germany). Following this, the phase diagram was created in a MRC Under Oil 96 Well
Crystallization Plate (SWISSCI AG, Neuheim, Switzerland), and 12µL of the protein
solution and 12µL of the salt solution were mixed. The plates were centrifuged in an
Eppendorf centrifuge 5810R (Eppendorf AG, Hamburg, Germany) at 1000 rpm for 1min
to remove all air bubbles. To avoid evaporation, the plate was sealed with Duck® Brand
HD Clear sealing tape (ShurTech® brands, Avon, OH, USA). Before the phase diagrams
were placed in the incubation chamber RockImager54 (Formulatrix, Bedford, MA, USA)
at 20℃ for 40 days, they were subjected to the respective freeze/thaw protocols, which are
described in the next section.
5.2.3. Freeze/thaw ramps
Different FT ramps as well as a number of cycles (FT cx; x=0, 1, 3) were tested. Initially, a
control plate (without FT stress) was directly placed in the incubation chamber. All other
plates were placed onto the cryo–device EF600M 105 (Grant Instruments, Cambridgeshire,
UK) after preparation. The cryo–device is controlled with the software iTools Engineering
Studio (Eurotherm, Worthing, UK) and equipped with a 96-well adapter. To facilitate
optimal heat transfer on the adapter, thermal conductivity grease was used. To prevent
direct contact of the thermal conductivity grease (Apiezon® N, Merk KGaA) with the
crystallization plate, a layer of plastic wrap was placed in between plate and grease.
Additionally, the plate was clamped on the adapter to ensure a contact of each well
with the adapter. The needed motor parameters for each ramp were calibrated using an
optimization run with a dummy prior to the actual experimental run. The ramps applied
are listed in Table 5.1. A detailed description of FT procedures is given in [224]. Using the
thermal grease, the clamps, and a very small sample volume of 24µL, it is supposed that
the temperature profile of the adjusted ramp is the same as the actual temperature profile
experienced by the sample solution. The temperature profile of R 3 is shown in FigureB.1
in the Supplementary Material.
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Table 5.1.: Overview of the system applied. The FT parameters for each ramp as well as the
overall process time of FT operations and the stability index (SI) are listed. Yellow marked
systems have a stability index above -100, grey marked between -100 and -200 and blue marked
between -200 and -340.
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5.2.4. Analytics
In this study, three different analytical methods were performed to score the phase states
and crystal morphology, and calculate the solubility line of each system.
Phase behavior and crystal morphology
After 40 days, pictures taken from the RockImager54 (Formulatrix, Bedford, MA, USA)
were scored visually concerning phase states and morphology. During this procedure we
differentiated between soluble, crystals and precipitate and for the crystals between micro,
small tetragonal, and tetragonal crystals, see Table 5.2 and Figure 5.5C. Additionally, some
conditions were characterized by combinations of the mentioned phase states.
Solubility line
Supernatant measurements were performed in triplicate with a NanoDrop™ 2000c UV/Vis
spectrophotometer. For each measurement 3µL of the supernatant was carefully pipetted
on the NanoDrop™2000c taking care not to pipette any visible aggregates. Then, the
method published by Galm et al. was used to calculate the solubility line [164]. In this work,
the supernatant concentration of conditions with crystals, and combinations of crystals
and precipitates were taken into account for the solubility line.
5.2.5. Stability index
To reach an empirical ranking or SI of the FT ramps investigated, a morphology–based
weighting was performed. The hypothesis behind this procedure is that stable systems (in
this study, favorable FT ramp combinations) show a lower susceptibility towards variations
in morphology over different FT cycles than unstable ones. The morphological composition
in each well of the different systems was determined and rated by an arbitrary weight (1:
soluble; 2 - 5: pure crystals of different habit; 10 - 13: occurrence of precipitation) given to
each of these compositions (see Table 5.2). Summing up the classification values of all 96
wells resulted in a morphology–based classification of the respective systems (R 1 –R15).
To differentiate between the process of an initial FT step and repeated cycling we introduced
two independent stability indices. For initial FT operations the SIFT c0 is defined according
to Equation 5.1 (MRFT cx) stands for the morphology rating according to Table 5.2 for a
given cycle x):
SIFT c0 = MRFT c0 −MRFT c1 (5.1)
To quantify potential changes in the morphological composition over cycle numbers of FT
ramps performed (repeated cycling), the value obtained for FT c3 is subtracted from the
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Table 5.2.: Rating system based on morphology. The pictures of the morphologies are
shown: soluble (8mg/mL lysozyme, 0.4M NaCl, FT c0), micro crystals (19mg/mL lysozyme,
0.5M NaCl, R 9, FT c1), small tetragonal crystals (21.75mg/mL lysozyme, 0.9M NaCl, R 2,
FT c1), big tetragonal crystals (19mg/mL lysozyme, 0.8M NaCl, FT c0), small tetragonal and
micro crystals (10.75mg/mL lysozyme, 0.9M NaCl, R 1, FT c1), micro crystals and precipitate
(16.25mg/mL lysozyme, 0.4M NaCl, R 4, FT c3), small tetragonal crystals and precipitate
(10.75mg/mL lysozyme, 0.9M NaCl, R 1, FT c3), light precipitate (16.25mg/mL lysozyme,
0.4M NaCl, R 2, FT c3) and precipitate (21.75mg/mL lysozyme, 0.4M NaCl, R 4, FT c3).
Rating no. Morphology
1 soluble
2 normal tetragonal crystals
3 small tetragonal crystals
4 small tetragonal and microcrystals
5 micro crystals
10 small tetragonal crys-
tals and precipitate
11 micro crystals and precipitate
12 light precipitate
13 precipitate
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value obtained for FT c1 (see Equation 5.2).
SIcycle = MRFT c1 −MRFT c3 (5.2)
The systems investigated were then sorted according to the lowest changes occurring in the
morphological composition (the highest value obtained after substation). Values obtained
and the respective rankings are listed in Table 5.1 and Table 5.3.
Table 5.3.: System ranking. Both stability indicies (SIcycle, SIFTc0) as well as the process
time of FT operations are listed, according to a descending SIcycle and ascending process time.
Yellow–marked systems have a SIcycle above -100, gray–marked ones between -100 and -200,
and blue–marked ones between -200 and -340.
System SIcycle =
MRFT c1 −
MRFT c3
System Process
time [min]
System SIFT c0 =
MRFT c0 −
MRFT c1
R9 -39 R14 30 R10 -35
R2 -63 R9 40 R3 -47
R12 -71 R3 50 R12 -48
R14 -75 R2 60 R4 -56
R3 -79 R11 112 R14 -57
R5 -141 R12 121 R5 -57
R10 -175 R6 126 R1 -57
R6 -309 R5 135.5 R7 -61
R11 -313 R13 139 R9 -80
R13 -335 R10 148 R6 -82
R7 -347 R4 154.5 R2 -84
R8 -387 R7 164 R13 -90
R1 -399 R8 220 R15 -96
R4 -427 R1 240 R8 -109
R15 -429 R15 400 R11 -122
5.3. Results
The aim of this study was to evaluate if a toolbox developed previously for investigating
the influence of fluid phase parameters on protein phase behavior during FT operations
[224] allows analysis or suitability of different FT ramps. The model system used to
perform this investigation consisted of lysozyme from chicken egg white, applying different
protein concentrations and different concentrations of NaCl as a precipitant at pH5. A
systematic investigation into the use of different ramping schemes was performed by varying
the ramping applied to freezing (R 1-7), thawing (R 2,8-13), and combinations thereof
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(R 14-15); see Table 5.1 and Figure 5.1. Additionally, the influence of the cycle number
(FT cx; x=0, 1, 3) was added as a variable parameter. In total 31 phase diagrams were
created. The results obtained describing solubility line, phase behavior, and morphology
are presented in the following. Prior to a detailed description of the data generated, the
overall trend obtained for varying cycle numbers is presented.
5.3.1. Influence of cycle number
In this section, an overall view of the influence of the number of cycles is given, and the
detailed changes for each ramping combination are described below in Sections 5.3.2, 5.3.3,
and 5.3.4.
An overall shift of the solubility line to lower NaCl and lysozyme concentrations is seen
when the number of cycles increases. Regarding the phase behavior at FT c0, a solubility
zone and a crystallization zone, starting at 0.5M NaCl and at 21.75mg/mL lysozyme,
were observed. At lower lysozyme concentrations, the aggregation onset took place at
increasing NaCl concentrations. While increasing the number of cycles, four main effects
were seen concerning the overall phase behavior. First, a decrease in the solubility zone
and an increase in the aggregation zone were detected, see Figure 5.2. Second, a zone with
co-appearance of crystals and precipitate occurs. Third, the creation of a pure precipitation
zone was observed, mainly at FT c3 (see Figures 5.4B and C and Figure 5.3). Fourth,
changes in the solubility line with increasing cycle number were mainly seen for high protein
concentrations and/or to low NaCl concentrations (see Figure 5.2). In the crystallization
zone at FT c0, mainly tetragonal crystals were observed for all systems. With increase
in the number of cycles, the crystal size decreased and zones with small tetragonal and
micro crystals grew. Additionally, co-appearance of crystals (mainly micro crystals) and
precipitate were observed. Finally, in some systems, a pure precipitation zone was observed,
see Figure 5.5.
Figure 5.1.: Ramping methodology. The performed process is shown for R 2, R 5, and R15
to visualize the listed parameters in Table 5.1. The blue rectangle highlight changes while
freezing and the red one while thawing.
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Figure 5.2.: The solubility lines for systems exhibiting high stability (a), medium stability
(b), and extreme combinations (c) (see Table 5.1 and Table 5.3). The solid line represents
0 cycles, the dotted lines FT c1, and the dashed line FT c3.
Figure 5.3.: Phase diagrams for systems R14 R15 representing a combination of steep and
flat ramps for FT c1 and FT c3. Detailed information for each ramp is listed in Table 5.1.
5.3.2. Variation of ramps during freezing
In this section, it was examined if the toolbox applied could distinguish the influence of
different freezing ramps (R 1-7) with a constant thawing ramp (Table 5.1 and Figure 5.1)
on the solubility line, phase behavior, and morphology. When increasing the slope of the
freezing ramp (R 1 to R 3) no significant differences for all three descriptors at FT c1, namely
solubility line (Figure 5.2 and FigureB.2A in the Supplementary Material), solubility zone
(Figure 5.4B), and aggregate morphology Figure 5.5A, could be seen. For FT c3, the only
main difference among the systems appeared for the aggregation morphology – a lower slope
of the freezing ramp (R 1) led to a larger zone of co-appearance of precipitate and crystals,
see Figure 5.4B. In contrast, R 2 and R3 representing faster freezing and thus steeper
ramps exhibited mainly small tetragonal and small micro crystals (Figure 5.4B). When
comparing R2 and R3, a slight difference was observed for the amount of micro crystals
formed. Here, slightly more micro crystals in R 2 than in R3 are visible, see Figure 5.5B.
Finally, for both systems a small amount of precipitate is seen mainly in the upper left
region of the aggregation area, representing high protein and low salt concentrations. To
investigate the necessity for rapid freezing for the whole range from 20 to -80℃ the systems
R 4–R7 show varying speeds for two inflection points, namely -20 and -35℃ (Table 5.1 and
Figure 5.4C). Again, for FT c1, no significant trend could be seen in terms of solubility
line, solubility zone (Figure 5.4C and FigureB.2) or aggregate morphology (Figure 5.4C
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Figure 5.4.: a Phase diagram obtained for 0 cycles. b Phase diagrams for systems R1-R 3
representing flat, mid and steep freezing ramps for FT c1 and FTc3. c Phase diagrams for
systems R4-R 7 representing flat and steep ramps with inflection points at -35 and -20℃ for
FT c1 and FT c3. A detailed information of each ramp is listed in Table 5.1
and Figure 5.5A). This picture changed at FT c3, where co–appearance of precipitate and
crystals was detected for all ramps (Figure 5.4C). R 5 also showed a larger amount of
conditions with small tetragonal and micro crystals, the number of crystalline conditions
decreased at R 6 and R7; they were mainly seen for low protein concentrations over the
span of salt concentration applied (R 6) and in the lower right corner of the aggregation zone
representing low protein and high salt concentrations (R 7). At R4, only co–appearance
and precipitation took place, see Figure 5.5B. As seen for R 1, precipitation occurred for
the systems R4 and R7 at the border between solubility and aggregation zone.
5.3.3. Variation of ramps during thawing
In this section, the influence of different thawing ramps (R 2, R 8-13) was investigated,
whereas the freezing ramp was kept constant at 5℃/min (Table 5.1 and Figure 5.1). In
analogy to the systems R1 -R 3 presented above, the influence of different thawing ramps
was evaluated in the set comprising R 8 (flat), R 2 (mid), and R 9 (steep). When comparing
the solubility lines at FT c1 and FT c3 to each other, a small shift to lower lysozyme and
NaCl concentration could be observed for R 8 at FT c1, whereas a mostly identical set of
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Figure 5.5.: An overview (percentage of appearance for a given system) of the morphology
portions is shown for FT c0 and all tested ramps for cycles FT c1 (a) and FTc3 (b). Gray
represents the portion of soluble states, the different shades of green represent the crystal habits
detected, and the shades of blue show the co–appearance of crystals and precipitate. Orange
illustrates light precipitate and red precipitate. c Example pictures of these morphologies are
shown: soluble (8 mg/mL lysozyme, 0.4M NaCl, FT c0), micro crystals (19mg/mL lysozyme,
0.5M NaCl, R 9, FT c1), small tetragonal crystals (21.75mg/mL lysozyme, 0.9M NaCl, R 2,
FT c1), big tetragonal crystals (19mg/mL lysozyme, 0.8M NaCl, FT c0), small tetragonal and
micro crystals (10.75mg/mL lysozyme, 0.9M NaCl, R 1, FT c1), micro crystals and precipitate
(16.25mg/mL lysozyme, 0.4M NaCl, R 4, FT c3), small tetragonal crystals and precipitate
(10.75mg/mL lysozyme, 0.9M NaCl, R 1, FT c3), light precipitate (16.25mg/mL lysozyme,
0.4M NaCl, R 2, FT c3) and precipitate (21.75mg/mL lysozyme, 0.4M NaCl, R 4, FT c3).
solubility lines was obtained at FT c3 for all systems investigated (see Figures B.2 and B.3).
This is also reflected in the dimensions of the solubility zone (see Figure 5.6A). Regarding
the morphology for FT c1 at all ramps mainly micro crystals and small tetragonal crystals
grew in the aggregation zone (see Figures 5.6A and Figure 5.5A), whereas the micro
crystals covered mainly the border of the solubility zone (data not shown). The amount
of micro crystals expressed was the highest at R 8 followed by R2 and R9 (Figure 5.5A).
The morphologies encountered in the aggregation zone at FT c3 differed among the three
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Figure 5.6.: (A) Phase diagrams for systems R 8, R 2 and R9 representing flat, mid and steep
thawing ramps for FT c1 and FT c3. (B) Phase diagrams for systems R10 -R 13 representing
flat and steep ramps with inflection points at -35 and -20℃ for FT c1 and FT c3. A detailed
information of each ramp is listed in Table 5.1
systems. At R8, the morphological composition found in the aggregation zone consisted
mainly of a co-appearance of precipitate and crystals, as well as pure precipitate, see
Figure 5.6A. In the systems where co–appearance took place, micro crystals always grew
next to precipitate. At R2 and R9, mainly crystals were observed (see Figure 5.6A),
whereas the amount of micro crystals was higher at R 9 than at R2 (Figure 5.5B). To
investigate the necessity for rapid thawing for the whole range from 20 to -80℃ the
systems R10 to R13 were created. These ramps show varying thawing speeds with two
different inflection points, namely -20 and -35℃ (Table 5.1 and Figure 5.1). For FT c1,
a difference in the solubility line between R13 and R10-12 is seen in a shift towards
lower NaCl and protein concentrations for R 13. This deviation, however, disappeared for
FT c3 (see Figure 5.2, FiguresB.2 and B.3). Concerning the aggregation zone for the two
systems, where a rapid thawing after the respective inflection point was set (R 10 and
R12), crystallization dominated the aggregation zone while the morphological composition
of the two other systems (R11 and R13) could be characterized by a co-appearance of
crystals and precipitate nearly quantitatively covering the respective aggregation zone
(Figure 5.6B). Additionally, R 11 and R13 showed higher amounts of micro crystals (see
Figure 5.5A). Again, micro crystals were mainly seen at the border between the aggregation
and solubility zone.
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5.3.4. Combinations
In the following section, the two systems R14 (fast) and R15 (slow) are compared rep-
resenting extreme cases (Table 5.1). Comparing these two extreme ramps to each other,
differences could be seen for all descriptors, mainly the solubility line, phase behavior,
and morphology. The solubility line of R 15 is shifted to lower lysozyme and NaCl con-
centrations at FT c1 and FTc3 (see Figure 5.2C). Regarding the phase behavior in the
aggregation zone, mainly crystals were created at FT c1. At FT c3 the aggregation zone of
R 15 consists of the co-appearance of precipitate and crystals as well as pure precipitate,
whereas R 14 mainly shows crystals (see Figure 5.3). Regarding the morphology at FT c1,
micro crystals and small tetragonal crystals grew for R 14 and R15 (see Figure 5.5A). This
was still observed for R 14 at FT c3, whereas the amount of micro crystals increased. Micro
crystals also grew at R 15 but only in combination with precipitate (see Figure 5.5B).
5.3.5. Stability index vs. process time
Next to the solubility line, phase behavior, and morphology, a stability index was estab-
lished trying to assess the variability of the morphological composition obtained over an
increasing number of cycles for a given system. Thus a measure for the stability of a given
system was created. Qualitatively, we attributed a certain value to each of the system
morphologies obtained (see Table 5.2).
Looking at the data obtained, it became clear that initial freezing and repeated cycling
provide different pictures in terms of underlying processes and initial system state. We
thus introduced two stability indices, one for initial freezing (SIFT c0) and one for repeated
cycling (SIcycle), see Equations 5.1 and 5.2.
SIcycle
Systems with a value above -100 in this stability index (marked yellow in Table 5.1 and
Table 5.3) represent the systems where crystallization dominated over all FT cycles. Blue
marked systems with a value between -100 and -200 (marked blue in Table 5.1 and Ta-
ble 5.3) represent systems with dominating crystallization but also show a clear onset of
precipitation over FT cycles. Unstable systems mostly characterized by a dominating
shift to precipitation exhibit a morphology variation value between -200 and -340 and are
gray–colored (see Table 5.1 and Table 5.3). The remaining systems with values lower than
-340 were left uncolored (see Table 5.1). According to this stability index, the systems are
ranked in Table 5.3. The ranking underlines the trends seen with the solubility line, the
phase behavior, and the morphology presented above. A similar ranking is seen when the
overall process time, without holding time, is used as classification (Table 5.3). While a
strong agreement between the four systems with a low stability index and a fast processing
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time was found, the systems R11, R 6, and R13 ranked less stable in the stability index
were ranked higher when using processing time as classification (see Table 5.3).
SIFT c0
The shift in morphology seen for the first FT cycle can be seen in Table 5.3. The order
deviates significantly from the order obtained for repeated cycling (SIcycle) and process
duration. The color scheme developed for SIcycle was applied to underline this finding.
5.4. Discussion
This study aimed to show the applicability of a phase diagram–based tool [224] to use
the analytically easily accessible phase behavior, crystal morphology, and solubility as
indicators for system stability and ongoing processes during FT applications. In this
context, different FT ramps were tested and data were obtained throughout the study
analyzed.
The ramps for freezing and thawing used in this study were halted at -80℃ for 30min.
We based our study on the prerequisite that no significant changes in solubility, phase
behavior, and morphology occurred during that period. Miller et al. claiming that there
are no destabilizing processes occurring when the protein is stored at -80℃ underline
this assumption [219]. The reason for this is that the chosen storage temperature is
well below Tg. At these temperatures, the protein mobility is not existent, following no
destabilizing processes taking place [146]. For lysozyme, Tg is in a region between -30 and
-70℃ depending on the solution conditions [146, 225].
5.4.1. Influence of cycle number and morphology changes
In this study, the applied toolbox detected changes in the solubility lines as a function
of the number of cycles (see Figure 5.2). In general, the creation of ice crystals, and
the subsequent exposure of the protein to the ice–water interface, freeze concentration
of solutes (buffer components, NaCl, lysozyme), and low temperatures, which can result
in cold denaturation and LLPS [35, 103, 133], influence the protein stability. NaCl is
known to be concentrate up to 22wt% (∼ 3.74M) and precipitates along with ice when the
eutectic point of 21.2℃ is reached in a binary system [226]. Salt concentration might shift
the equilibrium, between aggregated and soluble protein, toward aggregation. This effect
is probably mostly pronounced at low to medium salt concentrations where an interplay
between salt concentration, protein concentration and ramping scheme applied might lead
to different equilibrium states [96, 178, 227, 228]. This is detected by the shift of the
67
A phase diagram based toolbox to assess FT ramps on the phase behavior
solubility line to lower concentration and the decrease in the size of the solubility zone when
the number of cycles was increased. The morphology itself was affected. The greater the
number of FT operations performed, the smaller were the crystals, higher portions of micro
crystals, and precipitation co–appeared, and a zone with pure precipitation developed.
Changes in morphology mainly occur when protein–protein interaction becomes favorable
due to operations carried out. In this context, Chi et al. published that an increase in
the salt concentration due to freezing can reduce intermolecular repulsion between protein
molecules, which leads to more favorable attractive intermolecular interactions, resulting
in the formation of protein aggregates [14]. It is further assumed that this change of
intermolecular interactions might affect the aggregation mechanism or aggregation pathway
resulting in a change of aggregate morphology. In general, the aggregation rate is a
function of the protein and salt concentration. An increase in the aggregation rate leads
to a more unstructured aggregation, which results at a certain point in the appearance
of protein precipitates [41]. In addition, the amount of critical nuclei has an influence
on the size of the crystals. Freezing–induced LLPS leads to highly concentrated droplets
where the energetic barrier to create critical nuclei is easier to overcome and subsequently
smaller crystals grow [133, 186, 194]. Following this, a decrease in crystal size might be
an indicator for an increase in protein or salt concentration and/or decrease in solubility
[41]. Finally, Muschol et al. published, that solutions which are left in a two–phase liquid
region form micro crystalline precipitate [35]. With the above in mind, it is assumed that
the co–appearance, of different crystal sizes, morphologies, and precipitate, is a result
of various factors appearing during the FT cycles [109, 117, 219]. This is in accordance
with the observation, that the co–appearance is mainly detected at FT c3. Finally, the
system stability proved to be more susceptible to high protein concentrations than high
salt concentrations and the transition from solubility to aggregation zone was found to led
to changes in morphology mainly at this transition zone and high protein content.
5.4.2. FT ramping
In this section, the suitability of the toolbox applied to detect changes in system stability
arising from different FT ramps is investigated. During the freezing process, the protein
undergoes a state of freeze concentration, where protein degradation might take place.
After passing Tg and entering the glassy state, protein degradation/aggregation stops
[146, 219]. Before crossing Tg and entering the glassy state the eutectic point is crossed.
The position of the eutectic point and the way the solution behaves are dependent on the
solutes in the solution and describe how and when crystallization of the solutes and the ice
takes place. The different possibilities are described in the state systems of the solutions
[133]. This helps to get detailed information of the degree of concentration of the solutes
while freezing.
Considering the thawing process it is the other way around and by choosing a steep initial
ramp, the time, in which the protein is in the non-glassy, destructive state decreases [145,
153]. The influence of this in combination with the processing time during FT operations
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might thus be a focus point when evaluating FT operations.
Freezing ramps
Three different freezing ramps were tested, a flat (R 1), mid (R 2) and steep ramp (R 3) (see
Table 5.1). The phase behavior and the morphology showed clear differences, while changes
in solubility line were not significant among the three systems. The two rapid systems
R2 and R3 proved to be stable over the applied FT operations. This might be explained
by several underlying processes: a) The lower the freezing speed, the more the conditions
showed aggregation as seen for R 1. In general, the ratio of micro crystals to small tetragonal
crystals changed towards micro crystals by lowering the slope of the freezing ramp. These
trends are scored as more unstable (see Table 5.2). The trend to smaller crystals might be
explained by several processes occurring during FT operations. One reason could be freeze
concentration, leading to a situation where the energetic barrier is more easily overcome
and critical nuclei are created for conditions otherwise not susceptible to creation of nuclei
[28, 42, 45, 46], leading to an appearance of micro crystals. In addition, more critical
nuclei might be created [47, 208]. Both, a decrease in size of the solubility zone, and the
appearance of a lot small crystals have a negative impact on the solubility line. b) It is
assumed that lysozyme is not affected by the water–ice–surface; otherwise, the steepest
ramp would be the most damaging and the trend would be the other way around. With
fast freezing, ice dendrites with high ice–surfaces are created, and protein species which
denaturate on the ice surface are more damaged [109, 115]. In our case, however, the for-
mation of ice dendrites would be highly desirable for improving the protein stability as well
as its influence on the degree of freeze concentration [109, 229–233]. The faster the freezing
ramp, the more dendrites are created [117]. In these interdendritic spaces, lysozyme and
NaCl as well as all other solutes are trapped [117, 219] and extensive freeze concentration
is hindered [118]. This is in agreement with the order of crystal morphologies stated above.
Furthermore, when micro crystals they preferably grew in the low NaCl region. This might
be due to the influence of the salt concentration on the ice front velocity and the degree
of supercooling, which is higher for higher salt concentrations. Moreover, the route the
solution takes trough the state diagram to reach Tg, respectively crossing the eutectic point,
seems to be different for low NaCl concentrations compared to higher NaCl concentrations.
The concentration of NaCl could be higher at low NaCl concentrations due to the pure
crystallization of ice and no crystallization of NaCl, which leads to micro crystals. c)
Finally, the overall time the protein is exposed to cold temperatures (lower than 0℃)
diminishes when steep ramps are applied and reduces the glassy state [145, 153], leading to
an increase in the stability of a given system. This behavior could be observed in our study
as well. R 3 and R2 did show similar results for the solubility line, phase behavior and mor-
phology and also have a very short process time compared to the other ramps (see Table 5.3).
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Thawing ramps
The influence of the thawing ramp was investigated – in analogy to the freezing set up –
applying three different ramps, a flat (R 8), mid (R 2) and steep ramp (R 9) (see Table 5.1).
In general, the aggregation tendency increases when slow thawing is applied [118, 145].
This fits to a decreasing solubility zone observed. In addition flat thawing ramps show a
higher degree of recrystallization compared to steep ramps [118]. Finally, applying flat
thawing ramps the protein under investigation is exposed longer to the cold temperatures
[145, 153]. The degree of recrystallization and/or the time at cold temperatures might be
the reasons for the differences seen in phase behavior and morphology. The flat ramp (R 8)
consequently showed the smallest solubility zone and co–appearance of precipitate and
crystals at 0.4M NaCl. It might further happen that with flat thawing ramps unfolding of
protein increases [228], which in most cases results in protein precipitation [209].
5.4.3. Combinations
In addition to the above, two combinations with the potentially steepest (R 14) and flattest
(R 15) ramp of the single steps were tested. The outcome of this comparison clearly
highlights the above discussed dependencies on the processing speed (see Table 5.3).
5.4.4. Inflection points
The influence of different inflection points for ramps used in our study was tested during
freezing as well as during thawing. The order of the system when applying our stability
index (Table 5.3) showed that slow freezing or thawing in the higher temperature range
(above or close to Tg) results in more unstable systems (R4 and R13). This is due to
a high mobility of proteins above and a low mobility below this temperature [145, 153].
This might also have an influence on the morphology. The longer the protein is placed in
the glassy state the more critical nuclei are created and lead to micro crystals, unsorted
aggregation, and precipitation. The latter explains why these systems show an increasing
number of micro crystals, co–appearance of crystals and precipitate (even more at FT c3).
According to the literature, Tg of lysozyme is an a region between -30 and -70℃depending
on the solution conditions [146, 225]. Initial pre–tests with our system located Tg to be
between -50 and -60℃.
5.4.5. Stability index
The importance of the inflection point or Tg is further highlighted by the introduced
stability index. By analyzing Table 5.3, it became clear that the processing time gives a
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good first estimate on the suitability of a chosen ramp. However, a ranking according to
the process time alone could not take into account, that proteins undergo different states
trough trough the FT process. The introduced stability index SIcycles clearly confirmed
our hypothesis that suitable and stable systems show a low variability in morphology over
several FT cycles. Furthermore, using morphology as a classification parameter allowed us
to identify the significant influence the glass transition temperature has on the choice of
suitable FT operations.
In contrast the order of SIFTc0 showed no correlation to the order obtained for repeated
cycling or to process time. It can thus be derived that different processes dominate the two
unit operations, namely initial FT operation and repeated FT cycling. This said, it becomes
clear that the systems R 3, R 12, and R 14 were suitable for both initial FT operations and
repeated cycling and thus might be the systems of choice for further investigations.
5.5. Conclusion
The applied phase diagram–based toolbox allowed the detection of the influence of different
FT ramps on the protein solubility, phase behavior, and crystal morphology. It could
be clearly shown that the glass transition temperature is a highly important parameter
when designing suitable FT operations. Looking at the different process descriptors in
more detail, the solubility could only support the statements made regarding the phase
behavior and the morphology, with the morphology and morphological changes being the
most important parameters. The data obtained when applying the toolbox allowed several
assumptions to be made: (1) the ice surface does not have an influence on the stability of
lysozyme, (2) recrystallization seems not to be a problem for the stability, (3) the main
parameter influencing the FT operations seems to be the overall time of exposure to cold
temperatures while being in the glassy state of the protein. Finally, two ranking schemes
were applied based on the process time and variability of the system morphology. With
the help of the overall process time, a presorting of the systems could be made regarding
FT stability. Nevertheless, biochemical issues such as the glass transition temperature are
not captured by this procedure. For a more detailed sorting the variation in morphology
obtained between different cycles (FT c1 to FT c3) has to be taken into account. The
introduced stability index could clearly capture the glass transition temperature and was
found to be a good measure for system stability during FT operations.
In future work, the correlation of the underlying physical/biochemical processes with
system stability will be further investigated.
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Abstract
Short–term parameters correlating to long–term protein stability, such as the protein
cloud point temperature Tcloud, are of interest to improve efficiency during protein product
development. Such efficiency is reached if short–term parameters are obtained in a low
volume and HT manner. This study presents a low volume HT detection method for
(sub–zero) Tcloud determination of lysozyme, as such an experimental method is not
available yet. The setup consists of a cryogenic device with an automated imaging system.
Measurement reproducibility (median absolute deviation of 0.2℃) and literature–based
parameter validation (Pearson correlation coefficient of 0.996) were shown by a robustness
and validation study. The subsequent case study demonstrated a partial correlation between
the obtained apparent Tcloud parameter and long–term protein stability as a function of
lysozyme concentration, ion type, ionic strength, and freeze/thaw stress. The presented
experimental setup demonstrates its ability to advance short–term strategies for efficient
protein formulation development.
Keywords: freeze/thaw, long–term protein stability, phase diagrams, lysozyme, liquid–
liquid phase separation
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6.1. Introduction
Long-term protein stability is an important parameter to assess during the development
of biopharmaceutical products, as it determines safety, efficacy, and manufacturability of
the protein product concerned [6, 24, 26, 43, 234]. Long–term protein stability is gov-
erned by protein characteristics, such as structural flexibility, surface charge, and surface
hydrophobicity, which in turn are influenced by environmental conditions, such as pH,
excipients, temperature, and pressure [14, 24, 33]. Due to the intertwined influence of
protein characteristics and its environmental conditions, long–term protein stability needs
to be evaluated for each protein product separately. Currently, biopharmaceutical products
need to be stored for at least 18–24 months to demonstrate long–term stability [4]. A wide
range of environmental conditions is usually tested during the required storage time to
obtain a broader product understanding. This knowledge supports the development of
stable products, as well as the development of predictive approaches, which in turn leads
to quicker formulation development of future products.
A common approach to evaluate long–term protein stability is to establish protein phase
diagrams, where long–term protein stability is optically detected as a function of differ-
ent environmental conditions [41]. In this study, protein phase diagrams were generated
with microbatch experiments. These miniaturized experiments have been optimized for
HT screening [158], to limit material usage and reduce the experimental workload. The
microbatch experiments allow for screening a wide range of solution conditions, but these
experiments still require a long–term storage period. To eliminate this prolonged stor-
age period, and thereby reducing developmental resources, it is desired to move towards
short–term protein evaluation parameters which correlate to long–term protein stability
[233]. This can only be achieved when short–term evaluation parameters represent domi-
nant factors that govern protein stability over time. In general, conformational stability
(structural stability) and colloidal stability (protein–protein interactions) need to be rep-
resented, as modifications in these properties leads to protein aggregation [235]. Due to
the complexity of long–term protein stability, and the underlying interplay of colloidal
and conformational stability, various short–term parameters representing colloidal stability
[182, 236], conformational stability [164, 237, 238], and a combination of both [53, 183, 184,
239, 240], have been evaluated. However, a set of short–term parameters that is applicable
for most cases has not been established. A continued exploration of short–term parameters,
to either represent colloidal or conformational stability, will advance the development of an
analytical toolbox to determine environmental effects on long–term stability in a shorter
time frame.
This work focusses on the protein Tcloud as short–term protein parameter, which is defined
as the temperature at which LLPS occurs. Tcloud is dependent on the protein–protein
interaction strength, where strong attractive interactions lead to LLPS at higher tempera-
tures [149]. The dependency of Tcloud on protein–protein interactions makes it a known
representative parameter of colloidal stability [140, 149–151, 241–243]. Formulations at
low protein and salt concentration may need to reach sub–zero temperatures to induce
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LLPS [150], as relatively weak attractive protein–protein interactions are found under such
conditions [165]. When LLPS is induced by sub–zero temperatures, it occurs before the
aqueous solution starts to freeze. LLPS results in the formation of protein–rich droplets
in a protein–poor liquid phase, which causes an increase in solution turbidity [140]. The
subsequent change in solution turbidity is often used to determine Tcloud. Experimental
methods to determine Tcloud by means of solution turbidity include light scattering methods
[35, 41, 140, 150, 244], UV–Vis absorbance [243], thermo–optical analysis (TOA) [242],
microscopy [245, 246], and image analysis [247, 248].
Tcloud is a known representative of colloidal stability, but the incorporation of Tcloud as a
short–term parameter in HT formulation screenings is dependent on its screening method-
ology as well. HT screening efficiency is desired to maintain an advantage over HT phase
diagram construction. To achieve such screening efficiency in a Tcloud measurement, the
following criteria have to be met: (a) an HT setup, to keep workload to a minimum, (b)
low sample volume, to limit material use, and (c) the ability to measure at sub–zero Celsius
temperatures, which is required to reach Tcloud for low protein concentrations. These three
criteria are met separately by studies reported in the literature [242, 247]. However, to
the best of our knowledge, an experimental method that combines all these criteria has
not yet been reported. Therefore, this study seeks to combine all three criteria in a single
experimental setup. In previous studies concerning the effect of FT cycles on protein
formulations, an HT cryogenic device was employed [224, 249]. The HT cryogenic device
meets criteria (a) and (b), as it is compatible with low volume microtiter plates. Criterion
(c) is met as different FT rate combinations can be set within the operating temperature
range of 20.0℃ to -100.0℃ allowing controlled sub–zero Celsius measurements. As all
above–mentioned criteria are met with the HT cryogenic device, it was investigated whether
the cryogenic device could be adjusted for Tcloud detection. To achieve this, an image–based
analysis approach to detect the solution turbidity changes as a function of the temperature
was employed. This was realized by adding an image acquisition system and light source
onto the cryogenic device. The combination of the HT cryogenic device and the automated
imaging system results in a low volume, HT, and sub–zero experimental setup for the
detection of Tcloud.
The proposed experimental setup was subjected to a robustness and validation study to
evaluate its performance. The robustness study was performed to select a representative
Tcloud parameter and determine its reproducibility. The robustness was evaluated by Tcloud
determination of 60 replicates at three different temperature rate combinations. The valida-
tion study was performed to compare the results obtained with the presented experimental
setup to literature data. In addition to the robustness and validation study, the experimen-
tal setup was employed to perform a case study. In this case study, the effect of four different
salts (sodium chloride (NaCl), sodium sulfate (Na2SO4), ammonium chloride (NH4Cl), and
ammonium sulfate ((NH4)2SO4) at ten different ionic strengths (0 – 2025mM) on Tcloud of
chicken egg–white lysozyme at six different concentrations (3 – 18 g/L) was investigated.
These conditions were selected to cover a narrow range of low protein concentrations and a
relatively wide range of ionic strength to further evaluate the performance of the proposed
experimental setup. Subsequently, the correlation between Tcloud and long–term protein
phase behavior was assessed. All formulations were also subjected to FT stress, in order
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to investigate the correlation between Tcloud and FT stress–induced long–term protein
instability. The correlation between Tcloud and the different environmental conditions was
investigated to determine the applicability of the proposed experimental method as part of
an analytical toolbox to correlate the long–term storage stability of protein formulations
with short–term measurements. The robustness, validation, and case study were performed
to demonstrate the reproducibility, reliability, and applicability of the presented low volume
and HT protein Tcloud determination method in the field of long–term protein stability
research.
6.2. Materials and methods
6.2.1. Buffer preparation
A 0.1M acetate buffer at pH4.5 was used for the robustness study. The respective buffer
components were acetic acid (Merck KGaA, Darmstadt, DE) and sodium acetate (Sigma-
Aldrich, St. Louis, MO, USA). For the validation study, a 0.6M sodium phosphate buffer
consisting of di–hydrogen phosphate (Merck KGaA) and di-sodium hydrogen phosphate
(Merck KGaA), at eight different pH values (pH 5.8, 6.0, 6.3, 6.5, 6.8, 7.2, 7.4, and 7.8), was
used. For the case study, a 20mM MCB system [197] at pH5.0 was prepared. The MCB
consisted of AMPSO (33.01mM; Sigma–Aldrich, St. Louis, MO, USA), TAPSO (28.92mM;
Sigma–Aldrich, St. Louis, MO, USA), MES (24.35mM; AppliChem GmbH, Darmstadt,
DE), formic acid (9.58mM Merck KGaA), and D (+) malic acid (26.06mM; Sigma–Aldrich,
St. Louis, MO, USA). The pH value of each buffer was adjusted to ±0.2 pH unit accuracy
with 4M sodium hydroxide (Merck KGaA) or 32% hydrochloric acid (Carl Roth GmbH +
Co. KG, Karlsruhe, DE) as titrant, employing a five–point calibrated pH meter (HI-3220,
Hanna® Instruments, Woonsocket, RI, USA) equipped with a SenTix® 62 pH electrode
(Xylem Inc., White Plains, NY, USA). With the exception of the validation study buffer,
for which the pH value was adjusted by mixing 0.6M sodium di-hydrogen phosphate and
0.6M di–sodium hydrogen phosphate in the appropriate ratios. After preparation, buffer
solutions were filtered using a 0.2µm Supor® polyethersulfone (PES) (Pall Corporation,
Port Washington, NY, USA) filter. The pH value was verified and adjusted to an accuracy
of ± 0.02 pH unit prior to use. The buffers were stored at room temperature for a maximum
of 2 weeks after preparation.
6.2.2. Salt stock solution preparation
Salt stock solutions were prepared with sodium chloride (NaCl; Merck KGaA), ammonium
chloride (NH4Cl; Merck KGaA), sodium sulfate (Na2SO4; Merck KGaA), and ammonium
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sulfate ((NH4)2SO4; VWR, Radnor, PA, USA). For the robustness study, a sodium chloride
stock solution of 2200mM was prepared. For the case study, a stock solution with an ionic
strength of 2025mM was prepared for each of the four salts. This corresponds to a molar
concentration of 2025mM for NaCl and NH4Cl, and 675mM for Na2SO4 and (NH4)2SO4.
After stock preparation, the pH value was verified and adjusted when necessary. The salt
stock solutions were filtered as described for the buffers. The salt stock solutions were
stored at room temperature for a maximum of two weeks after preparation.
6.2.3. Protein stock solution preparation
A protein stock solution was prepared by dissolving lyophilized lysozyme from chicken
egg white (Hampton Research, Aliso Viejo, CA, USA) in a 0.1M acetate, 0.6M sodium
phosphate, or MCB buffer without salt for the robustness, validation, and case study,
respectively. The protein stock solution was filtered over a 0.2µm syringe cellulose acetate
filter (VWR, Radnor, PA, USA). Desalting was performed with PD columns (G-25 MiniTrap
or PD-10 Desalting, GE Healthcare, Uppsala, SE), employing the manufacturers spin
protocol [250]. The protein concentration was determined with a NanoDrop 2000c UVVis
spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA), using an extinction
coefficient E1%(280 nm) of 22.00 Lg-1cm-1. The concentration of the protein stock solution
was adjusted to 70.0 g/L, 90.0 g/L, and 54.0 g/L, with a standard deviation of ±2.0 g/L,
for the robustness, validation, and case study, respectively. Due to the detection range
(0 – 50 g/L for lysozyme) of the employed UVVis spectrophotometer, 1:10 dilutions were
prepared for all performed studies to determine the exact protein concentration. Protein
stock solutions were prepared on the same day as the experiment.
6.2.4. Cloud point measurement
The experimental setup to determine Tcloud is composed of a cryogenic device (EF600M 105,
Grant Instruments, Cambridgeshire, UK) and an image acquisition system. The complete
setup is schematically depicted in Figure 6.1, where red lines indicate data transfer and
blue lines indicate control connections. The image acquisition system includes a light
source (USB Port 20 LED Ring, Ledmondo GmbH, Warngau, DE)(Figure 6.1 c), and
a GoPro Hero4 camera (GoPro Inc., San Mateo, US)(Figure 6.1 d), which is controlled
by a tablet (Samsung Galaxy NotePro 12.2, Samsung, Seoul, KR)(Figure 6.1 b). Images
were obtained every 0.5 s for the robustness and the case study, and every 2.0 s for the
validation study. The photo time lapse mode and the 7megapixel medium mode were
employed for all studies. Image–based data was saved on the camera (Figure 6.1 c) and
transferred to the computer (Figure 6.1 a) after the measurement. Data on the measured
temperatures during the experiment was transferred from the cryogenic device (Figure 6.1 g)
to the computer (Figure 6.1 a). Employed settings of the cryogenic device are described
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in previous work [224, 249]. All samples were prepared and measured in crystallization
plates (MRC Under Oil 96 Well, SWISSCI AG, Neuheim, CH), sealed with Duck® Brand
HD Clear sealing tape (ShurTech® brands, Avon, OH, USA), with a sample volume of 24µL.
Figure 6.1.: Schematic drawing of the experimental setup. The setup is composed of a
desktop computer (a), a tablet (b), a light (c), a camera (d), and a cryogenic device (g). The
camera (d) is connected to a tablet (b) and a light (c). A microtiter plate (e) is clamped onto
temperature-controlled adapter (f) in the cryogenic device (g). The tablet (b) displays the
top view of the microtiter plate. The blue line represents control connections and the red line
represents data transfer.
Robustness study
For the robustness study, 60 replicates of 54 g/L lysozyme in a 0.1M acetate buffer at
pH 4.5 with 550mM NaCl were used to determine the reproducibility of the presented
experimental method and the effects of FT rate combinations on Tcloud determination. The
robustness study was also employed to evaluate the information content of the obtained
data, where different distinct points were extracted and assessed. Samples were prepared
using a mixing ratio of 2:1, which corresponds to 16µL of 70 g/L lysozyme stock solution
to 8µL 2200mM sodium chloride stock solution. To determine the effect of the selected FT
rate combinations on the Tcloud measurement, three FT rate combinations were evaluated:
(1) 0.5℃/min freezing and 0.5℃/min thawing, (2) 2.5℃/min freezing and 2.5℃/min
thawing, and (3) 10.0℃/min freezing and 2.5℃/min thawing. All combinations were used
to perform an FT run between 20.0℃ and -10.0℃, with a holding time of 1min at -10.0℃,
except for the first FT combination (0.5℃/min), where the holding time was omitted. For
each rate combination, the deviation between the set temperature and the actual measured
temperature in the cryogenic device can be found in the Supplementary Material, FigureB.5.
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Validation study
The validation study was used to validate the presented experimental setup by compar-
ing literature data to experimental Tcloud data obtained under similar conditions. The
validation dataset consisted of six replicates of 90 g/L of lysozyme at eight different pH
values (pH5.8, 6.0, 6.3, 6.5, 6.8, 7.2, 7.4, and 7.8) in a 0.6M sodium phosphate buffer.
Samples (400µL) were prepared in Eppendorf tubes (Eppendorf AG, Hamburg, DE) by
dissolving the lysozyme directly into the respective buffer. Further details of the protein
stock solution preparation are described in Section 6.2.3. The validation data was obtained
by performing an FT run between 10.0℃ and -20.0℃, employing a 0.1℃/min FT rate
and a holding time of 5min at -20.0℃. Comparative literature Tcloud data was obtained
from Taratuta et al. [151].
Case study
The case study was performed to evaluate the change in lysozymes long–term stability
and the correlation to Tcloud as an effect of four different salts (NaCl, NH4Cl, Na2SO4,
(NH4)2SO4) at ten different ionic strengths (0, 225, 450, 675, 900, 1125, 1350, 1575, 1800,
and 2025mM) in combination with six lysozyme concentrations (3, 6, 9, 12, 15, and
18 g/L). This resulted in 60 samples per salt type. The samples per salt type were prepared
manually in a single 96–well plate. Tcloud was determined with an FT rate combination of
2.5℃/min freezing and thawing to perform an FT run between 20.0℃ and -80.0℃, with
a holding time of 30min at -80.0℃. All plates were prepared and measured in duplicate.
These settings were chosen to match an FT cycle that was used to investigate the effect
of FT stress on long–term protein stability [249]. This allowed for the evaluation of the
correlation between the influence of FT stress on long–term stability and Tcloud, in addition
to the effects of protein concentration, salt type, and ionic strength on long–term stability.
6.2.5. Long–term storage
To evaluate the correlation between Tcloud and long–term protein phase behavior of lysozyme,
all case study samples were monitored at 20.0℃ for 40 days in the incubation chamber
RockImager54 (Formulatrix, Bedford, MA, USA). Monitoring long–term protein phase
behavior consisted of two experiments. The first experiment included the preparation,
storage, and monitoring of lysozyme under the case study conditions that were not subjected
to the FT cycle needed to determine Tcloud. The second experiment included the storage
of lysozyme under the case study conditions that were used to determine Tcloud. These
two experiments were performed as lysozyme aggregation during long–term storage is
influenced by the required FT run to determine Tcloud [249]. The employed approach
allowed for the evaluation of long–term phase behavior of lysozyme as a function of Tcloud
with and without FT stress effects. Preparation and handling of the long–term phase
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behavior experiments were performed as published by Baumgartner et al. [158]. Storage
was monitored via imaging with visible light at 0 h, 1 h, 2 h, every 2 h until day 1, every
4 h on day 2, every 6 h until day 8, and every 24 h from day 9 until day 40. In addition to
visible light imaging, cross–polarized light and ultraviolet (UV) light images were captured
on day 0, 1, 5, 10, 20, 30, and 40. All plates were prepared and monitored in duplicate.
6.2.6. Data processing
Unless stated otherwise, all images obtained during Tcloud measurements and long–term
storage experiments were imported for data processing, and all data processing and visual-
ization was conducted with MATLAB (version 2018b, MathWorks, Natick, MA, USA) and
R (version 1.0.136).
Cloud point detection
Images obtained during the Tcloud measurement capture the entire plate. The images were
converted to grayscale and cropped to evaluate each well separately. The total intensity
difference between the first image of a well and every other time point was calculated for
each of the 60 wells. The intensity difference between the first well image and each well
image in time was obtained by subtracting the respective images, using MATLAB function
imsubtract. The total intensity difference was subsequently calculated by summing up the
intensity of the subtraction image. This resulted in a total intensity difference value for
each time point. An example of the cropped well images and a schematic overview of the
described processing can be found in Supplementary FigureB.4. From the total intensity
difference data over time, four temperatures of interest were extracted: (1) clouding onset
temperature (TCO), (2) clouding end temperature (TCE), (3) declouding onset temperature
(TDO), and (4) declouding end temperature (TDE). All extracted temperature values
were based on the temperatures measured by the cryogenic device. Figure 6.2 a shows an
exemplary total intensity over time graph including these temperatures of interest. An
increase in total intensity difference can be observed as the temperature decrease, for which
the descriptive term clouding is used, and a decrease in total intensity difference is depicted
upon increasing the temperature, for which the descriptive term declouding is used.
To extract TCO and TCE , the maximum gradient in total intensity increase was determined
during cooling. The maximum gradient was extracted from the first derivative of the
total intensity difference data over time. A schematic of the first derivative is shown in
Figure 6.2 b. The first derivate was calculated from a smoothing spline fit of the total
intensity different data over time, employing MATLAB functions fit and differentiate.
A smoothing parameter of 0.03 was used. The maximum gradient was defined as the
maximum value of the first derivative within the search space during freezing. With the
identification of the maximum gradient, TCE and TCO were extracted. The point at which
the first derivative becomes negative before the maximum gradient was used to define TCO,
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Figure 6.2.: Schematic visualization of the employed data extraction protocol. (a) An
exemplary plot of a resulting intensity difference over time graph, with an indication of the start
of the temperatures of interest (circles), maximum gradient (diamond), and midtime (triangle).
The difference intensity (left y-axis; black) is plotted against the time (x-axis; seconds). The
measured temperature is shown as well (right y-axis; gray; řC). Four points are highlighted,
which are named (1) clouding onset temperature (TCO), (2) clouding end temperature (TCE), (3)
declouding onset temperature (TDO), and (4) declouding end temperature (TDE). (b) Schematic
of the first derivative of the data in (a). (c) Graph indicating the starting temperature of the
freezing search space (blue square) of the robustness study. (d) Graph indicating the starting
temperature of the freezing search space (blue square) of the validation study. (e) Graph
indicating the starting and end temperature of the freezing search space (blue square), as well
as the starting temperature of the thawing search space (orange square) of the case study.
while the first negative point after the maximum gradient was used to define TCE . TCO and
TDE were determined with the use of the maximum gradient of total intensity difference
decrease during thawing. The maximum gradient was defined as the minimum value in the
first derivative within the search space during thawing. TDO was defined as the maximum
total intensity value in the thawing search space before the maximum gradient. TDE was
defined as the point where the derivative becomes positive after the maximum gradient of
total intensity decrease.
Figure 6.2 c-e depict the temperature thresholds that were employed during data extraction
for each study. For the robustness and validation study, the freezing search space start
was set at 5.0℃ and the freezing search space end was set at middle time point of the
overall measurement (midtime). The freezing search space start was set to 5.0℃, as camera
movement was observed before this temperature was reached. The thawing search space
was set between midtime and the end of the measurement for both studies. For the case
study, the freezing search space was set between 0.0℃ and -50.0℃ and the thawing search
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space was set between -50.0℃ and the end of the measurement. A freezing search space
starting point of 0.0℃ was chosen to eliminate initial camera movement effects and a
freezing search space endpoint of 50.0℃ was chosen as solutions were assumed to be frozen
below -50.0℃.
For the validation study and case study, one image every 10.0 and 2.5 s was processed,
respectively, due to a large number of images generated (one every 2.0 and 0.5 s, respec-
tively) during the ∼10.0 h (validation study) and ∼2.5 h (case study) measurements. Data
obtained for the validation study was smoothed using a moving mean window of 100 data
points before fitting, employing the movmean MATLAB function. A similar smoothing
procedure was applied for the case study data, employing a moving mean window of
25 data points. An example of smoothed data can be found in the Supplementary Material,
FigureB.10.
Validation study
In the validation study, six replicates of eight samples were measured. TCE was determined
for each replicate separately. The median TCE of all six replicates was calculated to
represent the central tendency of each sample, and the MAD of the TCE was calculated to
represent the deviation between the replicate samples. To compare experimental data with
literature data, both datasets were scaled to the respective minimum and maximum value
using Equation 6.1.
y′ = y − ymin
ymax − ymin (6.1)
In Equation 6.1, y represents the scaled value, y represents the raw value, ymin represents
minimum value in the respective dataset, and ymax represents the maximum value in the
respective dataset.
The PCC and mean squared error (MSE) were used as evaluation parameters to determine
the correlation and error between literature and experimental data, respectively. The
PCC was calculated with MATLAB function corrcoef and the MSE was calculated with
Equation 6.2.
MSE = 1
n
∗
n∑
i=1
i ∗ (yi − yˆi)2 (6.2)
In Equation 6.2, yi represents the experimental data point, yˆi represents the literature data
point, and n the total number of data points.
MPPD
Long–term stability of lysozyme formulations was evaluated employing a MPPD [251]. In
an MPPD, morphologic and kinetic aggregation data obtained from images taken during
storage is compiled in one figure by data dimension reduction and subsequent clustering.
The following data was extracted from images obtained during storage: (1) length of a
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maximum of four crystals in m, (2) width of a maximum of four crystals in m, (3) percentage
of aggregation well coverage (nAgg), (4) aggregation growth onset time (t0) in hours, and
(5) aggregation cessation time (tE) in hours. The length and width of a maximum of four
crystals were used to calculate the mean crystal length (LC) and width (WC), as well as
the interquartile range of the crystal lengths (MLC) and widths (MWC). This data was
used to represent the average crystal dimensions and its distribution, respectively. For the
extraction of the aggregation growth onset and cessation time, it was decided to employ
UV light images. This was done as preliminary data extraction of aggregation growth
onset and cessation time based on UV light images showed a good correlation to initial
visual inspection (data not shown). The total intensity difference of UV images over time
was obtained and fitted as described in Section 6.2.6. The first derivative of the fitted total
intensity difference obtained from UV images over time was used to determine t0 and tE .
The time point at which 90% of the maximum value in the first derivative was reached was
defined as t0. The time point at which 20% of the maximum value in the first derivative
was reached after t0 was used to define tE . The difference between t0 and tE was used to
define aggregation growth time (tG).
The MPPDs were constructed using LC , WC , MLC , MWC , nAgg, t0, and tG. All data
was extracted for each duplicate plate and averaged. An MPPD for each plate was
also constructed separately to determine reproducibility. This data can be found in the
Supplementary Material, Figure B.14. The results of the long–term storage experiment
were shown to be reproducible for all conditions, except for the two plates containing
lysozyme in combination with (NH4)2SO4 stored without being subjected to an FT run.
One of these duplicate plates showed dried up wells after storage, which influenced the
observed aggregation morphology. Based on this observation, only the data obtained from
the plate without dried up wells was used. All settings for the MPPD construction have
been described in previous work [251], where the clustering algorithm selected an optimal
cluster number between 1 and 8 clusters.
6.3. Results and discussion
6.3.1. Robustness study
The robustness study was performed to evaluate the experimental performance and re-
producibility of the proposed experimental setup. The experimental performance was
assessed using three different FT rate combinations in three separate measurements. Repro-
ducibility was evaluated by measuring 60 replicate samples for each FT rate combination.
The robustness study was also used to evaluate four temperature points (TCO, TCE , TDO,
TDE) that were extracted from the resulting data as potential representation of Tcloud.
Table 6.1 lists the median ± MAD of the four temperature points obtained with three rate
combinations based on 60 replicate samples.
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Table 6.1.: Overview of TCO, TCE , TDO, and TDE for three different FT rate combinations
(℃/min) obtained for the robustness study. The values are given as median ± MAD, obtained
with a sample size of n = 60.
Freezing
rate [℃/min]
Thawing
rate [℃/min]
TCO [℃] TCE [℃] TDO [℃] TDE [℃]
0.5 0.5 -0.4 ± 0.2 -2.3 ± 0.1 1.6 ± 0.9 7.9 ± 0.4
2.5 2.5 -4.4 ± 1.2 -7.0 ± 0.3 4.9 ± 0.0 7.1 ± 0.5
10.0 2.5 -14.1 ± 0.4 -13.3 ± 0.3 4.0 ± 0.3 6.1 ± 0.3
The applied FT rate combinations were set to operate in a range between 20.0℃ and
-10.0℃. Temperature points measured outside the set boundaries, such as the TCO (-14.1
± 0.4℃) and TCE (-13.3 ± 0.3℃) for a freezing rate of 10.0℃/min, indicated a hardware
complication. It was observed that the set temperature differed from the actual mea-
sured temperature inside the cryogenic device, as shown in the Supplementary Material,
FigureB.5. The evaluation of different FT rates showed a larger deviation for faster
rates, where an MSE of 0.01℃2 was found for an FT rate of 0.5℃/min, and an MSE of
14.85℃2 for 10℃/min freezing in combination with 2.5℃/min thawing. This indicates
that temperature control in the presented experimental setup is less reliable for faster FT
rates compared to slower rates.
The applied FT rates affected the absolute temperature point (TCO, TCE , TDO, TDE)
values as well. Both clouding temperature points, TCO and TCE , were highest when a
freezing rate of 0.5℃/min was applied. Increasing the freezing rate to 2.5℃/min and
10.0℃/min showed a decrease of TCO (from -0.4 ± 0.2℃ to -4.4 ± 1.2℃ and -14.1 ± 0.4℃,
respectively) and TCE (from -2.3 ± 0.1℃ to -7.0 ± 0.3℃ and -13.3 ± 0.3℃, respectively).
This observation could be explained by two effects. The first effect considers a relatively
low detection sensitivity. It was assumed that it takes a certain amount of time for the
formulation to reach a level of cloudiness that is detectable by the presented experimental
setup. The temperature continues to decrease during this time, and faster freezing rates
resulted in a lower absolute temperature than slower freezing rates. Thus, upon reaching
the detectable level of cloudiness, a lower absolute temperature was found for TCO and
TCE for faster freezing rates. The second effect considers the inconsistency between the
measured temperature in the cryogenic device and the actual (unmeasured) temperature
of the sample. It has been reported for three different temperature decreasing steps (0.3℃,
1.0℃, and 3.0℃) that an increased amount of time (∼6, ∼20, and >30 min, respectively)
was required to obtain the desired sample temperature for larger temperature steps [247].
This would result in the detection of TCO and TCE at lower temperatures for faster freezing
rates, as the sample temperature adjusts slower than the measured temperature in the
cryogenic device. Both these effects could also explain the difference in TDO for different
thawing rates, where the 0.5℃/min thawing rate shows the lowest TDO.
Table 6.1 shows a difference between the range of the clouding temperature points (∼0.0℃
to ∼ -14.0℃) and the declouding temperature points (∼1.0℃ to ∼8.0℃). The occurrence
of formulation clouding at a lower temperature compared to the formulation declouding
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temperature has been reported in literature and was attributed to required nucleation
energy for the formation of a new phase [140]. The obtained differences between the
clouding temperature and the declouding temperature in the presented robustness study
(∼6℃) are larger than that reported in the literature (∼1.0℃). This could be due to the
employed combination of freezing and thawing instead of cycling through the clouding or
the employed freezing rate, where the freezing rate in literature was 0.2℃/min [140] instead
of 0.5-10.0℃/min. The freezing rate may have caused an increased distance between the
clouding and declouding temperature, as this effect was also observed for the different FT
rate combination results listed in Table 6.1.
The robustness study was also used to evaluate each temperature point individually, in
order to determine which temperature point could be used to represent Tcloud. An absolute
TDO value of 4.9 ± 0.0℃ and 4.0 ± 0.3℃ was obtained with a freezing rate of 2.5℃/min
and 10.0℃/min, respectively, while a similar 2.5℃/min thawing rate was used. The
difference between the TDO values indicates that the absolute value was influenced by the
freezing rate. This was attributed to the lack of temperature control for faster freezing rates.
The influence of the temperature control sensitivity on the freezing rate, and indirectly
on the absolute values of declouding temperature points, makes declouding temperature
points less reliable as a comparative evaluation parameter. Terefore, the declouding points
were not considered to represent the protein Tcloud. Between the two clouding points, TCO
and TCE , TCE showed a lower average MAD value (0.6℃ and 0.2℃ for TCO and TCE ,
respectively) and was, therefore, chosen as Tcloud representation.
Compared to the literature, the TCE MAD of 0.20℃ is only slightly higher than the
standard deviation of 0.13℃ reported for another image–based Tcloud detection setup
[247]. A light scattering–based approach to determine Tcloud reported a reproducibility
of a few tenths of a degree [35], which is comparable for the MAD shown in Table 6.1.
Thus, an average MAD of 0.20℃ reflects a low deviation between 60 replicates and shows
that the determination of TCE is precise and reproducible. The corresponding intensity
difference value for TCE and TDO as well as the absolute TCE value was inspected per well
to investigate the potential detection bias towards certain well positions as an effect of
the employed light and camera setup. Upon inspection of the intensity difference values
at TCE and TDO, a slight well position bias as a result of the experimental light and
camera location could be observed, as shown in the Supplementary Material, FigureB.6.
Despite this observation, the data extraction protocol has shown to be robust towards such
intensity deviations, as a high precision and reproducibility of TCE was found. A plate
format visualization of the absolute TCE values per well, for each FT rate combination, is
shown in the Supplementary Material, FigureB.7.
The robustness study showed that temperature point detection by means of image analysis
is precise and reproducible. However, the evaluation of three different FT rate combinations
showed a hardware complication regarding set temperature values, where a decrease in
temperature control was seen for faster FT rates. It was also observed that the applied
FT rate combinations influenced the absolute value of the observed temperature points.
This means that the results obtained with the proposed experimental setup are applicable
for comparative screening purposes when similar cryogenic device settings are employed.
Based on the robustness study results, TCE was selected as a representation of Tcloud.
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6.3.2. Validation study
The validation of the proposed experimental setup to yield a representative parameter of
Tcloud was conducted based on a comparison between experimental and literature data.
Eight samples were reproduced from the literature [151] and the corresponding TCE was
determined. The experimental and literature results are shown in Figure 6.3.
Figure 6.3 shows experimental and literature data, where normalized and absolute values
Figure 6.3.: (a) Comparison between normalized literature [151] (x–axis) and experimental
data obtained for the validation study (y–axis). Two evaluation parameters are shown,
(1) the Pearson correlation coefficient (PCC) and (2) the mean squared error (MSE). (b)
Absolute literature cloud point temperature values as open circle and experimental clouding
end temperature values as filled circles (y–axis; ℃) per pH value (x–axis).
are displayed in 6.3 a and 6.3 b, respectively. Both figures include MAD error bars for the
experimental data, which were calculated based on six replicates. The relatively small size
of the error bars indicates a precise measurement. This was confirmed by the inspection
of the experimental TCE per well (Supplementary Material FigureB.9) and the absolute
TCE values (Supplementary Material TableB.2). The normalized validation study results
displayed in Figure 6.3 a show a strong linear dependency between Tcloud reported in the
literature and TCE obtained with the proposed experimental setup. This is represented
by a PCC of 0.996, where a PCC of above 0.900 indicates a strong linear dependency
between evaluated datasets [252]. In addition, an MSE of 0.002 indicates a small error
between normalized experimental and literature data. The PCC and MSE reflect that
TCE is applicable as a representation of Tcloud. Despite the strong correlation between
normalized experimental and literature data, the absolute values shown in Figure 6.3 b
are not comparable. The strong correlation of normalized data in combination with the
absolute value differences indicates that TCE is an apparent Tcloud.
The detection of deviating absolute temperatures was attributed to the employed experi-
mental setup, where three differences were identified compared to the literature setup. The
first difference is the employed FT rate. An FT rate of 0.1℃/min was employed for the pre-
sented validation study. This rate was selected based on the mentioned temperature control
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accuracy of 0.1℃ in the literature study used for comparison, but an exact FT rate was
not documented. The applied FT rate has a large influence on the absolute temperature, as
discussed in the robustness study (Section 6.3.1). The experimental data consistently shows
lower absolute temperatures, which means that the employed freezing rate in the validation
study was faster than the actual rate employed in the literature. A difference between set
and measured temperature during the validation study measurements was not considered
as a reason for the absolute temperature deviation, as the set and measured temperature
were identical. This data can be found in the Supplementary Material, FigureB.8. The
second difference between literature and experimental data is the Tcloud detection approach.
With the proposed experimental setup, it was aimed to detect a Tcloud during an FT cycle,
which is the standard application of the employed HT cryogenic device. In the literature
study, the temperature was decreased until a light scattering beam disappeared (Tdisappear).
This was followed by a temperature increase to determine the temperature at which the
scattered light beam reappeared (Tappear). Tcloud was defined as the average of Tdisappear
and Tappear. Due to the different approaches, the literature study setup may have had
a relatively high detection sensitivity (light scattering versus visible light images) and a
higher control over sample temperature (cycling through Tcloud versus passing Tcloud). Both
effects are mentioned in the robustness study as factors that could lead to the detection
of a lower absolute temperature when the proposed experimental setup is employed. The
third difference is the sample volume. Although it remains speculative, the undocumented
sample volume used in the literature study was assumed to be larger compared to the
sample volume of 24µL used in this work. This was speculated as a sample volume of 20µL
was considered small in other work [242]. However, the influence of sample volume on the
absolute temperature values can be refuted based on the comparison of other absolute
temperature values reported on in literature. The comparable absolute Tcloud of ∼14.0℃
[150] and 12.1℃ [242] were obtained for similar formulations (87 g/L lysozyme at pH 7.0 in
a 20mM Tris buffer with 0.5M NaCl [150, 242]), while the sample volume was assumed to
differ at least one order of magnitude (20µL [242] and 2mL (undocumented) [150]). Based
on the identification of these experimental differences, it is speculated that the observed
absolute temperature deviation in the validation study is a result of the employed freezing
rate, the detection method, the detection approach, or a combination of these factors.
Absolute temperatures obtained with the proposed experimental setup are considered ap-
parent Tcloud values. Variations in temperature rates during the measurement and cycling
through Tcloud may allow for the detection of a true Tcloud while employing a cryogenic
device and image–based data evaluation. However, the exploration of these system settings
is not within the scope of this work. The objective was to obtain a comparative evaluation
parameter with the presented experimental setup that correlates to Tcloud. This objective
was reached as the validation study showed a strong correlation between literature and
experimental data.
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Figure 6.4.: (a) Average MPPD for four different salts (grid columns) and with or without
freezing/thawing (grid rows), as well as varying lysozyme concentrations (y–axis; g/L) and
ionic strength (x–axis; mM). Applied salts are sodium chloride (NaCl), sodium sulfate (NaSO4),
ammonium chloride (NH4Cl), and ammonium sulfate ((NH4)2SO4). Six clusters were identified
and visualized in the MPPD using the mean cluster color and cluster number similar to the
radar charts. The cluster regions are highlighted in the MPPD with a dashed line to guide the
eye. The normalized median values of each image feature are represented with a color surface
in the radar charts below the MPPD. The following image–based features are displayed per
cluster: median crystal length (LC), interquartile range (IQR) of the crystal width (MWC),
IQR of the crystal length (MLC), aggregation well coverage (nAgg), aggregation growth time
(tG), aggregation onset time (t0), and median crystal width (WC). The dotted line in the
radar chart represents the median absolute deviation within each cluster for each image feature.
Absolute cluster values can be found in Supplementary TableB.3. (b) Average cloud end
temperature (TCE ; ℃ for the same four salts shown for the MPPD (major grid columns),
as well as varying lysozyme concentrations (y–axis; g/L) and ionic strength (x–axis; mM).
Aggregation zones observed in the MPPD are represented with a solid line (aggregation zone
before freezing/thawing) and a dashed line (aggregation zone after freezing/thawing).
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6.3.3. Case study
A case study was performed to evaluate the correlation between TCE and long–term protein
stability. In particular, morphologic and kinetic changes observed in long–term instable
formulations as a result of different environmental conditions (lysozyme concentration,
ionic strength, salt type, and FT stress) were considered. Long–term protein stability was
assessed after a 40–day storage period at 20℃ with the use of MPPDs.
Long–term protein stability
Averaged results of the long–term storage experiment are depicted in the MPPDs in
Figure 6.4 a, where lysozyme was monitored for 40 days at 20℃ under 240 different formu-
lations. The top row presents formulations with NaCl, Na2SO4, NH4Cl, and (NH4)2SO4
that were not subjected to FT stress. The bottom row presents 240 similar formulations,
but these formulations were subjected to FT stress. For each MPPD, the lysozyme con-
centration is plotted on the y–axis, ranging from 3 to 18 g/L with a step size of 3 g/L.
The x–axis indicates the ionic strength of each corresponding salt, ranging from 0 to
2025mM with a step size of 225mM. The reproducibility of the long–term stability study
was confirmed based on the separate results for each measured duplicate, which are shown
in the Supplementary Material, FigureB.14.
MPPD construction includes a data dimension reduction step in order to visualize all mor-
phologic and kinetic data in a single figure. The data reduction step resulted in an energy
value of 93.6%, which indicates a 6.4% information loss. This percentage of information
loss falls within the accepted range of 10% information loss upon data dimension reduction
[253]. Clustering of the reduced dataset yielded an optimal number of six clusters, which
are shown as radar charts (I-VI) in the legend of Figure 6.4 a. Each radar chart represents
a different combination of image–based features, where the normalized median values are
visualized as a colored surface and the corresponding MAD is shown as a dashed line. The
image features used to construct the MPPD describe the crystal length (LC), variation in
crystal width (MWC), variation in crystal length (MLC), aggregation abundancy (nAgg),
aggregation growth time (tG), aggregation onset time (t0), and crystal width (WC). Abso-
lute values for each image feature per cluster can be found in the Supplementary Material,
TableB.3. An exemplary image for each MPPD cluster is presented in the Supplementary
Material, FigureB.12. MPPDs obtained for the case study were employed to visualize
the effects of environmental conditions on aggregation morphology and kinetics detected
during the long–term stability experiment. The applicability of MPPDs for this purpose
was already shown in previous work [251]. In the following three subsections, the effects of
anions, cations, and FT stress on long–term protein stability are presented. In the fourth
section, the correlation between TCE and the results obtained with the long–term stability
experiment will be discussed.
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Anions
Cluster I in Figure 6.4 a represents formulations that remained stable during the 40–day
storage period. All image features for the formulations part of cluster I are equal to
zero, as aggregation was not observed. Cluster I was identified for all formulations con-
taining sulfate (SO42– ) anions, as well as formulations containing chloride (Cl– ) anions,
but only at low lysozyme concentrations and low ionic strength. This trend remained
similar upon freezing/thawing the formulations, as can be observed when comparing the
top and bottom row of Figure 6.4 a. The maintained stability of lysozyme formulations
containing SO42– can be attributed to the difference in molar concentration and the ability
of the anions to promote salting–out effects. Formulations with monovalent Cl– anions
have a three–fold higher molar concentration compared to divalent SO42– anions, while
a similar ionic strength is reached [254]. The maintained stability may be due to the
relatively small absolute number of SO42– anions, which would be higher if similar molar
concentrations were used instead of similar ionic strength. The other explanation involves
the ability of anions to promote protein aggregation, which usually follows the order of the
Hofmeister series [72]. However, the direction of the Hofmeister series is determined by
ion-specific characteristics, such as polarizability, and protein-specific characteristics, such
as surface charge and surface hydrophobicity [255]. In turn, protein-specific characteristics
are dependent on environmental conditions, which results in a changing the Hofmeister
series direction as a function of, for example, the solution pH [73] or the ionic strength
[74]. According to the direct order of the Hofmeister series, SO42– is considered a protein
structure stabilizer (kosmotropic), which induces salting-out behavior. Cl– is considered a
weak protein structure destabilizer (weakly choatropic), which is prone to induce salting-in
behavior [255]. For a reversed Hofmeister series the opposite salting–in and salting-out
effects are expected. In this case study, lysozyme was formulated at pH 5.0. It was assumed
that lysozyme carries a positive charge at this pH value, as the theoretical pI of lysozyme
lies at 11.35 [23]. It has been reported that a reversed Hofmeister series was observed
for a positively charged lysozyme at low salt concentrations (<300mM), while a direct
Hofmeister series was observed for higher concentrations [74]. However, the mentioned
Hofmeister series reversal was seen for formulations at pH9.4 and was not confirmed for
similar formulations at pH4.1 (Supplementary data of [74]). The observations of this case
study are in line with the literature results at pH 4.1, as a reversal in aggregation propensity
as a function of molar salt concentrations was not seen between 0 and 2025mM. In other
works, it has been reported that lysozyme crystallizes readily at pH5.0 in the presence
of weakly hydrated anions such as Cl– , but not with SO42– anions, which confirms the
reversed Hofmeister series observed in the presented MPPD [163, 256]. This behavior
was attributed the direct binding of Cl– , which results in a neural lysozyme protein and
subsequent attractive protein-protein interactions, while the indirect interfacial effects of
strongly hydrated anion, such as SO42– anions, were assumed less dominant [257]. The
observed long–term stability of lysozyme formulations containing SO42– anions is, therefore,
attributed to the lack of anion binding, which was achieved by the weakly hydrated Cl–
anions.
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Cations
The dominance of anions on long–term protein stability is recognized by the observed
aggregation for formulations containing Cl– anions, and the lack thereof for formulations
containing SO42– anions. Therefore, the results obtained for formulations containing Cl–
anions will be used to discuss the influence of cations on long–term stability. MPPDs repre-
senting formulations containing sodium (Na+), with and without FT stress, show a larger
aggregation zone compared to formulations containing ammonium (NH4+). This translates
to a lower solubility limit for the evaluated formulations containing Na+ (3 g/L) compared
to formulations containing NH4+ (7 g/L). Solubility data was obtained by measuring the
protein concentration in the supernatant of the aggregated formulations after the 40 days
of storage. The corresponding data is shown in the Supplementary Material, FigureB.11.
The solubility data also shows that the solubility limit was reached at lower ionic strength
for formulations containing Na+ cations (1125mM) compared to formulations containing
NH4+ cations (1575mM). The ionic strength and molar concentration of NaCl and NH4Cl
are similar, and thus observed differences are a result of the employed cation. This is in
accordance with previously published work [194, 256] and was attributed to the larger
hydration force of Na+ compared to NH4+ [194].
The identified MPPD clusters are comparable between the cation types, where a cluster
transformation from cluster II to cluster III and cluster IV can be observed for increasing
ionic strength and lysozyme concentration. Cluster II is identified at the aggregation zone
border. The aggregation zone border is often referred to as the labile or crystallization zone,
where the energy barrier to create nuclei is overcome and crystal growth can occur [41]. The
observed morphology and kinetics in cluster II correspond to this phase. Cluster II repre-
sents a few (nAgg = 5 ± 4%) relatively large crystals (LC = 271 ± 67µm and WC = 157 ±
67µm) that have a relative late onset time (t0 = 301 ± 61 h) and grow for 553 ± 173 h. The
mentioned values are median ± MAD, which are calculated based on all formulation within
the mentioned cluster. Upon supersaturation increase (increasing lysozyme concentration
or ionic strength), cluster III is identified. An increase in supersaturation from the labile
zone is expected to result in larger crystals, due to the increased ability to support crystal
growth [258]. This corresponds to the changes in image features observed for cluster III
compared to cluster II. For cluster III, an increase in crystal amount (nAgg = 8 ± 4%),
size (LC = 424 ± 138µm and WC = 295 ± 99µm), and growth time (tG = 660 ± 116 h)
was observed compared to cluster II. A further increase in supersaturation should result in
increased crystal abundance while the crystal size decreases [258, 259]. This corresponds
to the features represented by cluster IV, where a higher abundance (nAgg = 23 ± 15%) of
smaller crystals (LC = 340 ± 124µm and WC = 219 ± 84µm) with a more uniform size
distribution (MLC = 98± 84µm and MWC = 84± 81µm) was found compared to cluster III.
Freezing/thawing
The adverse effect of freezing/thawing protein formulations with respect to long–term
protein stability was observed for NaCl and NH4Cl formulations. This was reflected by
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a decrease in solubility, and thus an increase in aggregation zone, as well as by MPPD
cluster transformations. For formulations containing NaCl, 675mM was the lowest ionic
strength for which aggregation occurred before applying FT stress. After subjecting NaCl
formulations to FT stress, the lowest ionic strength that induced protein aggregation was
450mM. The influence of FT stress was more pronounced for NH4Cl formulations, where
a minimal ionic strength of 900mM and 450mM were found, respectively. The solubility
limit of lysozyme for the evaluated NH4Cl formulations after freezing/thawing decreased
from 7 to 6 g/L compared to formulations when no FT stress was applied (Supplementary
Material, FigureB.11). These solubility limits were reached at 1125mM and 1575mM
ionic strength, respectively. The decrease in solubility indicates that supersaturation of the
metastable zone formulations was increased upon subjection to FT stress. This suggests
that formulations which only showed long–term instability upon FT stress application
were part of the metastable zone before FT stress application. In the metastable zone, the
required energy to support crystal growth is present, but the energy barrier that needs
to be overcome to create critical nuclei is too high [28, 208]. Presumably, the applied FT
stress allowed for crossing the required energy barrier, as a result of a supersaturation
increase by freeze concentration effects. Freeze concentration effects are defined as the
increase of dissolved substance concentrations, such as buffer components, excipients, and
proteins, caused by the formation of ice crystals [35, 133]. Such environmental changes
during freezing can cause a higher level of supersaturation, and thereby induce protein
aggregation [224, 249].
Most of the NaCl and NH4Cl formulations showed an MPPD cluster transformation from
cluster II, III, and IV to clusterV or VI when FT stress was applied. The identification of
clusterV and VI confirmed the increase in supersaturation as a result of FT stress. As
mentioned in Section 6.3.3 (Cations), supersaturation is expressed by increased nucleation,
which results in small and uniformly-sized crystals. This morphology is embodied by
clusterVI, which represents formulations with a large amount (nAgg = 95 ± 4%) of fast
growing (tG = 296 ± 101 h), small (LC = 35 ± 25µm andWC = 26 ± 18µm) uniform (MLC
= 6 ± 6µm and MWC = 4 ± 3µm) crystals. The identification of clusterV formulations
at the aggregation zone border after FT stress was applied, indicates the existence of a
small labile zone. ClusterV represents a high abundance (nAgg = 79 ± 19%) of relatively
small crystal (LC = 44 ± 53µm, WC = 36 ± 32µm). Compared to cluster II, III, and IV,
the crystals in clusterV showed a more uniform size (MLC = 16 ± 20µm and MWC = 8
± 9µm). However, the relatively late appearance of the crystals (t0 = 424 ± 104 h) and
crystal growth for the remaining storage period (tG = 536 ± 104 h) indicates that slower
kinetics were involved compared to clusterVI.
NaCl formulations at 1800mM and 2050mM ionic strength do not show an MPPD cluster
transformation after application of FT stress. These formulations consistently showed a
lower abundance of relatively big crystals that grow over a long period of time, as was
described for formulations without FT stress. This means that the nucleation rate did
not increase as a result of FT stress, as was seen for previously discussed formulations.
It was stated in the literature that the nucleation rate is dependent on supersaturation,
temperature, and interfacial tension [260]. In addition, it was reported that for the
same value of initial supersaturation, an increasing precipitant concentration results in
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a crystal number decrease [259]. The observation made in this study may be a result of
the combination of relatively low temperatures and increased ionic strength due to FT
stress and freeze concentration, as this combination results in a viscosity increase. For
example, the dynamic viscosity of water already shows a temperature–induced increase
of 145% in (from 1002.0µPas*s at 20℃ to 2456.6µPas*s at -8.28℃) [138]. A similar
trend in dynamic viscosity is also seen for aqueous NaCl solutions, as well as a 1.1 times
higher dynamic viscosity for a 2000mM NaCl concentration compared to 1000mM NaCl
at 0℃ (1884µPas*s for 1000mM and 2052µPas*s for 2000mM at 0℃) [261]. It has
also been shown that such a viscosity effect is different for each salt, where the viscosity
of NaCl solution increases for increasing salt concentration, whereas NH4Cl solutions in
a similar concentration range show a slight minimum [262]. This demonstrates that a
higher NaCl content causes an increased viscosity at similar temperatures. In turn, higher
viscosities are known to lead to lower nucleation rates, due to a slower diffusion rate of the
protein material in solution [263, 264]. It was assumed that a substantially high viscosity
was reached for formulations containing 1800mM or more NaCl, which did not allow for
additional nuclei formation. Subsequently, more protein material remained available for
crystal growth over time, which corresponds to the features of cluster IV formulations. This
was not the case for NH4Cl solutions due to the lower viscosity increase compared to NaCl,
which was reflected by a cluster transformation to clusterVI upon FT stress application.
6.3.4. Correlation of long–term protein stability to TCE
Figure 6.4 b presents the obtained TCE values, where a similar visualization format as in
Figure 6.4 a was used. Two lines were added to the TCE results of NaCl and NH4Cl to
indicate the observed aggregation zone before (solid line) and after (dashed line) FT stress
was applied. The results for each of the duplicate plates indicated the reproducibility of
the obtained TCE data and can be found in the Supplementary Material, FigureB.13.
Formulations containing SO42– anions showed little TCE variation compared to the TCE
values obtained for formulations containing Cl– anions. This was quantified by a variance
of 26℃2 and 12℃2 for Na2SO4 and (NH4)2SO4, respectively, compared to a variance of
107℃2 and 37℃2 for NaCl and NH4Cl, respectively. The lack of influence of the ionic
strength on TCE for formulations which contain SO42– anions does not correspond to data
reported in literature, where an influence of Na2SO4 and (NH4)2SO4 above 1000mM ionic
strength was reported for 87 g/L lysozyme formulations [150]. The lack of influence in
the current study was attributed to the use of a lower lysozyme concentration (3 - 18 g/L
instead of 87 g/L), as it has been shown that a lower protein concentration results in a lower
LLPS temperature for similar ionic strength [35]. This led to the assumption that tested
lysozyme concentrations were too low to induce LLPS before freezing occurs. The observed
mean plate TCE values of -35.4 ± 5.5℃ and -36.2 ± 3.4℃ for Na2SO4 and (NH4)2SO4,
respectively, are therefore thought to represent formulation freezing instead of LLPS. The
small fluctuations within each plate were attributed to data analytical fluctuations, as the
data analytical workflow was not optimized towards intensity changes that occur during
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freezing of formulations. An interesting opportunity for future work might be the inclusion
of more advanced data analytical techniques to distinguish between formulation freezing
and LLPS. Upon realization of such a data analytical workflow, the obtained data should be
validated by means of an orthogonal method that is able to distinguish between LLPS and
freezing points, such as differential scanning calorimetry [265, 266]. Low temperatures of
approximately -35.0℃ were not only found for formulations containing SO42– anions, but
also for lysozyme formulations containing Cl– anions at low ionic strength and low lysozyme
concentration. Moreover, all formulations part of MPPD cluster I show a TCE value below
approximately -35.0℃, as shown in Figure 6.4 a and Figure 6.4 b. This translates to a
correlation between long–term stability and the absence of LLPS detection under tested
conditions and settings.
In contrast to formulations containing SO42– anions, formulations containing Cl– anions
showed a change in TCE upon increasing protein concentration and ionic strength. An
exemplary influence of NaCl on the TCE can be observed in Figure 6.4 b, where the TCE
increased from -34.1 ± 0.9℃ to -5.4 ± 1.4℃ (mean ± standard deviation of duplicates)
for an ionic strength from 0mM to 1800mM at a lysozyme concentration of 15 g/L.
The increasing TCE values correlate to the previously discussed supersaturation increase
(Section 6.3.3 (Cations)). A change in TCE was observed for formulations containing NaCl,
starting at 18 g/L lysozyme with 900mM NaCl (TCE = -19.4 ± 0.4℃) and 12 g/L lysozyme
with 2025mM NaCl (TCE = -14.8 ± 3.3℃). Formulations with equal or higher NaCl
ionic strength and lysozyme concentration showed an increase in TCE as well. Any TCE
variation seen below these ionic strengths and lysozyme concentrations were considered
data analytical fluctuations, as it was assumed that LLPS did not occur due to sample
freezing. Most of the NaCl formulations that showed an increasing TCE values were part
of MPPD cluster IV. This indicates that a certain level of supersaturation had to be
reached to induce LLPS under the tested circumstances. However, not all cluster IV NaCl
formulations showed an increase in TCE . This demonstrates a limitation of the short–term
representation of long–term stability, where LLPS was not induced for relatively low protein
concentrations while protein aggregation can still occur over time. The correlation between
specific supersaturation levels and TCE changes as a function of ionic strength and lysozyme
concentration remains speculative, and should be confirmed by screening formulations with
a wider lysozyme concentration range.
A relatively small increase in TCE was seen for formulations containing NH4Cl, starting
at 18 g/L lysozyme and 450mM NH4Cl (TCE = -28.7 ± 0.9℃) and 15 g/L lysozyme and
675mM NH4Cl (TCE = -30.0 ± 1.6℃). As mentioned for NaCl, formulations with equal or
higher NH4Cl ionic strength and lysozyme concentration showed an increase in TCE as well,
while changes below these conditions were attributed to sample freezing. Interestingly, the
mentioned conditions for NH4Cl formulations where the first increase of TCE was observed
coincide with the upper border of the aggregation zone that was found after FT stress
was applied. This hints at the possibility of using TCE as a short–term parameter for FT
stress–induced long–term protein instability. However, it should be noted that formulations
at lower lysozyme concentrations do not show a TCE value effect despite the observed
instability after FT stress application.
A partial correlation between long–term protein stability and measured TCE values was
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observed. The applied experimental method did not detect LLPS for stable formulations
under the applied settings. A tentative correlation between increasing TCE values and
increasing supersaturation was established. In addition, NH4Cl formulations indicated a
correlation between TCE increase and long–term instability induced by FT stress. Solely
a partial correlation was established due to the chosen lysozyme concentration range of
3 - 18 g/L, and the described observations should therefore be confirmed for a wider protein
concentration range in future work. Nevertheless, the proposed experimental setup allows
for a high–throughput determination of a short–term representative parameter of colloidal
stability which can easily be added to the analytical toolbox to investigate long–term
protein stability in a shorter time frame.
6.4. Conclusion
This study presented a low volume (24µL) HT (60 samples) experimental setup for the
determination of an apparent Tcloud parameter, consisting of a cryogenic device combined
with an automated image acquisition system. The performance of the presented exper-
imental setup was evaluated by means of a robustness, validation, and case study. The
robustness study identified the TCE as parameter to represent Tcloud. The applicability of
this parameter to represent Tcloud was confirmed by the validation study, where a PCC
of 0.996 was found for normalized literature Tcloud data and TCE data for eight similar
lysozyme formulations. An average MAD of 0.2℃, obtained during the robustness study
for 60 replicates measured with three different FT rate combinations, demonstrated the
precision and reproducibility of the measurement. The robustness and validation study also
reflected that TCE is solely applicable for comparative formulation screening purposes when
similar device settings are employed. The case study evaluated the correlation between
TCE and the influence of lysozyme concentration, ion type, ionic strength, and FT stress
on long–term lysozyme stability. A partial correlation between TCE and long–term protein
stability was established. Long–term instable lysozyme formulations showed an increasing
TCE value for increasing supersaturation. Formulations containing NH4Cl indicated that
formulations sensitive to FT stress have higher TCE values compared to formulations that
did not show instability over time due to FT stress. However, evaluation of the case
study results demonstrated that the obtained correlations were limited by the investigated
lysozyme concentration range. Observed correlations should be confirmed in future work,
where a wider lysozyme concentration range is employed. Future work might also include
a more advanced data acquisition and analysis approach, which may allow for the dis-
tinction between formulation clouding and freezing. The combined results of the current
work demonstrated that the developed experimental method can be incorporated into
a short–term analytical screening toolbox that optimizes the development of long–term
stable protein formulations.
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Abstract
Formulation conditions have a significant influence on the degree of FT stress–induced
protein instabilities. Adding cryoprotectants might stabilize the induced FT stress in-
stabilities. However, a simple preservation of protein stability might be insufficient and
further methods are necessary. This study aims to evaluate the addition of a heat cycle
up to 40℃ after FT stress application as a function of different cryoprotectants with
lysozyme as exemplary protein. Sucrose and glycerol were shown to be the most effective
cryoprotectants and reached the best reversibility as compared to PEG200 and Tween20.
Here, aggregation was partly reversible and the solubility of non-stressed systems could be
reached after the heat cycle. Next to long–term protein stability, short–term stability was
investigated by determining the size and structure of lysozyme. However, the short–term
stability was not influenced by any stress type (FT/ heat cycle), amount of stress (up to
three FT cycles), or cryoprotectant tested.
Keywords: aggregation, lysozyme, phase diagram, heat–induced reversibility, morphology
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7.1. Introduction
Freezing and thawing enable a higher degree of flexibility during manufacturing and improve
long–term stability during storage [215–217]. To guarantee protein stability, chemically,
mechanically, and physically induced stresses, including cold temperatures, have to be
taken into account [50, 103, 109, 178]. The influence of freezing and thawing on the protein
stability is complex and depends on formulation parameters (buffer, excipient, and protein
type and concentration, pH value), system parameters (freezing and thawing point, glass
transition and clouding point), and process parameters (cycle number, freezing/thawing
ramp, storage temperature and time) [41, 103, 109, 117, 133, 140, 224, 249, 267]. Besides,
the characteristics of induced FT stress are dependent on these parameters. Besides, the
characteristics of induced FT stress are dependent on these parameters. These induced FT
stress types might cause protein damage, which implies colloidal instabilities (aggregate
formation), conformational instabilities (structural changes), and biological activity loss
[103, 139, 178, 217, 218]. The different FT stress types include several processes. Freeze
concentration of all solutes (e.g. buffer components, excipients, protein) [35, 133] due
to ice crystal formation. Furthermore, LLPS might take place, which can be due to
the increasing concentrations [35], and/or the decreasing temperature, also called cloud
point (Tcloud) [140, 150]. The decreasing temperature might result in cold denaturation,
which is the structural loss of proteins with quaternary structure [104]. An additional
issue is the growing ice surface, due to the possible denaturation of the protein molecules
on this surface [90, 109]. Consequently, protein aggregates, native or non–native, might
occur because of the mentioned effects. Protein aggregates can appear through different
mechanisms [26], depending on the protein surface charge, conformational changes, and
excipients in the solutions. These parameters influence intermolecular and intramolecular
interactions of proteins and/or excipients. On the one hand, when covalent binding (e.g
disulfide bonds) arises, aggregates are irreversibly bonded to each other. On the other
hand, when non–covalent binding (e.g. electrostatic, hydrophobic, van der Waals [18, 165])
occurs, aggregates might be reversible [13, 25, 26, 33, 43]. Normally, in order to stabilize
proteins in solution and to prevent aggregation, the formulation is adjusted using different
excipients. To inhibit FT–induced instabilities, cryoprotectants are used [33, 103, 268]. The
excipients, including cryoprotectants, show different mechanisms to stabilize or destabilize
proteins in solution. The excipients are either preferentially included or excluded from the
proximity environment. Whereas preferential exclusion, or hydration, results in hydration
of the protein surface which induces a stabilizing effect [63, 75]. As a function of the type
and strength of the resulting interactions, protein aggregates form and can be classified
irreversible or reversible. Of special interest are reversible native aggregates. Among
these, one has to differentiate between two kinds of reversible aggregates: a) aggregates
are in equilibrium with monomers, and b) induced aggregation by perturbation of the
solution conditions (pH, temperature, etc.). The first type of aggregates a) is reversible
by diluting the solution, whereas for the second type of aggregates, b) original solution
conditions need to be re–established. Additionally, it has shown to be possible to dissociate
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reversible protein aggregates by special treatments, for example through the application
of heat [25]. This said, heat might cause protein denaturation and/or induce irreversible
aggregation [26]. Taken all together, an investigation of the reversibility/dissociability of
FT stress–induced protein aggregates as a function of different excipients using heat cycling
is currently missing and promises new insights when dealing with reversible aggregation
during bioprocessing.
In this study the influence of different excipients, known to be cryoprotectants, on FT
stress–induced colloidal instability on the long–term stability of lysozyme is investigated.
Whereas, colloidal instability is defined as a change in the phase behavior and/or crystal
morphology. The excipients chosen belong to different groups, namely two osmolytes (the
sugar sucrose and the polyol glycerol), a polymer (polyethylene glycol 200 (PEG200)), and
a surfactant (Polysorbate 20 (Tween20)). Subsequently, the reversibility of these induced
instabilities by including a heat cycle to the respective FT protocol is investigated. In
order to visualize the occurrences, phase diagrams were chosen and systems clustered using
a MPPD approach. The descriptors for clustering chosen consisted out of morphological
and rate values. Additionally, solubility and protein structure of the different systems was
measured.
7.2. Materials and methods
In this study, phase behavior, aggregation kinetics, and morphology of aggregates were
investigated by creating a MPPD. In addition, the SL was calculated and the colloidal
stability (size) as well as the conformational stability (protein structure) was studied.
In the following, the preparation of the stock solutions, the creation of the MPPD, the
performance of the FT-cycling with and without an additional heat step, as well as the
analytical methods used (DLS and FTIR) are explained.
7.2.1. Preparation of stock solutions
For each experiment, a three buffers (base buffer, salt buffer, excipient buffers) and a
protein stock solution had to be prepared. As base buffer, a 20mM MCB was used. It
was created using of a tool described by Kröner et al. [197] and consisted of the buffer
substances AMPSO (Sigma–Aldrich), TAPSO (Sigma–Aldrich), MES (AppliChem GmbH,
Darmstadt, Germany), formic acid (Merck KGaA), and D-(+)-malic acid (Sigma–Aldrich).
Furthermore, the pH value was adjusted, using NaOH or HCl (Merck KGaA), with a
five–point calibrated pH meter (HI-3220, Hanna® Instruments, Woonsocket, RI, USA)
equipped with a SenTix® 62 pH electrode (Xylem Inc., White Plains, NY, USA). The pH
value was adjusted to a value differing by up to ±0.1 pH units from the final pH value.
Prior to the use of the buffer, the pH value was verified again and finally adjusted to a
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value differing by only ±0.02 pH units. In addition, the IS was adjusted to 10.08mS/cm
with an accuracy of ±1mS/cm at 24℃ ±1℃ by using the conductivity meter CDM
230 (Radiometer Analyticals, Lyon, France) and the four–point calibrated conductivity
cell E61M014 (Radiometer Analyticals, Lyon, France) using NaCl (Merck KGaA). A
salt buffer with different concentrations, 2.0M, 3.75M, and 4.29M, was prepared. The
respective amount of NaCl (Merck KGaA) was dissolved in the base buffer. The same
procedure was performed on the excipient buffer. Stock excipient buffer with 1.8M sucrose
(Sigma-Aldrich), 3M glycerol (VWR, Radnor, PA, USA), 84mM polyethylene glycol 200
(PEG200)(Sigma-Aldrich), and 0.72mM polysorbate 20 (Tween20) (AppliChem GmbH)
were prepared. The pH values of all additives (salt, and excipient) were adjusted on the
day of preparation and prior to use as described above. All buffers were filtered through a
0.2µm Supor® Polyethersulfone (Pall Corporation, Port Washington, NY, USA) filter and
stored at room temperature. The buffers were not used for longer than two weeks after
preparation.
The protein stock solution was prepared with lyophilized lysozyme from chicken egg white
(Hampton Research, Aliso Viejo, CA, USA). The protein was dissolved in the base buffer
and filtered through a 0.2µm syringe cellulose acetate filter (VWR). A desalting step
was attached to remove aggregates and production–related additives, using PD-10 (GE
Healthcare, Uppsala, Sweden) columns and the respective spin protocol [198]. To adjust the
final protein concentration of 87mg/mL, a 1:10 dilution was prepared and measured using
the NanoDrop™2000c UV-Vis spectrophotometer (Thermo Fisher Scientific, Waltham, MA,
USA). Thereby, an extinction coefficient of E1%(280 nm)=22.00 Lg-1cm-1 was used for the
measurement. The protein stock solution was prepared freshly and was not used for more
than one day.
7.2.2. Phase diagrams
To create the phase diagrams, a method described by Baumgartner et al. was used [158].
The final lysozyme concentrations varied between 2.5mg/mL and 25mg/mL, and the
final NaCl concentrations between 0M and 2.5M. The excipient concentration was kept
constant at 300mM sucrose, 1000mM glycerol, 6.81mM PEG200 or 0.03mM Tween20.
The protein and salt stock solutions were placed onto a Freedom EVO® 100 fully automated
liquid handling station (Tecan Group Ltd., Männedorf, Switzerland) platform. The liquid
handling station is equipped with fixed tips and 250µL dilutors and controlled by Freedom
EVO® 2.4 SP3 (Tecan Group Ltd.). The protein and salt concentration dilution rows were
prepared in a Deepwell PP plate (Greiner Bio-one, Frickenhausen, Germany). After the
salt dilution row was prepared, either 57.2µL of sucrose or glycerol or 25µL of PEG200
or Tween20 were added and mixed manually. Then, the phase diagram was created
automatically in a MRC Under Oil 96–well Crystallization Plate (SWISSCI AG, Neuheim,
Switzerland), whereas 18µL of the salt/additive solution was mixed with 6µL protein
solution. Before the plates were sealed with Duck® Brand HD Clear sealing tape (ShurTech®
brands, Avon, OH, USA), to avoid evaporation, plates were centrifuged in an Eppendorf
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centrifuge 5810R (Eppendorf AG, Hamburg, Germany) at 1000 rpm for 1min to remove all
air bubbles. After performing the FT protocols with and without heat cycling (Section
7.2.3), the plates were placed in the incubation chamber RockImager 54 (Formulatrix,
Bedford, MA, USA) at 20℃ for 40 days.
7.2.3. Cycling
FT cycling: FT protocol with different cycles numbers (FT cx; x=0, 1, 3) were carried
out. A plate at FT c0, not subjected to any FT stress application, was used as a reference
plate. This plate was directly placed into the incubation chamber after preparation.
The other plates were placed onto the cryogenic device EF600M105 (Grant Instruments,
Cambridgeshire, UK) after preparation. The plate handling and the adjustments on the
cryogenic device are described in the publication by Wöll et al. [249]. In this study, all
plates were frozen at 0.5℃/min and thawed at 2.5℃/min.
Heat cycling: Heat cycling following FT cycling was performed (FT cyh; y=1, 3) as
follows. The respective plates were heated to 40℃ for 30minutes using an HLC Cooling-
ThermoMixerMKR13 (Ditabis AG, Pforzheim, Germany). Upon completion, the plates
were directly placed in the incubation chamber at 20℃.
7.2.4. Multidimensional protein phase diagram (MPPD)
To evaluate phase transition, long–term stability and reversibility of aggregates of the
used lysozyme formulation, an MPPD was employed [251]. An MPPD combines data
on morphology, kinetic and aggregation obtained from images taken during storage, in
one figure by data reduction and subsequent clustering. In this study, the following data
was extracted manually from the images: (1,2) length and width of a maximum of eight
crystals in µm, (3) percentage aggregation amount per well (nAgg), (4) aggregation onset
time (tonset) in hours, and (5) aggregation growth time (tG) in hours. The mean crystal
length (LC) and width (WC) as well as the IQR of the crystal lengths (MLC) and widths
(MWC) were calculated. In addition, the ratio of the length and width (LC : WC) and
the interquartile range of this ratio (M(LC :WC)) were calculated. By using all of these
mentioned parameters, the MPPDs were constructed. The used settings for the MPPD
construction have been described in a previous work [251], where the clustering algorithm
selected an optimal cluster number between three and ten clusters.
In addition, to evaluate the occurrence of each cluster, the total amount of each cluster per
phase diagram was determined and the occurrence in percentage per plate was calculated.
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7.2.5. Analytics
In order to evaluate if structural parameter alter due to a) initial stress and b) heat
reversibility, FTIR and DLS measurements were applied. Stable conditions were chosen
at 18mg/mL and 22mg/mL at the four lowest salt concentrations (0.00, 0.23, 0.45, and
0.68M). A condition was only analyzed when no visible aggregation appeared prior to the
actual measurement (tonset > t0). This resulted in a total amount of 151 samples (non–
stressed (FT c0), stressed (FT c1 and FT c3), stressed and heated (FT c1 h and FT c3 h)).
In addition, supernatant measurements of all phase diagrams were performed to calculate
SLs.
The protein stock solution for the analytics was prepared as described in Section 7.2.1.
The pipetting was performed manually, whereas the protein, salt, and excipient solutions
were mixed in the same ratio as was done for the phase diagrams, see Section 4.2.2. A
maximum of 180µL of the samples was prepared in 0.5mL Eppendorf tubes (Eppendorf
AG). For the stressed samples (FT cx; x=1, 3 and FT–heating FTcy h; y=1, 3), the
samples were split into up to six 30µL proportions and pipetted in the crystallization plate,
after preparation in 0.5mL Eppendorf tubes (Eppendorf AG). Afterwards, plate handling
was done as described in Sections 4.2.2 and 7.2.3. After the respective stress protocol
was performed the samples were pipetted back into Eppendorf tubes and mixed. Before
the analytical method could be performed, the samples were filtered, using an Eppendorf
centrifuge 5810R (Eppendorf AG) at 2000 g for 5min, through a 0.2µm AcroPrep™ 96 filter
plate (350µL)(Pall Corporation, New York, New York, USA) into a 96–well PP-Microplate
(U-shape)(Greiner Bio-one). After filtration, the samples were split to be used with the
different analytical methods which are described below.
Dynamic light scattering (DLS)
The hydrodynamic radius of the protein in the respective solution was measured with DLS
using the Wyatt DynaPro Plate Reader I (Wyatt,Santa Barbara, California, USA) and a
polystyrene 384–well assay plate (Corning Inc., Corning, New York, USA). Therefore, 25µL
of the filtered sample was pipetted into the wells in triplicate and was covered with 10µL
Xiameter™ PMX-200 Silicon fluid 20cs (Dow Corning Inc. Midland, Michigan, USA) to
avoid evaporation. The plate was centrifuged in an Eppendorf centrifuge 5810R (Eppendorf
AG) at 400 g for 1min to remove all air bubbles. Next, the plate was placed in the plate
reader and each sample was measured twice at 20℃ with an acquisition time of 5 seconds
and an acquisition number of 10 as well as automatic attenuation.
Fourier–transform infrared spectroscopy (FTIR)
To investigate changes in the secondary protein structure FTIR spectroscopy, a Tensor
27 (Bruker Optics, Ettlingen, Germany) was used. The FTIR was equipped with a
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cryo–cooled mercury cadium telluride (CC-MTC) narrow detector (Bruker Optics) and
a BioATR II crystal (Bruker Optics) and controlled by OPUS7.2 (Bruker Optics). For
the measurement, 25µL of background or sample were pipetted onto the crystals, covered
with a lid, and then measured for 5minutes (mirror speed of 160KHz) with a resolution of
2 cm−1 in a range from 3500 cm−1 to 900 cm−1. The background subtraction, as well as
automatic compensation, was automatically performed by the software. Additionally, data
pre–processing was performed. After atmospheric compensation and vector normalization,
the data was smoothed using a Savitzky–Golay filter with a second–order polynomial and
a frame length of 17 in a wavenumber region from 1750 to 1550 cm−1. This data was
then used to calculate the average of the samples measured in duplicate. The area within
the amid I range (1700-1600 cm−1) for the α–helix, β–sheet, and β–sheet antiparallel was
extracted using the trapz function available in MATLAB (Version 2019b). Therefore, the
peak minimum for α–helix (1650 - 1685 cm−1), β–sheet antiparallel (1670 - 1685 cm−1),
and the peak maximum for β–sheet (1615 - 1635 cm−1) were detected, using the function
peakdet available in MATLAB (Version 2019b). The area was then calculated at the
interval of the min/max peak ± 2 cm−1.
Solubility line (SL)
For determining the SLs, the supernatant of the phase diagrams was measured. For this
purpose, 3µL of the supernatant of each condition was carefully (no air bubbles, no visible
aggregates) pipetted on the NanoDrop™2000c, and the concentration was measured in
triplicate. Afterwards, the solubility lines were calculated using a method published by
Galm et al. [164]. For this study, the conditions with crystals were taken into account.
Furthermore, the curves were integrated, using the function integral available in MATLAB
(Version 2019a), and the areas from 0M to 2.5M salt and from 0mg/mL to 25mg/mL
protein were calculated.
7.3. Results
This study aimed to evaluate twofold: a) whether the influence of different excipients on the
long–term protein stability of FT–stressed formulations can be followed by the creation of
MPPDs and b) whether the induced instabilities are reversible by a simple heat treatment.
The model system used to perform this investigation consisted of chicken egg white lysozyme,
different amounts of NaCl and cryoprotectants. The protein concentrations ranged from
2.5mg/mL to 25mg/mL at pH5. The NaCl concentration as precipitant was increased
up to 2.5M. Four different cryoprotectants a) 300mM sucrose, b) 1000mM glycerol, c)
6.81mM PEG200, and d) 0.03mM Tween20 in a solution containing NaCl were added to
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this model system separately. Different FT cycle numbers (FT cx; x=0, 1, 3), as well as a
heat cycle (FT cy h; y= 1, 3), were performed for each of the formulations during the study.
7.3.1. Multidimensional protein phase diagram (MPPD)
Overall, 2400 different formulations were studied and resulted in different phase states,
soluble and crystalline (exemplary pictures see Figure 7.1). To visualize all morphologies
and kinetic data in one figure, the MPPD construction includes a data reduction step.
This reduction step results in an energy value of 95.5%, which indicates an information
loss of 4.5%. An optimal number of seven clusters were obtained when the reduced
dataset was clustered; they are shown as radar charts (I-VII) in Figure 7.2A. Each radar
chart represents a specific combination of image–based features: the crystal length (LC)
and widths (WC), variation in crystal length (MLC) and width (MWC), the aggregation
amount (nagg), the aggregation onset time (tonset), and aggregation growth time (tG), as
well as the ratio of crystal length and width (LC : WC), and the variation of this ratio
(M(LC : WC)). The normalized median values are visualized as a colored surface, and
the corresponding MAD is shown as a dashed line in Figure 7.1. An overview of the
absolute values, representing the median ± MAD, which is calculated based on all for-
mulations within the mentioned cluster, and their ranges of each cluster is given in Table 7.1.
Table 7.1.: Overview of median ± MAD image–based feature values. The values are listed
per cluster identified in the separate multidimensional protein phase diagram.
I II III IV V VI VII
LC [µm] 0 ± 0 202 ± 186 192 ± 209 34 ± 14 34 ± 11 105 ± 92 915 ± 380
WC [µm] 0 ± 0 141 ± 124 139 ± 150 24 ± 10 25 ± 8 16 ± 9 13 ± 4
LC : WC [-] 0 ± 0 1.4 ± 0.2 1.3 ± 0.2 1.3 ± 0.1 1.4 ± 0.1 7.8 ± 9.3 76.4 ± 37.9
tonset [hours] 0 ± 0 6 ± 9 1 ± 1 0 ± 0 0 ± 0 0 ± 0 0 ± 0
tG [hours] 0 ± 0 892 ± 95 456 ± 142 12 ± 15 16 ± 19 620 ± 208 783 ± 195
nAgg [%] 0 ± 0 10 ± 7 15 ± 7 25 ± 7 77 ± 11 60 ± 22 75 ± 22
MLC [µm] 0 ± 0 51 ± 52 52 ± 56 11 ± 7 11 ± 6 37 ± 35 1032 ± 529
MWC [µm] 0 ± 0 46 ± 49 78 ± 58 9 ± 6 8 ± 4 7 ± 5 6 ± 4
M(LC : WC) [-] 0 ± 0 0.3 ± 0.3 0.4 ± 0.3 0.3 ± 0.2 0.4 ± 0.2 3.3 ± 4.2 93.2 ± 43.4
Cluster I (Cl I) represents soluble conditions, all values of the image features are equal to
zero, as no aggregation took place. However, for some conditions which were clustered to
Cl I aggregates were observed. These conditions were analyzed manually and are bordered
by dashed lines in Figure 7.2. Cl II represents a few (nagg = 10 ± 7%) relatively large
(LC = 202 ± 186µm and WC = 141 ± 124µm) crystals which have an onset time after a
few hours (tonset = 6 ± 9 hours) but a very long growth time (tG = 892 ± 95 hours). An
exemplary picture of such a crystal is shown in Figure 7.1. Cl III represents crystals which
show a slightly higher amount (nagg = 15 ± 7%) and an earlier crystal growth onset time
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Figure 7.1.: The clusters detected for the data set are shown with the respective example
pictures of exemplary crystals. The color surface in the radar charts represents the normalized
median values of each image feature. The following image–based features were used for the
clusters: the crystal length (LC) and widths (WC), the IQR of the crystal length (MLC) and
width (MWC), the aggregation abundance (nAgg), the aggregation onset time (tonset), and
aggregation growth time (tG), as well as the ratio of crystal length and width (LC : WC), and
the IQR of this ratio (M(LC : WC)). The median absolute deviation within each cluster for
each image–based feature is shown by a dashed line in the radar charts. The absolute cluster
values can be found in Table 7.1. The exemplary crystal pictures are made with visible light.
Soluble conditions were presented by Cl I, tetragonal crystals are presented by Cl II, complex
structured crystals by Cl III, either tetragonal crystals at FT c0 (top) or dense grown micro
crystals with FT stress (bottom) by Cl IV, micro crystals by ClV, sea urchin (top) and small
tetragonal crystal (bottom) by cluster VI, and sea urchin crystals by ClVII.
(tonset = 1 ± 1 hours) as well as a shorter growth time (tG = 456 ± 142 hours). Within Cl IV
and ClV the amount of crystals increased to nagg = 25 ± 7% / 77 ± 11%, and the crystal
size decreased significantly to LC = 32 ± 14µm / 34 ± 11µm and WC = 24 ± 10µm / 25
± 8µm, receptively (see Table 7.1 and Figure 7.1). Whereas Cl IV indicated two different
morphologies: tetragonal crystals and densely grown micro crystals, see Figure 7.1. The
tetragonal crystals grew preferably when no stress was applied, whereas the micro crystals
grew after FT stress was applied. ClVI showed a significant higher crystal growth time
(tG = 620 ± 208 hours) and a significant increased rati between crystal width and length
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(LC :WC = 7.8 ± 9.3). This cluster also represented two types of crystal morphologies:
sea urchin crystals and small tetragonal crystals. The sea urchins are dominant in the
supersaturated region, and the small tetragonal crystals grow at lower salt and protein
concentrations. ClVII showed the highest values for the crystal length and the ratio
between crystal length and width, as well as crystal growth time (LC = 915 ± 380µm,
LC :WC = 76.4 ± 37.9, tG = 783 ± 195 hours).
7.3.2. Formulations
The results of the long-term storage experiment are presented in the MPPD in Figure 7.2,
where lysozyme was monitored for 40 days at 20℃ using 2400 different formulations. The
different columns (C 1-5) in Figure 7.2A represent the different formulations with NaCl (C 1),
NaCl + 300mM sucrose (C 2), NaCl + 1000mM glycerol (C 3), NaCl + 6.81mM PEG200
(C 4), and NaCl + 0.03mM Tween20 (C 5), whereas the different rows (R1-5) represent
the different cycles performed (FT c0, FT c1, and FTc3 (R 1-3)) and the combination of
FT stress followed by a heat cycle (FT c1 h and FT c3 h (R 4-5)). Figure 7.2B summarizes
the percentages occupied by the different clusters for each system.
Initial state - FT c0 NaCl: All clusters were present at FT c0, whereas Cl II and Cl III
were dominant in the transition zone from the soluble (Cl I) to the aggregation zone,
see Figure 7.2A, R 1. Increasing the NaCl and lysozyme concentration resulted in Cl IV,
ClV, and ClVI. At the highest lysozyme concentrations (23mg/mL and 25mg/mL) and
NaCl concentrations (2.27M and 2.5M), ClVII appeared. The overall contribution of the
different clusters were for Cl I 47.92%, Cl II 15.63%, Cl III 20.83%,Cl IV 8.33%, ClV 2.08%,
ClVI 6.25%, and ClVII 4.17%, see Figure 7.2B, R 1 and C1.
Sucrose: Adding sucrose to the formulations, the aggregation zone slightly decreases for
FT c0, and ClV and VI disappeared, see Figure 7.2A, C 2. Cl IV was present at lysozyme
concentrations above 18mg/mL and NaCl concentrations between 1.14M and 2.05M. The
transition zone from the soluble zone (Cl I) to the aggregation zone consisted of Cl II and
Cl III. ClVII was present at the highest lysozyme and NaCl concentrations. The overall
contribution of the different clusters were for Cl I 41.67%, Cl II 16.67%, Cl III 20.83%,Cl IV
8.33%, ClV 2.08%, ClVI 6.25%, and ClVII 4.17%,see Figure 7.2B, R 1 and C2.
Glycerol: Replacing sucrose by glycerol in the formulation, resulted in a smaller aggregation
zone/larger soluble zone (Cl I) compared to pure NaCl formulations for FT c0. In the
transition zone to Cl I was still created out of Cl II and Cl III, whereas it was smaller
compared to NaCl formulations. In the remaining aggregation zone, Cl IV was dominant,
see Figure 7.2A, C 3. The overall contribution of the different clusters were for Cl I 47.92%,
Cl II 13.54%, Cl III 8.33%,Cl IV 26.04%, and ClV 4.17%, see Figure 7.2B, R 1 and C3.
PEG200 : PEG200 formulations showed phase behaviors very similar to those of NaCl
formulations, see Figure 7.2A, C 4. In the transition zone from the soluble zone (Cl I) to
the aggregation zone, Cl II, and at increasing protein and salt concentrations, Cl III were
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Figure 7.2.: In A the MPPDs for five different lysozyme formulations (NaCl, NaCl + sucrose,
NaCl + glycerol, NaCl + PEG200, NaCl + Tween20 (C 1-5)) and different stress protocols
(R 1-5). The lysozyme concentration [mg/mL] was varied over the NaCl concentration [M].
Seven clusters were identified and used for the MPPD using the mean cluster color and cluster
number similar to the radar charts, shown in Figure 7.1. In B the calculated occurrence in [%]
of each cluster per phase diagram is shown with the respective values.
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dominant up to a NaCl concentration of 1.82M. In the high concentration region, mainly
ClVI and VII were created. The overall contribution of the different clusters were for
Cl I 42.71%, Cl II 25.00%, Cl III 17.71%,Cl IV 1.04%, ClV 1.04%, ClVI 8.33%, and ClVII
4.17%, see Figure 7.2B, R 1 and C4.
Tween20 : For Tween20 formulations ClV was most dominant at FT c0, see Figure 7.2A,
C 5. The occurrence of Cl I was slightly lower compared to that of the NaCl formulations.
The overall contribution of the different clusters were for Cl I 43.75%, Cl II 7.29%, Cl III
7.29%,Cl IV 11.46%, ClV 28.13%,and %,ClVI 2.08%, see Figure 7.2B, R 1 and C5.
FT cycles - FT c1 and FT c3 In general increasing the number of FT cycles resulted in
a decrease in the Cl I region (soluble region) for all formulations tested, see Figure 7.2B,
R 1-3. The more FT cycles were applied, the higher the amount of Cl IV was observed.
NaCl: NaCl formulations showed an increase of condition belonging to Cl IV when increasing
the cycle number, 8.33% to 13.54% to 30.21%, see Figure 7.2B, C 1. Cl IV at FT1 was
created at lysozyme concentrations higher than 21mg/mL up to 1.59M NaCl. At FT c3
the region expanded and Cl IV was dominant at all lysozyme concentrations up to 1.59M
NaCl, see Figure 7.2A, R 3. Considering that, the higher the lysozyme concentration, the
more salt had to be added to create Cl IV. At high supersaturations still ClVI and ClVII
were dominant for FT c1 and FT c3.
Sucrose: Sucrose formulations do also show a cluster transformation to Cl IV and ClV
by increasing the cycle number, see Figure 7.2A, C 2. The occurrence of these clusters
increased from 17.71% to 28.13% to 27.08% for Cl IV and from 0% to 8.33% to 19.97%
for ClV while increasing the number of cycles, see Figure 7.2B, R 1-3 C2. Regarding
the positions of the clusters, the Cl IV region is spilt by ClV, see Figure 7.2A, C 2. The
occurrence of ClVII stayed the same (8.5%) whereas the region with Cl II and Cl III
decreased significantly. For Cl II the occurrence decreased from 15.63% to 4.17% to 2.08%
and for Cl II from 10.42% to 8.33% for FT c1 and FT3, see Figure 7.2B, C 2. The Cl I
zone, however, was not significantly decreased at FT c1, compared to NaCl formulations,
only slightly decreased at FT c3 (47.92% to 42,71% to 33.33%).
Glycerol: Formulations containing glycerol showed a signification increase of Cl II from
FTc0 to FT c1, 13.54% to 32.29%, respectively, see Figure 7.2A, C 3 and Figure 7.2B, C 3.
At FT c3 a cluster transformation to mainly Cl IV (46.88%) took place. The Cl I region was
slightly decreased when the number of cycles was increased (47.92% to 36,46% to 32.29%).
PEG200: PEG200 formulations showed the same cluster transition as NaCl formulations,
see Figure 7.2A, C 4. Concerning the occurrence of the clusters small differences were
seen. When the formulations were stressed the occurrence of Cl IV was dominant whereas
Cl II and Cl III were less present compared to NaCl formulations. At FT c3 44.79% of the
conditions belong to Cl IV whereas only 30.21% belong to this cluster when only NaCl was
in the formulation, see Figure 7.2A, C 4 and Figure 7.2B, C 4.
Tween20 : Tween20 formulation did show a cluster transformation to Cl IV from FT c0 with
an occurrence of 11.46% to FT c1 with an occurrence of 69.79%. To FT c3 the occurrence
of Cl IV slightly increased to maximum of 73.96%, see Figure 7.2A, C 5 and Figure 7.2B,
C 5. The occurrence of the soluble zone (Cl I) decreased significantly from 43.75% at FT c0
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to 25.00% at FT c1 and FT c3.
Heat cycle - FT c1 h and FT c3 h The reversibility regarding the phase state (sol-
uble/aggregate) and the occurrence of Cl II and Cl III were analyzed. In general, the
additional heat cycle increases the Cl I region compared to the corresponding FT cycles,
see Figure 7.2A R4-5.
NaCl: For NaCl formulations similar positions of the cluster at FT c1 h and FT c3 h com-
pared to FT c0 could have been observed. Regarding the reversibility of the phase states,
the occurrence of Cl I reached values similar to those at FT c0 (41.67%) at FT c1 h with
45.83% and at FT c3 h with 39.58%, see Figure 7.2A, C 1 and Figure 7.2B, C 1. The
occurrence of Cl II and Cl III did not significantly change between all the cycles applied.
The Cl II and Cl III appeared again adjacent to Cl I as it was the case for FT c0, when a
heat cycle was performed.
Sucrose: When sucrose was added to the formulations and heat cycling was performed after
the formulations were FT–stressed, a significant zone of Cl II were created in zone adjacent
to Cl I which was not the case at FT c1 and FT c3, see Figure 7.2A, C 2. The occurrence
of these clusters was very low at FT c1 and FT c3, but Cl II reached a similar occurrence
compared to FT c0 (16.67%), when a heat cycle was performed (FT c1 h 13.54%, FT c3 h
15.63%), see Figure 7.2B, R 4-5 and C2. The occurrence of Cl I increased significantly for
FT c1 h and FTc3 h (45.83% and 39.58%) compared to the respective systems at FT c1
and FT c3 (33.33% and 25.00%), whereas nearly the same occurrence as at FT c0 (41.67%)
with sucrose were reached, see Figure 7.2A, C 2 and Figure 7.2B, C 2.
Glycerol: Applying a heat cycle to glycerol formulations after they were stressed with
freezing/thawing resulted in an appearance of the same clusters as occurred at FT c0,
as well as the position of these clusters are similar, see Figure 7.2, C 3. Concerning the
occurrence of Cl I, the same occurrence as at FT c0 (47.92%) could be reached at FT c3 h
(47.92%), and was even increased at FT c1 h (54%). In addition the occurrence of Cl II
and Cl III (FT c1 h 17.71%/11.46%, FT c3 h 14.58%/3.13%) reached values close to those
at FT c0 (Cl II 13.54%, Cl III 8.33%), with the exception of Cl III at FT c3 h (3.31%), see
Figure 7.2B R4-5 and C3.
PEG200 : The addition of a heat cycle to PEG200 formulations resulted in a similar
positioning of the Cl II and Cl III region compared to FTc0, which was adjacent to Cl I.
Nevertheless, these region was significant at FT c1 h (Cl II 7.29%, Cl III 8.33%) and FT c3 h
(Cl II 9.38%, Cl III 5.21%) smaller than at FT c0 (Cl II 25.00%, Cl III 17.71%), see Fig-
ure 7.2A, C 4 and Figure 7.2B. The occurrence of Cl I for FT c1 h (33.33%) and FTc3 h
(34.38%) only reached values of FT c1 (31.25%) and not the one of FT c0 (42.71%).
Tween20 : The heat cycle influenced only the occurrence of Cl I for Tween20 formulations
and not the cluster formation itself. Still mainly Cl IV was observed like at FT c1 and FT c3.
At FT c1 h a similar occurrence of 40.63% of Cl I compared to FT c0 with 43.75% could be
observed. FT c3 h showed a slightly smaller occurrence of Cl I with 35.42% compared to
FT c0, see Figure 7.2A, C 5 and Figure 7.2B, C 5.
Formulation comparison Adding different excipients to a NaCl phase diagram resulted
in a different phase behavior for each excipient, see Figure 7.2A, R 1/C 1-5. In the following
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a comparison with a focus of the effects arising from the different excipients is laid for the
initial state and the different cycles studied. In general the influence of FT cycles and the
reversibility by heat is strongly dependent on the cryoprotectant.
Initial state - FT c0 : In the transition zone to Cl I for all formulations, Cl II and Cl III are
present, whereas for Tween20 formulations, the region is very small. Regarding the size
of the Cl I region, NaCl and PEG200 formulations showed a slightly smaller region than
formulations containing sucrose, glycerol or Tween20, see Figure 7.2B, R 1. ClVII was only
created in the highly concentrated region for NaCl, sucrose and PEG200 formulations.
FT cycle - FT c1 and FT c3 : The influence of the FT cycles, as well as the phase behavior
at FT c0, were very similar for NaCl and PEG200 formulations. The position of the
clusters changed similar when FT stress was applied, see Figure 7.2A, R1-3, C 1 and C4.
The occurrence of Cl I was highest with sucrose and glycerol formulations compared to
the other formulations tested, see Figure 7.2B. Furthermore, the FT stress did not have
such a significant impact on the occurrence of Cl II for sucrose and glycerol formulations.
In general, the higher the cycle number, the lower the occurrence of Cl I. For Tween20
formulations there was no difference between FT c1 and FT c3 regarding the Cl I occurrence
visible, see Figure 7.2B, R 1-3.
Heat cycle - FT c1 h and FT c3 h: When a heat cycle was performed the increase of the
Cl I region when a heat cycle was added, was less pronounced for PEG200 and Tween20
formulations compared to the other formulations tested. All formulations showed cluster
transformation back to the clusters seen at FT c0, with the exception of PEG200 and
Tween20 formulations, see Figure 7.2A, R 4-5 and Figure 7.2B, R 4-5. With a heat cycle
ClV occurred for PEG200 formulations, which was not seen at any other system with
PEG200 formulations. With Tween20 the heat cycle only influenced the occurrence of Cl I
and did not result in a cluster transformation at all.
7.3.3. Analytics
Information of three different analytic methods: (1) protein solubility (SL), (2) protein size
(DLS), and (3) protein structure (FTIR) was added to the MPPDs. These measurements
were performed for two reasons: a) to evaluate if initial stress leads to changes in structural
parameter or size of the proteins under investigation and b) to evaluate if the process
exploiting heat reversibility leads of structural (FTIR) or size (DLS) based alterations.
Solubility line (SL)
To investigate the protein solubility, supernatant measurements of each phase diagram
were performed and SLs were calculated, as described in Section 7.2.5 and presented in
Figure 7.3A. To identify more easily differences of the SLs, the area was calculated un-
derneath the curves as described in Section 7.2.5. Bar graphs of these values are shown
in Figure 7.3B. The trend regarding the influence of FT stress and the heat reversibility
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are similar for all lysozyme formulations tested. For the formulations with NaCl and the
formulations where PEG200 was added, the area was the largest without any FT stress,
see Figure 7.3B. The smaller the calculated SL area, the more the SL is shifted to lower
protein and salt concentrations. A large SL area indicates high protein solubility and a
small aggregation zone in the respective phase diagram. In formulations where sucrose or
Tween20 were added, the area of FT c0 was similar to that of FT c1 h. With glycerol, the
area with the formulations which performed FTc1 h was even larger than for FT c0. An
overall trend could be observed when the influence of FT cycles was taken into account.
The more FT cycles were applied to the formulations, the smaller the SL area became. In
addition, the heat cycle results in a significant increase in the SL area for FT c1 and FT c3.
The only exception was shown with Tween20 formulations. Here, the heat cycle did not
increase the SL area for FT c1, see Figure 7.3B.
Comparing the different excipients to each other, the formulations with sucrose addition
showed the highest SL area values, followed by glycerol formulations, see Figure 7.3B. These
formulations are followed by NaCl, NaCl + PEG200, and NaCl + Tween20 formulations
in the order from high to low SL area values.
Dynamic light scattering (DLS)
The protein size of the formulations investigated was measured performing DLS mea-
surements in triplicate, see Figure 7.4. No significant changes could be observed. The
stress type (FT and the heat) and amount (cycle number) did not influences the protein
size. Comparing the results of the different formulations to each other, small differences
were observed: Formulations with NaCl, PEG200, and Tween20 show radii in a lower
range (app. 2.0 nm to 2.5 nm), whereas formulations with sucrose or glycerol show radii
with approximately 2.3 nm to 3.3 nm. Finally, heat reversibility did not show significant
alteration in the size of the protein when compared to the initial dimensions.
Fourier–transform infrared spectroscopy (FTIR)
Protein structure information were investigated using FTIR. All samples measured with
DLS were also analyzed using FTIR. After data pre-processing (see Section 7.2.5), the
spectra is shown in Figure 7.5A. In the interesting amid I region where the alpha–helix
(1650 - 1685 cm−1), beta–sheet (1615 - 1635 cm−1) and beta–sheet antiparallel (1670 -
1685 cm−1) structures absorb nearly no differences were detected. This becomes clearer
when the calculated areas for each region are compared to each other, see Figure 7.5B.
With these results, no influence of protein and salt concentration, stress type (FT or heat
cycling), FT cycle number, and excipients could be determined in this study.
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Figure 7.3.: In A the solubility lines of lysozyme in different formulations where different
stress protocols were applied. The lysozyme concentration in mg/mL is plotted over a varying
NaCl concentration in M. In B the calculated area of each phase diagram investigated is shown.
The SL area is plotted over the different formulations tested, the different shades of gray
represents FT c0 (darkest gray), FT c1, FT c3, FT c1 h, FT c3 h (lightest gray).
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Figure 7.4.: The results of the 151 DLS measurements are shown. The NaCl concentration
is plotted over the cycle number for the different formulations investigated. The upper row
shows the results for 21mg/mL lysozyme and the lower row for 18mg/mL. The color bar
represents the radius in nm. Measurements with the formulations where the box is marked
gray were not possible due to aggregation appearance. The respective deviations from the
triplicate measurements are shown in the Supplementary Material FigureB.16.
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Figure 7.5.: In A the pre–processed FTIR spectra for all 151 samples, which performed also
the DLS measurements, are plotted (see Figure 7.4). The range between a wave number of
1650 - 1685 cm−1 represents alpha–helix structure, 1615 - 1635 cm−1 beta–sheet structures, and
1670 - 1685 cm−1 beta–sheet antiparallel structures. In B the calculated areas of the interesting
regions for alpha–helix (top), beta–sheet (middle) and beta–sheet antiparallel (bottom) are
shown for all measured samples (Sample no. 1-8: NaCl; 9-16: NaCl + sucrose; 17-24: NaCl +
glycerol; 25-32: NaCl + PEG200; 33:40: NaCl + Tween20). Blue dots represent 0 cycles, red
points 1 cycle, yellow dots 3 cycles, purple dots 1 cycle heat, and green dots 3 cycles heat.
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7.4. Discussion
In the following section, results are discussed concerning the influence of the tested excip-
ients (300mM sucrose, 1000mM glycerol, 6.81mM PEG200, 0.03mM Tween20) on the
long–term protein stability of FT–stressed formulations, as well as whether these changes
are reversible by adding a heat cycle after the respective FT protocol was performed. The
results are discussed separately for each formulation tested and the respective influence of
the heat cycle. Finally, a comparison is made across the different formulations.
7.4.1. Multidimensional protein phase diagram (MPPD)
The creation of the MPPDs resulted in an information loss of only 10% due to data
dimension reduction from nine to three dimensions. Consulting literature, this falls in an
acceptable range [253].
The MPPD procedure allowed an automated evaluation and clustering providing a rapid
overview over a huge data set of complex phase transitions taking place in the phase
diagrams. As shown in Figure 7.2 it further provided insight into positioning (Figure 7.2A)
and occurrence (Figure 7.2B) of different phase states. While clustering as such occurs in
an automated fashion, the choice of suitable descriptors is of course subjective and great
care needs to be taken when deciding on a certain set. Two examples underlining this are
seen in the current study. The misclassifications seen for Cl I (meant to represent soluble
formulations only) were due to accommodating the high variety of crystal sizes in a single
data set. The data set included length and width values, which are very large (due to sea
urchin crystals) and very small (due to micro crystals).
With the normalizing step during MPPD creation, the small size values close to zero let to
an incorporation into Cl I. In addition, the formulations belonging to a cluster do show a
distinct distribution and the transition from one to another cluster might lead to overlaps.
This is visualized in FigureB.15 in the Supplementary Material, where all 2400 conditions
are plotted.
A second issue going hand-in-hand with the above findings is the appearance of two different
morphologies seen for Cl IV and ClVI, as shown in Figure 7.1. Here, the reason lies clearly
in the similarity of the image-based parameters taken into account, namely size and time.
This shows the care and orthogonality needed when choosing descriptors for an automated
classification scheme. In the present study, a distinction of different morphologies could
be possibly reached by an addition of the crystal intensity, due to the higher intensity
of sea urchin crystals and the dense micro crystal when compared to tetragonal crystals
(independent of size).
Nevertheless, a MPPD creation allows an objective scoring and clustering of phase diagrams,
based on crystal dimensions and other descriptors chosen. In a second step, however, the
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raw data of the created clusters needs to be checked to ensure that choice of descriptors,
overlap, and distribution of features does not lead to a false interpretation of data.
7.4.2. Formulations
In the following section the results obtained for each system tested using the MPPD
approach are discussed. The evaluation of molecular starting conditions, namely the
DLS and FTIR measurements of the soluble regions chosen (Figure 7.4 and Figure 7.5)
for two different concentrations show no significant alteration in measured values as a
function of stress applied. From this it can be concluded that the formation of different
crystal morphologies and thus cluster distribution is not dependent on structural protein
parameter. But it should keep in mind that a small fraction of protein might undergo
partial unfolding and/or aggregation, which is not detectable using the described DLS or
FTIR measurements. These small changes might cause undesirable particle formation and
change in the crystallization kinetics.
The increase in apparent size seen for increasing salt concentrations, and respectively
higher ionic strengths, within a certain formulation subgroup might be due to increasing
hydrophobic protein–protein interactions [203]. The greater the protein–protein interac-
tions, the lower the molecule diffusion in the solutions and the bigger the hydrodynamic
radius estimated by DLS measurements [172]. The slightly bigger apparent radii of sucrose
and glycerol formulations can be explained by an overall increased viscosity, due to the
high excipient concentrations used, and the procedure of how the hydrodynamic radius is
estimated (Stokes–Einstein equation) [171, 172].
The respective excipients were chosen due to their different protein interaction mechanism,
which are explained in the following.
Salt: Using NaCl as an additive only, the salt concentration mainly modulates electrostatic
interactions and suppressing these allows hydrophobic interactions to play a more dominant
role. Lysozyme with a pI of 11.35 [23] is positively charged at the operating pH of pH5.
Given this, the distance to its pI seems wide enough so that a slight change in pH will
not result in changes of surface charge and effects seen can be related to alteration in
additive solely. The concentration range from 0-1.1M NaCl was chosen due to the ability
of stabilizing or destabilizing the protein stability depending on the protein surface charge
and the salt concentration [74].
Osmolytes: Two different osmolytes were chosen in this study, due to their ability to
stabilize the native structure of the protein upon environmental stress [141–143] and thus
also act as cryoprotectants. The osmolytes used in this study are sucrose [88, 89], a sugar,
and glycerol [142, 272], a polyol.
Sucrose: Sucrose is known to be an effective cryoprotectant, due to stabilizing the native
structure of proteins by thermodynamic stabilization. Thereby, preferential exclusion of
sucrose and subsequently hydration of the protein surface are taking place [67].
Glycerol: The mechanisms triggered by adding glycerol are not completely understood. The
most significant contributions are twofold. There is preferential exclusion effect of glycerol,
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comparable with sucrose, where the native protein structure is stabilized. Furthermore,
stabilization of glycerol is assumed to be also due to preferential interaction of glycerol
and the hydrophobic regions on the protein surface and following the inhibition of protein
unfolding [272].
Polymers: Polymers are also known to generally stabilize protein solutions [75, 274],
whereas the mode of action is strongly dependent on their molecular weight [84] and concen-
tration applied [85]. Low molecular weight PEG present in low concentrations may induce
protein stabilization due to the steric shielding of attractive protein-protein interactions [85,
143]. This effect is exploited in this study using 6.81mM (6w/w%) PEG200. Depending on
the hydrophobicity of the protein surface, the mechanism of PEG is influenced. When the
protein surface is hydrophobic, destabilizing preferential interaction of the hydrophilic PEG
molecules and the hydrophobic patches on the protein surface is taking place. Otherwise,
like in this study where the protein surface is positively charged, stabilizing preferential
exclusion of the PEG molecules is taken place [274].
Surfactant: Finally surfactants, and in this group of excipients especially Tween20 and
Tween80 are commonly used, due to their ability to stabilize protein stability against freeze
stressinduced aggregation [90, 91]. In this study, 0.03 mM of Tween20 was chosen. The
chosen concentration was distinctly below the critical micelle concentration (CMC) of
0.57mM [275] to potentially prevent surface loss and aggregation [81]. Surfactants are
known to interact with the hydrophobic regions on the protein surface [81, 82, 276]. In
addition, surfactants are also known to prevent the unfolding of the protein on hydrophobic
surfaces such as airwater [80].
Initial state – FT c0
Using NaCl as an additive, the salt concentration influenced the phase behavior, the
aggregation kinetics, the crystal morphology, and the radius of lysozyme. Here we clearly
see the interplay of electrostatic and hydrophobic interactions. In short, at lower salt
concentrations, long-range repulsive electrostatic protein interactions are significant [158,
269]. These forces are reduced by the presence of salt ions and short-range attractive
forces become dominant, which results in aggregation [18, 199, 202, 203]. Consequently, at
low sNaCl concentrations (< 300mM), a salting-in (stabilizing) effect and at high NaCl
concentrations, a salting–out (destabilizing) effect was observed [74].
The salt concentration not only determined protein solubility but also influenced the crystal
morphology. The aggregation zone occurs adjacent to Cl I, representing the soluble zone.
This zone is often referred to as the labile or crystallization zone; here, the energy barrier
to create nuclei is overcome and crystal growth can occur [41]. As the appearance of Cl II
and Cl III corresponded to this zone, they showed similar crystal sizes but the growth time
differs.
For Cl III the growth time (tG) is smaller, however, this cluster was mainly seen for higher
lysozyme concentrations, thus a higher supersaturation [258] and as a consequence en-
hanced creation of critical nuclei [47, 208]. Higher supersaturation is assumed to correlate
to shorter growth time, which results of crystal growth to bigger sizes. Bigger crystals
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were not reached in the phase diagram, here, it is assumed that the concentration steps
of lysozyme and NaCl were too huge to reach this zone after Cl II and Cl III appeared.
Instead, the supersaturation was too high for supporting crystal growth but with increasing
salt concentrations and high protein concentrations, resulted in an increase in the amount
of crystals and a decrease in crystal size [186, 258, 259], corresponding to Cl IV and ClV,
see Table 7.1. At very high lysozyme and NaCl concentrations, the supersaturation reaches
a level where the growth of unstable polymorph crystals (sea urchin crystals) is promoted
[35, 191]. This morphology is represented partly by ClVI and mainly by ClVII.
When adding sucrose – representing the group of osmolytes – to the salt containing systems
at FT c0 a slightly higher lysozyme solubility was reached, whereas the size of the aggrega-
tion zone slightly decreased. Subsequently, a small stabilizing effect can be attributed, due
to the mentioned preferential exclusion of sucrose [67].
Regarding cluster positioning and occurrence, the transition to the soluble zone seems
unaltered, while the aggregation shape changed to smaller crystals (from Cl III to Cl IV)
at higher protein and medium NaCl concentrations, when sucrose was added. The super-
saturation level is high enough to create critical nuclei but due to preferential exclusion
of sucrose, the growth time (tG) is reduced, which results in a higher amount of small
crystals. In addition, at higher NaCl concentrations, the zone of ClVII is larger adding
sucrose to the formulations when compared to pure NaCl formulations. This might be
due to the higher viscosity of sucrose formulations in this region compared to pure NaCl
formulations. The viscosity of a 300mM sucrose solution (∼10w/w%) at 25℃ is 1.31mPas
which is higher than the viscosity of pure water at 25℃ of 0.89mPas [271]. Due to the
lower nucleation rate, high supersaturation in these formulations and the formation of
temporary LLPS, sea urchin crystals grow preferably in this region [35, 191].
Comparable to the addition of sucrose, we see an increase of Cl I (soluble region) when
adding glycerol. A higher viscosity of the formulation might also explain the increasing
amount of small crystal sizes at intermediate salt concentrations. The viscosity at25℃ of a
1000mM glycerol (∼9 w/w%) solution is slightly lower (1.15mPas) compared to a 300mM
sucrose formulation (1.31mPas) [271]. The cluster formation only differed in the high–salt
region compared to sucrose formulations. No sea urchins (ClVI or ClVII) appeared with
glycerol formulations, see Figure 7.2A, C 3. Glycerol seems to influence the nucleation rate
in this region. Nevertheless, due to the still very high nucleation rate micro crystals grow
(Cl IV).
PEG200 – representing the group of polymers – is known to be preferentially excluded.
However, according to the size of the aggregation zone, lysozyme solubility, and cluster for-
mation, no significant changes were observed compared to the pure NaCl formulations. In
the applied concentration (as compared to protein and salt concentration present) PEG200
is probably to low concentrated for non–stressed conditions to lead to a significant change.
Due to NaCl attractive protein–protein interactions occur, which can be shielded by the
PEG molecules. However, in this case it is assumed that the attractive protein–protein
interactions are too present and/or the PEG concentration is too low to stabilize lysozyme.
A higher PEG concentration or molecule weight is assumed to be more effective [84, 85].
Finally, the influence of surfactants was probed by adding Tween20. The protein phase
behavior was not changed significantly by the addition of Tween20, but the morphology
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and the protein solubility differ compared to pure NaCl formulations. The interaction of
Tween20 probably resulted in lower protein solubility, and the SL area showed smaller
values, see Figure 7.3B, due to the shifted equilibrium between monomer and aggregated
proteins towards aggregated proteins. The interaction of Tween20 with the hydrophobic
patches on the protein surface [81, 82, 276] might have resulted in a significant cluster
formation of ClV, indicating micro crystals. It can be assumed that, due to the interaction
of Tween20 on the protein surface, the formation of bigger tetragonal crystals is inhibited.
Finally, unfolding on hydrophobic water-air interfaces seems to be not a problem for
lysozyme in this study and subsequently, no stabilizing by Tween20 at FT c0 could be
observed.
FT cycle – FT c1 and FT c3
The unmet ability of the MPPD approach to visualize positioning (Figure 7.2A) and
occurrence (Figure 7.2B) of cluster transformation can also be seen in the development
of cluster during FT cycling. In general, all tested excipients had an impact on the
MPPD and the SL area compared to the pure NaCl formulations. In the following, the
potential mechanistic processes occurring (shielding attractive proteinprotein interactions,
preferential hydration, and the stabilization of the native state) and thus being the driver
behind the cluster transformations during FT cycling are discussed. For all tested excipients,
a reduction of Cl I is seen and can be linked to freeze concentration effects experienced
during FT cycling. Freeze concentration results in an increase of supersaturation, leading
to an increase in the concentration of all solutes, such as buffer components, excipient,
and proteins, due to the formation of ice crystals [35, 268]. This results in protein
aggregation [224, 249] and subsequently, the protein solubility is lowered due to the shifted
aggregate/monomer equilibrium towards aggregates, which was observed with the solubility
lines, see Figure 7.3B. In addition to the effect of freeze concentration, the decrease in Cl I
can also be attributed to the repetition of the FT stress effects as such. In combination,
next to freeze concentration [35, 268], temperature–induced LLPS [35, 140, 150] and
denaturation on the water–ice interface [90, 109] might take place. Among these effects,
however, denaturation on the water–ice interface can be excluded, at least for the measured
samples, due to the shown similarity of the FTIR spectra to those of FT c0 (Figure 7.5).
A cluster transformation towards a higher portion of Cl IV and shift towards lower salt
concentrations was shown for NaCl formulation (and all other systems discussed below),
when FT stress was applied, see Figure 7.2. This indicates a change to more and smaller
crystals, pointing towards a freeze concentration effect. The nucleation rate of crystals
depends on the degree of supersaturation (Mullin, 1992). Due to freeze concentration, the
supersaturation is increased and consequently, the nucleation rate is increased as well. For
pure NaCl systems, above 1.82M mainly ClVI and ClVII appeared, indicating a shift to
sea urchin crystals. It can be assumed that the initial viscosity in these formulations (due to
temperature [138] and protein concentration) was very high leading to a lower diffusion rate,
which in return results in a lower nucleation rate [264]. Next to the lower nucleation rate,
high supersaturation, as well as temporary LLPS, is another prerequisite for the growth of
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sea urchin crystals [35, 191]. The application of FT stress to sucrose formulations resulted in
an overall lower decrease in protein solubility. Thus, the known effectiveness of sucrose as a
cryoprotectant could be confirmed with these observations [88, 89]. The dominating cluster
formation of ClV and ClVI and spread towards lower excipient concentrations mimics
the above stated line of argumentation, namely an increase in the nucleation rate due to
freeze concentration [35, 191, 270]. For glycerol containing systems, FT stress application
resulted in a smaller occurrence of Cl I and a decrease in solubility, but less significant
than for NaCl formulations, see Figure 7.2B and Figure 7.3B. Subsequently, glycerol was
- as expected - able to stabilize lysozyme regarding FT stress. The intermediate cluster
transition from small (Cl IV) to bigger (Cl II) crystals seen for FT c1 took place at protein
concentrations below 2mg/mL lysozyme. This might be an indication for a situation where
FT stress is no yet the dominating factor and the addition of glycerol resulted in slower
aggregation kinetics and larger crystals [164]. When performing the FT cycles three times
the observed cluster formation of ClVI and its positioning resembled the above-described
dominant situation. PEG200 showed no stabilizing effect, seen in the decrease of Cl I,
compared to the NaCl formulations. Overall, as found for the other systems, the scheme
of a dominant growth of Cl IV is seen and due to the above-described combination of FT
stress. The systems containing Tween20 already started with a dominating ClV. With an
increase in FT stress, a clear decrease in Cl I was observed pointing towards the inability of
the current formulation to act as stabilizing formulation under the given conditions. This
is underlined by the most dominant appearance of Cl IV during FT cycling over the whole
aggregation zone.
Overall, the highest values of the calculated SL area were reached with the osmolytes
tested (sucrose and glycerol) due to preferential hydration of the surface and minimized
protein–protein interactions. The smaller the proteinprotein interactions, the higher the
solubility [164, 165]. Consequently, sucrose and glycerol are the excipients that were able
to stabilize lysozyme the most regarding solubility and size of the solubility zone during
FT cycling. PEG did not change stability significantly. For all systems investigated the
addition of Tween20 led to destabilization when compared to pure NaCl containing systems,
which is probably due to the applied concentration.newline
Heat cycle - FT c1 h and FT c3 h
When applying heat cycling after FT cycling a clear cluster transformation and thus
reversibility of already formed aggregates resulting in a decrease of Cl IV and increase in
Cl I as well as an increase in protein solubility (Figure 7.3) is seen. This clearly shows that
heat cycling might be applied to exploit the reversibility of aggregates formed during FT
cycling but also during general processing, i.e. other unit operations creating aggregates. In
general, mainly Cl IV areas transformed back to Cl I, but also Cl II and Cl III. In common
to these clusters is either no tonset for Cl I (fully soluble area) or tonset > t0 for Cl II and
Cl III, whereas the other clusters (Cl IV ClVII) showed aggregates from the beginning
when the plates were pictured the first time tonset = t0. The heat–induced reversibility
is assumed to lead to a reset of the reversible systems and new arrangement of crystals
independent of and undisturbed by stress resulting from FT or heat cycling.
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7.5. Conclusion
A potential cause for a reset of systems in this study mainly systems lying in the metastable
zone containing reversible aggregates by heat cycling might be that the applied heat/energy
input was high enough to loosen proteinprotein interactions (only weak noncovalent protein
interactions) [25], but also low enough not to induce heat aggregation and/or unfolding
(Wang et al., 2010). In this context, it is assumed that aggregates in the lower supersat-
urated region (adjacent to Cl I) created weak proteinprotein interactions and therefore
those are able to dissolve by heat [25], and consequently the same clusters are created than
without FT stress or heat.
The good reversibility found for the osmolyte systems containing sucrose or glycerol is as-
sumed to relate to weak proteinprotein interactions [25, 138] and thus potentially reversible,
due to the preferential hydration of the protein surface supported by the excipients.
Also for the PEG200 systems, heat–induced reversibility was observed. However, the effect
was found not as significant as for NaCl formulations. In contrary, PEG200 molecules
seemed to stabilize the aggregates, which occurred due to the FT stress. The reason
for this might be based on the overall higher polymer concentrations in solution due to
freeze concentration, resulting in a displacement of the PEG molecules from between the
protein molecules instead of steric stabilization [277]. Hence, the restructuring of the
PEG molecules seems to be not completely reversible. For Tween20 formulations, the
heat cycle only influences the occurrence of Cl I and the overall protein solubility. The
protein solubility could be completely reversed by heat (Figure 7.2B). The occurrence of
Cl I, representing the soluble zone, was not completely reversed to the size observed at
FT c0, but most of the FT stress–induced aggregates dissolved when heat was applied, see
Figure 7.2B.
In summary, the best performance (increase of Cl 1) in the heat–induced reversibility
showed glycerol containing systems. The follow–up systems were sucrose, pure NaCl and
the Tween20 systems (the latter showing a reduced reversibility for increasing FT cycling).
The lowest effect on heat–induced reversibility was seen for the PEG200 containing systems.
7.5. Conclusion
In this study, the effects of instabilities induced by FT stress (up to three cycles) and
the reversibility of those instabilities induced by heat on the long–term (MPPD,SL) and
short–term protein stability (size and structure) were investigated using lysozyme as an
exemplary protein. It was shown that a re-set of areas consisting of reversible aggregates
could be reached by heat cycling. This led to a resolution of reversible aggregates. The
influence of different well–known cryoprotectants (sucrose, glycerol, PEG200 and Tween20)
showed, that the degree of instabilities and reversibility of aggregates was formulations
dependent. The effects of FT induced instabilities and their reversibility by heat–cycling,
depending on the different formulations can be summed up as follows: The addition
of sucrose and glycerol resulted in the best performance as cryoprotectant. Regarding
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aggregate reversibility (increase in Cl I) glycerol performed best, followed by sucrose, NaCl
and Tween. Finally, the use of MPPD to study the complexity and interplay of different
formulations and processing situations showed to be excellent in terms of data visualization.
In future work, the influence of heat cycling on reversible aggregation will be investigated.
Furthermore, different formulation parameters like pH value, salts, cryoprotectants, and
buffer systems need to be investigated. The transfer to other protein molecules and also to
highly concentrated protein formulations is mandatory for applications in industry. Finally,
the addition of a heat cycle might be an effective tool to minimize instabilities throughout
general processing.
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8. Conclusion and Outlook
A phase diagram–based method was developed which allows the investigation of FT stress–
induced protein instabilities. For the developed method only a small sample volume (max.
30µL) for each condition is needed, and HTS (96–well) is possible. Combined with the
phase diagrams, the developed method is simple, cheap, and time–saving. The huge flexibil-
ity while creating phase diagrams allowed a screening of different formulation parameters,
like different protein and salt concentrations, buffer systems, pH values, and additives
(salts and cryoprotectants). The basic created phase diagram contained formulations with
lysozyme from chicken egg white and sodium chloride. While varying their concentration a
phase transition with different phase states, as soluble, crystal, and precipitate, appeared.
Changes within these phase states, varying crystal morphologies and different protein
solubilities, which were determined by supernatant concentration measurements, were
identified to be sensitive parameters to rate FT stress–induced instabilities. All the named
formulation parameters showed an influence on the phase behavior and result in a different
degree of FT stress sensitivity. In addition, while handling the phase diagram the FT
process parameters can be varied before the plates are placed in an incubation chamber for
40 days to investigate the long–term protein stability. Here, the influence of the number of
FT cycles and different freezing/thawing ramps were investigated. The more FT cycles
are applied to the formulations, the more instabilities were rated. Furthermore, the choice
of the freezing rate was found to be more critical than the choice of the thawing rate
for formulations with lysozyme. In addition, the faster the freezing/thawing rate was
chosen, the less instabilities were induced due to the fact that probably not the water–ice
interface but the overall process time was the destabilizing factor. After the method
development and verification, the method was extended to be able to also detect system
parameters and create even more knowledge about the freezing/thawing process. Therefore,
images of the phase diagrams were recorded during freezing/thawing. The images were
evaluated regarding their turbidity changes, which indicates Tcloud. A high sensitivity
and robustness of this method extension was validated and a partial correlation of the
short–term parameter Tcloud and long–term protein stability was determined. In addi-
tion, the reversibility of FT stress–induced protein instabilities as a function of different
cryoprotectants was investigated. Dependent on the cryoprotectant, stabilization during
freezing and thawing and reversibility by heat treatment was possible. For the degree of
reversibility the type of the created aggregates might be critical. In addition, a correlation
of short–term parameters (size and structure) of soluble formulations to long–term protein
stability was strived. However, neither the size nor the protein structure were influenced
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by the amount of FT stress, the addition of cryoprotectants, or the applied heat and a
correlation to long–term stability was not possible.
In summary, the developed method enables a simple HT screening of small volumes of for-
mulation and process parameters during freezing/thawing. Here, the crystal morphology is
one of the main evaluation parameters. Subsequently, for proteins which do not crystallize,
the method has to be developed further and another sensitive evaluation parameter has to
be figured out. Then the transfer to biopharmaceutical proteins is easy and straight forward.
Furthermore, the investigation of other process parameters like the storage temperature and
its correlation to Tg, measured with e.g. DSC, might enable an even better understanding
of the impact of freezing/thawing on proteins. Here, the sensitivity of Tg to formulation
changes and/or process parameters might clarify and simplify the challenge regarding the
choice of the storage temperature to be economically but still low enough to guarantee
long–term protein stability. Within all the generation of the data and the influences of
different parameters, the data handling, like visualization of effects, and the correlation of
these parameters, has to be improved to identify all correlations. Here, the combination
with protein characteristics to each other, e.g. protein structure, protein surface charge
distribution, the pI of the protein, or the protein size, might be a successful step towards
the prediction of protein long–term stability in combination with their stability during
freezing and thawing. This would simplify the development of the freezing/thawing step
and would save time, expenses, and would lower the loss of protein functionality. To also
save product, needed for such developments, a correlation of small volumes (µL) to large
volumes (L) is needed. The volume is known to be one of the critical parameters, due to
the appearance of ice fronts within the bulk. This is strongly dependent on the geometry
of the freezer. To investigate these effects and successfully scale–up/–down the process
parameters, e.g. the FT ramp, and the degree of supercooling have to be the same due to
their impact on the protein stability.
In general, freezing and thawing is applied within nearly all production processes of biophar-
maceutical proteins. The detailed knowledge about this step is lacking and production loss
was an increasing problem in the last years. This work developed a method to investigate
the parameters affecting protein stability in a simple, cheap (low sample volume), and
time–saving way (HT format). However, the method has to be further enhanced to be
able to deepen the knowledge about freezing and thawing in general, but specifically about
the correlation between the protein stability and the formulation, system, and process
parameters even more. With this knowledge the research and development of a FT step
for the production of biopharmaceutical proteins might be significantly enhanced, and the
adaptation to changing formulation parameters would be simplified.
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A. Abbreviations and Symbols
Abbreviations
CMC critical micelle concentration
DLS dynamic light scattering
DSC differential scanning calorimetry
DSP downstream process
FT freeze/thaw
FTIR Fourier transform infrared spectroscopy
HT high–throughput
HTS high–throughput screening
IQR interquartile range
IS ionic strength
LLPS liquid–liquid phase separation
MAD median absolute deviation
MCB multi–component buffer
MPPD multidimensional protein phase diagram
MSE mean squared error
PCC Pearson correlation coefficient
PEG polyethylen glycol
PES polyethersulfone
pI isoelectric point
SEC size exclusion chromatography
SI stability index
SL solubility lines
TOA thermo–optical analysis
USP upstream process
UV ultraviolet
Symbols
A variable parameter
cprotein protein concentration
csalt salt concentration
cx cycle number (x = 0, 1, 3, 5)
Dt diffusion coefficient
η viscosity
G gibbs free energy
G∗ critical gibbs free energy
Γ decay rate
γ interfacial free energy
kb Boltzmann constant
LC crystal length
n total number of data points
nAgg percentage of aggregation well coverage
ν molar volume
q wave vector
r radius
r∗ critical nucleus radius
R0 variable parameter
RH hydrodynamic radius
Ry ramp(y = 1-15)
S enthropy
S0 theoretical protein solubility
Ssat supersaturation
Ssol protein solubility
T temperature
t0 start point
tonset aggregation growth onset time
tE aggregation cessation time
tG growth time
TCE clouding end temperature
Tcloud cloud point
TCO clouding onset temperature
TDE declouding end temperature
TDO declouding onset temperature
Teu eutectic point
Tg glass transition temperature
WC crystal width
y raw value
yˆi literature data
ymax maximum value
ymin minimum value
y scaled value

B. Supplementary Material
B.1. Analysis of phase behavior and morphology during
freeze-thaw applications of lysozyme
Table B.1.: Parameters and coefficients used for correlation of experimental data to Eq. (1)
in the manuscript for creating the solubility lines.
pH buffer systems cycle S0 A R0 R2
3
Citrate
0 0.7203 55.9489 3.2210 0.9958
1 0.7436 59.5678 3.3186 0.9989
3 0.8653 87.9429 4.5668 0,9934
5 0.8726 90.7610 4.4721 0.9922
MCB
0 0.8122 92.394 3.6183 0.9977
1 0.8045 50.7459 3.5686 0.9954
3 0.7362 33.0881 3.1105 0.9977
5 0.7585 53.7530 3.5621 0.9977
MCBIS
0 0.6125 35.3575 2.9458 0.9975
1 - - - -
3 - - - -
5 - - - -
5
Acetate
0 1.5391 42.3201 2.4778 0.9338
1 0.9208 13.0441 1.3040 0.9685
3 1.1361 18.1945 1.7710 0.9728
5 1.7836 59.3601 3.0552 0.9701
MCB
0 2.3471 58.1755 3.2288 0.9637
1 2.1266 29.9694 2.5820 0.9800
3 2.2411 77.4003 4.0093 0.9964
5 2.0560 49.9577 3.3660 0.9976
MCBIS
0 2.5607 56.1989 2.7339 0.9790
1 2.9398 62.0308 4.3738 0.9900
3 2.6542 52.8444 4.4027 0.9957
5 2.5168 42.6943 4.0984 0.9948
B.2. A phase diagram based toolbox to assess the impact of
freeze/thaw ramps on the phase behavior of proteins
Figure B.1.: Exemplary Temperature-Time-Profile of Ramp3. The blue line represents the
actual temperature at the sample and the red line represents the temperature profile which is
adjusted.
Figure B.2.: An overview of the solubility lines at FT c1 is shown. A Freezing speed; B
Changing speed at different temperature while freezing; C Thawing speed; D Changing speed
at different temperature while thawing; E Combinations fast; F Combinations slow
Figure B.3.: An overview of the solubility lines at FT c3 is shown. A Freezing speed; B
Changing speed at different temperature while freezing; C Thawing speed; D Changing speed
at different temperature while thawing; E Combinations fast; F Combinations slow
B.3. Apparent cloud point temperature determination
using a low volume high-throughput cryogenic device
in combination with automated imaging
B.3.1. Data evaluation
This section of the Supplementary Material shows more information on the image processing
steps as well as the extraction of temperatures of interest, which was used for all studies
presented in this work.
Image processing
An image processing workflow was designed to extract the total intensity difference between
the first image and all images captured over time. This image processing workflow is shown
in FigureB.4.
Figure B.4.: Overview of image processing steps. (1) The raw GoPro Hero4 image is cropped
into separate wells, (2) cropping is repeated for each time point, (3) the t0 image is subtracted
from each time point image, for each well, and (4) the intensity per image resulting from the
subtraction is summed up and plotted over time. The experimental data (black dot) is then
fitted (red line).
B.3.2. Robustness study
Temperature rates
Three different temperature rate combinations were employed in the robustness study.
The set temperature values, the measured temperature values, and the absolute difference
between these two temperatures, is plotted in FigureB.5. FigureB.5 shows an increasing
deviation of the set temperature compared to the measured temperature for increasing
freezing rates and thawing rates, represented by an increase of the MSE from 0.01 to
Figure B.5.: Overview of the set (black dotted line) and measured (black solid line) tempera-
tures during the cloud point measurement at three different temperature rate combinations.
(a) Freezing rate of 0.5℃/min in combination with a thawing rate of 0.5℃/min, (b) freezing
rate of 2.5℃/min in combination with a thawing rate of 2.5℃/min, and (c) freezing rate of
10.0℃/min in combination with a thawing rate of 2.5℃/min. The difference between the set
and measured temperature is shown as a grey solid line. The mean squared error (MSE; ℃2)
between the set and measured temperature is given in the text box.
14.85 when comparing the slowest freezing and thawing rate (FigureB.5 a; 0.5℃/min for
each) and the fastest freezing and thawing rate (FigureB.5 c; 10.0℃/min and 2.5℃/min,
respectively). The high MSE value for the fastest freezing and thawing is a result of a
higher measured temperature during freezing and a lower temperature during thawing.
Figure S3b shows an MSE of 2.25 for a freezing and thawing rate of 2.5℃/min, where
the set temperature deviates most during thawing. In FigureB.5 b it is observed that the
measured temperature is lower than the set temperature. A similar effect during thawing
at 2.5℃/min is observed for FigureB.5 c.
Position sensitivity
Intensity
The influence of the well position was also evaluated for the intensity that could be detected
for TCE and TDO This was also extracted from the data obtained with the robustness study.
This was evaluated as location specific trends could indicate uneven lighting or issues
due to the fisheye lens of the GoPro Hero4 camera. The results are shown in FigureB.6.
FigureB.6 shows a difference in intensity between the upper half of the plate (row B to D)
and the bottom half of the plate (row E to G), where a lower intensity is seen for the upper
half of the plate. This is consistent for all three freezing and thawing rate combinations.
As mentioned before, this may be due to the primitive lighting setup or the use of a GoPro
Hero4 fish eye lens. In order to determine whether the intensity difference influences the
results, the cloud end temperature was assessed as a function of the well position too.
Figure B.6.: Total intensity obtained at the clouding end temperature (TCE ; a, c, and e) and
declouding onset temperature (TDO; b, d, and f) for three different freezing and thawing rate
combinations. (1) freezing rate of 0.5℃/min in combination with a thawing rate of 0.5℃/min
(a and b), (2) freezing rate of 2.5℃/min in combination with a thawing rate of 2.5℃/min (c
and d), and (3) freezing rate of 10.0℃/min in combination with a thawing rate of 2.5℃/min
(e and f). Intensity values are shown per plate row (y-axis) and plate column (x-axis).
Cloud end temperature
The influence of the well position on the multi–well plate on the extraction of TCE for
each well was evaluated with the data generated for the robustness study. FigureB.7
shows TCE heat maps for each of the employed freezing and thawing rate combinations,
using the standard 96–well plate orientation. FigureB.7 shows no influence of the well
position regarding the measurement of TCE . FigureB.7 b shows two deviating TCE values
at position D5 and D6, compared to the rest of the data in FigureB.7 b. FigureB.7 c
Figure B.7.: TCE ; ℃) for 60 replicate samples obtained with three freezing and thawing rate
combinations, shown per plate row (y-axis) and plate column (x-axis). (a) Freezing rate of
0.5℃/min in combination with a thawing rate of 0.5℃/min, (b) freezing rate of 2.5℃/min
in combination with a thawing rate of 2.5℃/min, and (c) freezing rate of 10.0℃/min in
combination with a thawing rate of 2.5℃/min.
shows one deviating TCE value for well C8, compared to the rest of the TCE values in
FigureB.7 c. These three deviations were considered outliers and not a result of measure-
ment bias towards the position of the well, as the outlier position is not similar for each plate.
B.3.3. Validation study
Freezing and thawing rate
The difference between the set and measured temperature during the validation study is
shown in FigureB.8.
FigureB.8 shows a MSE of 0.004, which indicates a low difference between the set and
measured temperature during the validation study.
Position sensitivity
To determine whether there was an influence of the well positions during the validation
study, the TCE per replicate sample is shown in FigureB.9.
FigureB.9 shows an increase in TCE for increasing pH values. This is a reproducible trend
as it is observed for each of the replicates of the samples. Two outliers can be identified
at pH5.8 and pH6.5 for replicate number 6. These outliers were not removed during the
calculations as descriptive statistics such as the median and MAD are less sensitive to
outliers than the mean value and the standard deviation. FigureB.9 shows no influence of
the well position on the extraction of TCE .
Figure B.8.: Overview of the set (black dotted line) and measured (black solid line) tempera-
tures during the cloud point measurement, employing a freezing and thawing rate of 0.1℃/min
during the validation study. The difference between the set and measured temperature is
shown as a grey solid line. The mean squared error (MSE; ℃2) between the set and measured
temperature is given in the text box.
Figure B.9.: Clouding end temperature (TCE ; ℃) for all validation samples, shown per
replicate (y–axis) and pH (x–axis). TCE values were extracted from raw data obtained during
the validation study.
Absolute literature comparison
The exact absolute temperature values estimated from literature graphs [151] and obtained
with the proposed experimental setup are listed in TableB.2.
TableB.2 is solely added to present the absolute values, interpretation of the results is
discussed in the main text and therefore considered redundant in this section.
Table B.2.: List of temperature values per pH, where literature values were obtained from
[151] and experimental data is given as median ± median absolute deviation based on six
replicate measurements.
pH Literature [℃] Experimental [℃]
5.8 -6.5 -19.4 ± 0.3
6.0 -5.9 -17.4 ± 0.2
6.3 -4.9 -14.9 ± 0.0
6.5 -4.2 -13.0 ± 0.2
6.8 -2.9 -11.3 ± 0.0
7.2 -2.1 -9.0 ± 0.2
7.4 -1.4 -7.8 ± 0.1
7.8 -0.6 -5.6 ± 0.1
Moving mean
FigureB.10 shows an example of the validation data smoothing by means of a moving
mean window of 100.
Figure B.10.: Exemplary plot of raw data (black dot) and the data smoothed with a moving
mean window of 100 (red line) during the validation study, where the intensity difference
(y–axis) is plotted over time (x–axis; seconds).
B.3.4. Case study
Solubility Line
Supernatant lysozyme concentration measurements were performed to determine the
solubility line of different formulations. In order to do so, the supernatant lysozyme
concentration of all formulations that showed a phase transition in the respective phase
diagrams was measured. It was performed like described by Galm et.al [164]. The resulting
solubility lines are shown in FigureB.11.
Figure B.11.: Lysozyme solubility for varying concentration (y-axisl g/L) and ionic strength
(x-axis; mM). Solubility lines are shown for sodium chloride (NaCl) and ammonium chloride
(NH4Cl), without being subjected to a freeze and thaw run (no FT) and after a freeze and
thaw run (FT).
Average MPPD cluster values
TableB.3 lists the absolute image-based feature values for each of the clusters (I-VI) found
for the average MPPD.
TableB.3 shows the absolute vales for the crystal length (LC), variation in crystal width
(MWC), variation in crystal length (MLC), aggregation abundancy (nAgg), aggregation
growth time (tG), aggregation onset time (t0), and crystal width (WC). These values cor-
respond to the MPPDs in Figure 6.4, presented and discussed in Section 6.3.3 (Long–term
protein stability).
Table B.3.: Overview of median ± MAD image-based feature values. The values are listed
per cluster identified in the average MPPD.
I II III IV V VI
LC [µm] 0 ± 0 271 ± 67 424 ± 138 340 ± 124 44 ± 53 35 ± 25
WC [µm] 0 ± 0 157 ± 67 295 ± 99 219 ± 84 36 ± 32 26 ± 18
t0 [hours] 0 ± 0 301 ± 61 273 ± 135 0 ± 0 424 ± 104 0 ± 0
tG [hours] 0 ± 0 553 ± 173 660 ± 116 534 ± 341 536 ± 104 296 ± 101
nAgg [%] 0 ± 0 5 ± 4 8 ± 4 23 ± 15 79 ± 19 95 ± 4
MLC [µm] 0 ± 0 185 ± 61 371 ± 86 98 ± 84 16 ± 20 6 ± 6
MWC [µm] 0 ± 0 130 ± 73 253 ± 58 84 ± 81 8 ± 9 4 ± 3
Example cluster images
Each of the clusters found for the construction of the MPPD using the average long-term
stability data, represents a group of formulations that have similar morphologic and kinetic
features. An example visible light, cross polarized light, and UV light for each of the
clusters is shown in FigureB.12.
Figure B.12.: Exemplary images for the six MPPD clusters (first column) obtained with
the average image-based data (legend). Three different light sources are shown: (1) visible
light (second column), (2) cross polarized (pol.) light (third column), and (3) UV light (fourth
column).
Cloud end temperature per plate
FigureB.13 shows the TCE for each salt and each plate per well, in order to represent the
reproducibility of the TCE obtained during the case study.
Figure B.13.: Cloud end temperature (TCE ; ℃) for sodium chloride (NaCl; a and b), sodium
sulfate (Na2SO4; c and d), ammonium chloride (NH4Cl; e and f), and ammonium sulfate
((NH4)2SO4; g and h), under varying lysozyme concentrations (y–axis; g/L) and ionic strength
(x–axis; mM). Duplicate plates are shown (major grid columns).
Multidimensional protein phase diagrams per plate
To determine the reproducibility of the long–term stability storage results, all plates were
stored in duplicate. The resulting MPPD is shown in FigureB.14. FigureB.14 indicates the
reproducibility of the long-term storage in terms of observed aggregation morphology and
aggregation kinetics. This is shown by the identification of similar MPPD Clusters for the
duplicate plates, thus similar morphology and kinetics for duplicate conditions. A difference
is observed for Plate 1 and Plate 2 for ammonium chloride, where cluster IV is identified
for Plate 1 and cluster I for Plate 2. This was attributed to dried-up wells in Plate 1 for
ammonium chloride conditions, which significantly affected the extracted morphology and
kinetic data. Therefore, only Plate 2 data was used during the construction of the averages
MPPD, which is presented in the main text.
TableB.4 lists the absolute image-based feature values for each of the clusters (I-V) found
for the MPPD constructed for all plates separately, presented in FigureB.14.
TableB.4 shows the absolute vales for the crystal length (LC), variation in crystal width
Table B.4.: Overview of median ± MAD image-based feature values. The values are listed
per cluster identified in the separate MPPD.
I II III IV V
LC [µm] 0 ± 0 696 ± 202 315 ± 100 496 ±ś 250 38 ± 26
WC [µm] 0 ± 0 433 ± 128 184 ± 112 200 ± 101 28 ± 19
t0 [hours] 0 ± 0 252 ± 374 0 ± 0 0 ± 0 0 ± 0
tG [hours] 0 ± 0 628 ± 137 582 ± 201 262 ± 726 301 ± 137
nAgg [%] 0 ± 0 5 ± 0 15 ± 7 90 ± 7 95 ± 5
MLC [µm] 0 ± 0 471 ± 141 99 ± 92 635 ± 112 9 ± 9
MWC [µm] 0 ± 0 306 ± 127 78 ± 73 334 ± 147 8 ± 7
(MWC), variation in crystal length (MLC), aggregation abundancy (nAgg), aggregation
growth time (tG), aggregation onset time (t0), and crystal width (WC).
Figure B.14.: (a) MPPD for four different salts (grid rows) and with or without freezing
and thawing (major grid columns) for duplicate plates (grid columns), as well as varying
lysozyme concentrations (y–axis; g/L) and ionic strength (x-axis; mM). Applied salts are
sodium chloride (NaCl), sodium sulfate (NaSO4), ammonium chloride (NH4Cl), and ammonium
sulfate ((NH4)2SO4). Five clusters were identified and visualized in the MPPD using the mean
cluster color and cluster number similar to the radar charts shown in (b). The cluster regions
are highlighted in the MPPD with a dashed line to guide the eye. (b) Radar charts representing
the normalized median values of each image feature with a color surface. The dotted line in
the radar chart represents the median absolute deviation within each cluster for each image
feature. The following image-based features are displayed per cluster: median crystal length
(LC), IQR of the crystal width (MWC), IQR of the crystal length (MLC), aggregation well
coverage (nAgg), aggregation growth time (tG), aggregation onset time (t0), and median crystal
width (WC). Absolute cluster values can be found in Supplementary TableB.4.
B.4. Investigation of the reversibility of freeze/thaw
stress-induced instability using heat cycling as a
function of different cryoprotectants
B.4.1. MPPD construction
Scatterplot
FigureB.15 shows the position of all 2400 conditions regarding the RGB color code.
Figure B.15.: The position of all 2400 tested conditions regarding the RGB color code after
clustering, in 3D (A) and 2D (B). Grey represents Cluster I, dark brown Cluster II, brown
Cluster III, orange Cluster IV, green ClusterV, dark green ClusterVI, and blue ClusterVIII.
B.4.2. Analytic
DLS data
The DLS data shown in Figure 7.4 in the manuscript are shown with the respective deviation
from the triplicate measurements in FigureB.16.
Figure B.16.: The DLS data plotted with the respective deviations for 21mg/mL (top) and
18mg/mL (bottom) lysozyme. The radius in nm is plotted over the NaCl concentration in M.
All 153 conditions are plotted which performed different stress protocols.
